|
Product Number |
Product |
quantity |
Price () |
|
|
|
|
|
|
20001-1 |
Bovine Serum Control IgG (non-immune) purified |
1 mg |
135 |
|
20001-2-1 |
Bovine (non-immune) Serum IgM, purified |
0.5 mg |
239 |
|
20003-1 |
Hamster (Syrian) Serum IgG (non-immune), purified |
1 mg |
135 |
|
20003-1AH |
Hamster (Armenian) Serum IgG, purified |
1 mg |
278 |
|
20003-2-1 |
Hamster (Syrian, non-immune) Serum IgM, purified |
0.5 mg |
239 |
|
20004-1 |
G. Pig Serum IgG (non-immune), purified |
1 mg |
135 |
|
20004-2-1 |
G. Pig (non-immune) Serum IgM, purified |
0.5 mg |
239 |
|
20005-1 |
Rat Serum IgG (non-immune), purified |
1 mg |
135 |
|
20005-10 |
Rat Serum IgG (non-immune), purified |
10 mg |
434 |
|
20005-1-FAB |
Rat IgG Fab fragment, purified |
1 mg |
174 |
|
20005-1-FAB2 |
Rat IgG F(ab')2 fragment, purified |
1 mg |
174 |
|
20005-1-FC |
Rat IgG (Fc) fragment, purified |
0.5 mg |
265 |
|
20005-2-1 |
Rat Serum IgM (non-immune),purified |
0.5 mg |
200 |
|
20005-5 |
Rat Serum IgG (non-immune), purified |
5 mg |
304 |
|
20006-1 |
Sheep (non-immune) Serum IgG, purified |
1 mg |
135 |
|
20006-2 |
Sheep (non-immune) control Serum IgM purified |
1 mg |
304 |
|
20006-3 |
Sheep (non-immune) control Serum IgA purified |
100 ug |
304 |
|
20007-1-1 |
Human (non-immune) Serum IgG, purified |
1 mg |
135 |
|
20007-1-100 |
Human (non-immune) Serum IgG, purified |
100 mg |
954 |
|
20007-1-25 |
Human (non-immune) Serum IgG, purified |
25 mg |
694 |
|
20007-1-5 |
Human (non-immune) Serum IgG, purified |
5 mg |
304 |
|
20007-1-FAB |
Human IgG Fab fragment, purified |
1 mg |
174 |
|
20007-1-FAB2 |
Human IgG F(ab')2 fragment, purified |
1 mg |
174 |
|
20007-1-FC |
Human IgG (Fc) fragment, purified |
1 mg |
219 |
|
20007-2 |
Human (non-immune) Serum IgM, purified |
1 mg |
174 |
|
20007-2-10 |
Human (non-immune) Serum IgM purified |
10 mg |
954 |
|
20007-2-5 |
Human (non-immune) Serum IgM purified |
5 mg |
564 |
|
20007-2-FC5M |
Human IgM Fc5u fragment, purified |
100 ug |
174 |
|
20007-3 |
Human IgE (myeloma, Kappa), purified |
100 ug |
434 |
|
20007-3-1000 |
Human IgE (myeloma, Kappa), purified |
1000 ug |
3.170 |
|
20007-3P |
Human IgE (Plasma), purified |
50 ug |
434 |
|
20007-4 |
Human IgM Fab mu fragment (myeloma), purified |
1 mg |
239 |
|
20007-5-1 |
Human (non-immune) IgA purified |
1 mg |
174 |
|
20007-5-5 |
Human (non-immune) IgA purified |
5 mg |
629 |
|
20007-6-100 |
Human IgA1 (myeloma) purified |
100 ug |
174 |
|
20007-6-500 |
Human IgA1 (myeloma) purified |
500 ug |
499 |
|
20007-7-100 |
Human IgA2 (myeloma) purified |
100 ug |
174 |
|
20007-7-500 |
Human IgA2 (myeloma) purified |
500 ug |
499 |
|
20007-F100 |
Human Serum IgG-Fc fragment purified |
100 ug |
148 |
|
20007-F1000 |
Human Serum IgG-Fc fragment purified |
1 mg |
369 |
|
20008-1 |
Mouse (non-immune) Serum IgG, purified |
1 mg |
135 |
|
20008-100 |
Mouse (non-immune) Serum IgG, purified |
100 mg |
635 |
|
20008-1-FAB |
Mouse IgG Fab fragment, purified |
1 mg |
174 |
|
20008-1-FAB2 |
Mouse IgG F(ab')2 fragment, purified |
1 mg |
174 |
|
20008-1-FC |
Mouse IgG (Fc) fragment, purified |
0.5 mg |
265 |
|
20008-2 |
Mouse (non-immune) Serum IgM, purified |
100 ug |
148 |
|
20008-25 |
Mouse (non-immune) Serum IgG, purified |
25 mg |
499 |
|
20008-5 |
Mouse (non-immune) Serum IgG, purified |
5 mg |
304 |
|
20009-1 |
Rabbit (non-immune) Serum IgG, purified |
1 mg |
135 |
|
20009-1-FAB |
Rabbit IgG Fab fragment, purified |
1 mg |
174 |
|
20009-1-FAB2 |
Rabbit IgG F(ab')2 fragment, purified |
1 mg |
174 |
|
20009-1-FC |
Rabbit IgG (Fc) fragment, purified |
0.5 mg |
265 |
|
20009-2-1 |
Rabbit (non-immune) Serum IgM, purified |
0.5 mg |
239 |
|
20009-25 |
Rabbit (non-immune) Serum IgG, purified |
25 mg |
499 |
|
20009-5 |
Rabbit (non-immune) Serum IgG, purified |
5 mg |
304 |
|
20009-BT-1 |
Rabbit (non-immune) Serum IgG-biotinylated |
1 mg |
174 |
|
20010-1 |
Chicken (non-immune) IgG, purified |
1 mg |
135 |
|
20010-2-1 |
Chicken (non-immune) Serum IgM, purified |
0.5 mg |
239 |
|
20010-5 |
Chicken (non-immune) IgG, purified |
5 mg |
239 |
|
20011-1 |
Goat (non-immune) Serum IgG, purified |
1 mg |
135 |
|
20011-1-FAB |
Goat IgG Fab fragment, purified |
1 mg |
174 |
|
20011-1-FAB2 |
Goat IgG F(ab')2 fragment, purified |
1 mg |
174 |
|
20011-1-FC |
Goat IgG (Fc) fragment, purified |
0.5 mg |
265 |
|
20011-2-1 |
Goat (non-immune) Serum IgM, purified |
1 mg |
239 |
|
20011-25 |
Goat (non-immune) Serum IgG, purified |
25 mg |
499 |
|
20011-5 |
Goat (non-immune) Serum IgG, purified |
5 mg |
304 |
|
20012-1 |
Monkey Serum IgG (Rhesus, non-immune), purified |
1 mg |
213 |
|
20012-10 |
Monkey Serum IgG (Rhesus, non-immune), purified |
10 mg |
954 |
|
20013-1 |
Monkey Serum IgM (Rhesus, non-immune), purified |
100 ug |
174 |
|
20015-1 |
Donkey (non-immune) Serum IgG, purified |
1 mg |
135 |
|
20015-10 |
Donkey (non-immune) Serum IgG, purified |
10 mg |
304 |
|
20016-1 |
Dog (non-immune) Serum IgG, purified |
1 mg |
135 |
|
20016-1-FAB |
Dog IgG Fab fragment, purified |
1 mg |
174 |
|
20016-1-FAB2 |
Dog IgG F(ab')2 fragment, purified |
1 mg |
174 |
|
20016-1-FC |
Dog IgG (Fc) fragment, purified |
0.5 mg |
265 |
|
20016-2-1 |
Dog (non-immune) Serum IgM, purified |
0.5 mg |
239 |
|
20017-1 |
Pig (swine non-immune) Serum IgG, purified |
1 mg |
135 |
|
20017-2-1 |
Pig (swine non-immune) IgM, purified |
0.5 mg |
239 |
|
20039-100 |
Rabbit (non-immune) Serum IgM purified |
100 ug |
174 |
|
20039-1000 |
Rabbit (non-immune) Serum IgM purified |
1000 ug |
564 |
|
20101-1 |
Control Mouse Serum IgG1k (non-immune), purified |
1 mg |
304 |
|
20102-100 |
Mouse IgA isotype control, purified |
100 ug |
174 |
|
20102-101 |
Mouse IgG1 isotype control, purified |
100 ug |
148 |
|
20102-102 |
Mouse IgG2a isotype control, purified |
100 ug |
148 |
|
20102-103 |
Mouse IgG2b isotype control, purified |
100 ug |
148 |
|
20102-104 |
Mouse IgG3 isotype control, purified |
100 ug |
148 |
|
20102-105 |
Mouse IgM isotype control, purified |
100 ug |
148 |
|
20102-106 |
Mouse IgE isotype control, purified |
100 ug |
174 |
|
20102-SET |
Mouse IgA, IgGs (1, 2a, 2b, 3), IgM, and IgE isotype controls (set of 7
IgGs) |
1 Set (100 ugx7) |
635 |
|
20111-1 |
Chicken (non-immune) Egg Yolk IgY, purified |
1 mg |
135 |
|
20111-5 |
Chicken (non-immune) Egg Yolk IgY, purified |
5 mg |
239 |
|
20112 |
Chicken (non-immune) total Egg Yolk proteins |
50 mg |
148 |
|
20113 |
Chicken (non-immune) total Egg White proteins |
50 mg |
148 |
|
20115-1 |
Turkey (non-immune) Serum IgG, purified |
1 mg |
135 |
|
20115-5 |
Turkey (non-immune) Serum IgG, purified |
5 mg |
239 |
|
20211-1 |
Turkey (non-immune) Egg Yolk IgY, purified |
1 mg |
135 |
|
20211-5 |
Turkey (non-immune) Egg Yolk IgY, purified |
5 mg |
239 |
|
20212-1 |
Turkey (non-immune) total Egg Yolk proteins |
50 mg |
148 |
|
20213-1 |
Turkey (non-immune) total Egg White proteins |
50 mg |
148 |
|
20311-1 |
Quail (non-immune) Egg Yolk IgY, purified |
1 mg |
135 |
|
20311-5 |
Quail (non-immune) Egg Yolk IgY, purified |
5 mg |
239 |
|
20312 |
Quail (non-immune) total Egg Yolk proteins |
50 mg |
148 |
|
20313 |
Quail (non-immune) total Egg White proteins |
50 mg |
148 |
|
6230-RS |
Mouse C3 reference serum (~10 ug/ml) |
1 ml |
213 |
|
8OH2G16-N-1 |
8-hydroxy-2-deoxy Guanosine, compound |
1 mg |
252 |
|
8OH2G16-N-5 |
8-hydroxy-2-deoxy Guanosine, compound |
5 mg |
629 |
|
8OHG11-M |
Monoclonal Anti-8-Hydroxyguanosine (8OHG) IgG # 1 |
100 ug |
434 |
|
8OHG12-S |
Anti-8-Hydroxyguanosine (8OHG) antiserum # 2 |
100 ul |
434 |
|
8OHG15-N-1 |
8-hydroxy Guanosine, compound |
1 mg |
161 |
|
8OHG15-N-5 |
8-hydroxy Guanosine, compound |
5 mg |
564 |
|
90110 |
GST-Fusion Protein Purification Kit (5-10 purifications; 25-50 mg
protein) |
1 kit |
434 |
|
A1R11-A |
Anti-Rat Adenosine receptor 1 (A1R) IgG #1, Aff. Pure |
100 ug |
434 |
|
A1R11-P |
Rat Adenosine receptor 1 (A1R) Control/blocking peptide #1 |
100 ug |
174 |
|
A1R11-S |
Anti-Rat Adenosine receptor 1 (A1R) antiserum # 1 |
100 ul |
369 |
|
A2aR21-A |
Anti-Canine Adenosine receptor 2a (A2aR) IgG #1, Aff. Pure |
100 ug |
434 |
|
A2aR21-Cb |
Bovine Adenosine receptor 2a (A2aR) WB Positive Control |
100 ul |
239 |
|
A2aR21-P |
Canine Adenosine receptor 2a (A2aR) Control/blocking peptide #1 |
100 ug |
174 |
|
A2aR21-S |
Anti-Canine Adenosine receptor 2a (A2aR) antiserum |
100 ul |
369 |
|
A2bR23-A |
Anti-Human Adenosine receptor 2b (A2bR) IgG #1, Aff. Pure |
100 ug |
434 |
|
A2bR23-P |
Human Adenosine receptor 2b (A2bR) Control/blocking peptide #1 |
100 ug |
174 |
|
A2bR23-S |
Anti-Human Adenosine receptor 2b (A2bR) antiserum #1 |
100 ul |
369 |
|
A3R31-A |
Anti-Rat Adenosine receptor 3 (A3R) IgG # 1, aff pure |
100 ug |
434 |
|
A3R31-P |
Rat Adenosine receptor 3 (A3R) Control/blocking peptide # 1 |
100 ug |
174 |
|
A3R31-S |
Anti-Rat Adenosine receptor 3 (A3R) antiserum # 1 |
100 ul |
369 |
|
A3R32-A |
Anti-Human Adenosine receptor 3 (A3R) IgG # 2, aff. Pure |
100 ug |
434 |
|
A3R32-P |
Human Adenosine receptor 3 (A3R) Control/blocking peptide # 2 |
100 ug |
174 |
|
A3R32-S |
Anti-Human Adenosine receptor 3 (A3R) antiserum # 2 |
100 ul |
369 |
|
ABCG11-A |
Anti-mouse ATP binding cassette, subfamily G, member 1 (ABCG1) IgG #1,
aff pure |
100 ug |
434 |
|
ABCG11-P |
Mouse ATP binding cassette, subfamily G, member 1, (ABCG1)
Control/blocking peptide # 1 |
100 ug |
161 |
|
ABCG21-A |
Anti-human ATP binding cassette, subfamily G, member 2 (ABCG2) IgG #1,
aff pure |
100 ug |
434 |
|
ABCG21-P |
Human ATP binding cassette, subfamily G, member 2, (ABCG2)
Control/blocking peptide # 1 |
100 ug |
161 |
|
ABCG31-A |
Anti-mouse, ATP binding cassette, subfamily G, member 3 (ABCG3) IgG # 1,
aff pure |
100 ug |
434 |
|
ABCG31-P |
Mouse ATP binding cassette, subfamily G, member 3,
(ABCG3)Control/blocking peptide # 1 |
100 ug |
161 |
|
ABCG41-A |
Anti-mouse ATP binding cassette, subfamily G, member 4 (ABCG4)IgG # 1,
aff pure |
100 ug |
434 |
|
ABCG41-P |
Mouse ATP binding cassette, subfamily G, member 4,
(ABCG4)Control/blocking peptide # 1 |
100 ug |
161 |
|
ABCG51-A |
Anti-human ATP binding cassette, subfamily G, member 5, (ABCG5) IgG #
1, aff pure |
100 ug |
434 |
|
ABCG51-P |
Human ATP binding cassette, subfamily G, member 5, (ABCG5)
Control/blocking peptide # 1 |
100 ug |
161 |
|
ABCG52-A |
Anti-rat ATP binding cassette, subfamily G, member 5, (ABCG5) IgG # 2,
aff pure |
100 ug |
434 |
|
ABCG52-P |
Rat ATP binding cassette, subfamily G, member 5, (ABCG5)
Control/blocking peptide # 2 |
100 ug |
161 |
|
ABCG81-A |
Anti-rat ATP binding cassette, subfamily G, member 8, (ABCG8) IgG # 1,
aff pure |
100 ug |
434 |
|
ABCG81-P |
Rat ATP binding cassette, subfamily G, member 8, (ABCG8)
Control/blocking peptide # 1 |
100 ug |
161 |
|
ABCG82-A |
Anti-rat ATP binding cassette, subfamily G, member 8, (ABCG8) IgG # 2,
aff pure |
100 ug |
434 |
|
ABCG82-P |
Rat ATP binding cassette, subfamily G, member 8, (ABCG8)
Control/blocking peptide # 2 |
100 ug |
161 |
|
ACC11-A |
Anti-Human Acetyl-CoA Carboxylase-1 (ACC-1) IgG, aff pure |
100 ug |
434 |
|
ACC11-P |
Human Acetyl-CoA Carboxylase-1 (ACC-1) Control/blocking peptide |
100 ug |
161 |
|
ACC11-S |
Anti-Human Acetyl-CoA Carboxylase-1 (ACC-1) antiserum |
100 ul |
369 |
|
ACC21-A |
Anti-Rat Acetyl-CoA Carboxylase-2 (ACC-2) IgG, aff pure |
100 ug |
434 |
|
ACC21-P |
Rat Acetyl-CoA Carboxylase-2 (ACC-2) Control/blocking peptide |
100 ug |
161 |
|
ACC21-S |
Anti-Rat Acetyl-CoA Carboxylase-2 (ACC-2) antiserum |
100 ul |
369 |
|
ACE11-A |
Anti-Mouse Angiotensin converting enzyme 1 (ACE-1) IgG # 1, aff pure |
100 ug |
434 |
|
ACE11-C |
Recombinant purified mouse Angiotensin converting enzyme protein 1
(ACE-1) WB +ve control |
100 ul |
258 |
|
ACE11-P |
Mouse Angiotensin converting enzyme 1 (ACE-1) control peptide # 1 |
100 ug |
161 |
|
ACE12-A |
Anti-Human Angiotensin converting enzyme 1 (ACE-1) IgG # 2, aff pure |
100 ug |
434 |
|
ACE12-P |
Human Angiotensin converting enzyme 1 (ACE-1) control peptide # 2 |
100 ug |
161 |
|
ACE13-A |
Anti-Human Angiotensin converting enzyme protein (ACE1) IgG # 3, aff
pure |
100 ug |
434 |
|
ACE13-C |
Human Angiotensin converting enzyme protein (ACE1) WB +ve control |
100 ul |
258 |
|
ACE15-C |
Purified Rat Lung Angiotensin converting enzyme protein 1 (ACE-1) WB +ve
control |
100 ul |
258 |
|
ACE15-M |
Mouse monoclonal anti-rat/human Angiotensin converting enzyme protein 1
(ACE-1) IgG # 4 (aff pure) |
100 ug |
434 |
|
ACE18-N-250 |
Human Angiotensin converting enzyme (ACE1) purified (active) |
250 mU |
278 |
|
ACE18-N-500 |
Human Angiotensin converting enzyme (ACE1) purified (active) |
500 mU |
434 |
|
ACE21-A |
Anti-Mouse Angiotensin converting enzyme 2 (ACE-2) IgG # 1, aff pure |
100 ug |
434 |
|
ACE21-P |
Mouse Angiotensin converting enzyme 2 (ACE-2) control peptide # 1 |
100 ug |
161 |
|
ACE22-A |
Anti-Human Angiotensin converting enzyme 2 (ACE-2) IgG # 2, aff pure |
100 ug |
434 |
|
ACE22-C |
Recombinant purified Human Angiotensin converting enzyme protein 2
(ACE2) WB +ve control |
100 ul |
258 |
|
ACE22-P |
Human Angiotensin converting enzyme 2 (ACE-2) control peptide # 2 |
100 ug |
161 |
|
ACE23-M |
monoclonal anti-Human ACE2 IgG # 3 (aff pure) |
100 ug |
434 |
|
ACE25-R-10 |
Recombinant purified Human Angiotensin converting enzyme-2 purified
protein |
10 ug |
694 |
|
ACF11-A |
Anti-human APOBEC complementation factor (ACF) IgG, aff pure |
100 ug |
434 |
|
ACF11-P |
Human APOBEC complementation factor (ACF) Control/blocking peptide # 1 |
100 ug |
161 |
|
ACRP301-A |
Anti-Mouse Acrp30 (adipocyte complement-related protein of 30 kDa) IgG #
1, aff pure |
100 ug |
434 |
|
ACRP301-C |
Mouse purified recombinant Acrp30 protein (full length) control for WB |
100 ul |
258 |
|
ACRP301-P |
Mouse Acrp30 (adipocyte complement-related protein of 30 kDa)
control/blocking peptide # 1 |
100 ug |
161 |
|
ACRP301-S |
Anti-Mouse Acrp30 (adipocyte complement-related protein of 30 kDa)
antiserum # 1 |
100 ul |
369 |
|
ACRP302-A |
Anti-Human Acrp30 (adipocyte complement-related protein of 30 kDa) IgG #
2, aff pure |
100 ug |
434 |
|
ACRP302-C |
Human purified, recombinant Acrp30 protein (full length) control for WB |
100 ul |
258 |
|
ACRP302-P |
Human Acrp30 (adipocyte complement-related protein of 30 kDa)
control/blocking peptide # 2 |
100 ug |
161 |
|
ACRP302-R-10 |
Human purified, recombinant Acrp30 protein, full length |
10 ug |
434 |
|
ACRP302-R-5 |
Human purified, recombinant Acrp30 protein, full length |
5 ug |
304 |
|
ACRP302-S |
Anti-Human Acrp30 (adipocyte complement-related protein of 30 kDa)
antiserum # 2 |
100 ul |
369 |
|
ACRP303-A |
Anti-Mouse gAcrp30 (globular adipocyte complement-related protein of 30
kDa) IgG # 3, aff pure |
100 ug |
434 |
|
ACRP303-C |
Mouse purified, gAcrp30 (globular adipocyte complement-related protein
of 30 kDa) control protein for WB |
100 ul |
258 |
|
ACRP303-P |
Mouse gAcrp30 (globular adipocyte complement-related protein of 30 kDa)
control/blocking peptide # 3 |
100 ug |
161 |
|
ACRP303-R-10 |
Mouse purified, recombinant gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) protein |
10 ug |
434 |
|
ACRP303-R-100 |
Mouse purified, recombinant gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) protein |
100 ug |
1.285 |
|
ACRP303-R-10XX |
Mouse purified, recombinant gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) protein |
10 ug |
694 |
|
ACRP303-R-25 |
Mouse purified, recombinant gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) protein |
25 ug |
694 |
|
ACRP303-S |
Anti-Mouse gAcrp30 (globular adipocyte complement-related protein of 30
kDa) antiserum # 3 |
100 ul |
369 |
|
ACRP304-C |
Human purified, recombinant gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) control protein for WB |
100 ul |
258 |
|
ACRP304-R-10 |
Human purified, recombinant gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) protein |
10 ug |
434 |
|
ACRP304-R-5 |
Human purified, recombinant gAcrp30 (globular adipocyte
complement-related protein of 30 kDa) protein |
5 ug |
343 |
|
ACRP304-S |
Anti-Human gAcrp30 (globular adipocyte complement-related protein of 30
kDa) protein antiserum # 4 |
100 ul |
369 |
|
ACRP305-R-100 |
Mouse purified recombinant Acrp30 protein (full length) for ELISA |
100 ug |
759 |
|
ACRP305-R-25 |
Mouse purified recombinant Acrp30 protein (full length) for ELISA |
25 ug |
408 |
|
ACRP308-R-10 |
Human purified, recombinant gAcrp30 variant (globular adipocyte
complement-related protein of 30 kDa) protein |
10 ug |
434 |
|
ACRP308-R-25 |
Human purified, recombinant gAcrp30 variant (globular adipocyte
complement-related protein of 30 kDa) protein |
25 ug |
759 |
|
ACRP309-TR-10 |
Human recombinant purified Acrp30/Adiponectin protein, Trimeric |
10 ug |
434 |
|
ACRP309-TR-5 |
Human recombinant purified Acrp30/Adiponectin protein, Trimeric |
5 ug |
304 |
|
ACRP310-TR-10 |
Mouse recombinant purified Acrp30/Adiponectin protein, Trimeric |
10 ug |
434 |
|
ACRP310-TR-5 |
Mouse recombinant purified Acrp30/Adiponectin protein, Trimeric |
5 ug |
304 |
|
ACRP311-M |
Mouse monoclonal anti-Human Acrp30/adiponcetin protein IgG purified |
100 ug |
434 |
|
ACTB11-C |
Purified human beta-Actin (non-muscle) Protein control for WB |
100 ul |
258 |
|
ACTB11-P |
Human Beta-Actin (non-muscle) Control/blocking peptide #1 |
100 ug |
161 |
|
ACTB11-S |
Anti-Human Beta Actin (non-muscle) peptide antiserum # 1 |
100 ul |
369 |
|
ACTB12-C |
Purified human beta-Actin (non-muscle) Protein control for WB |
100 ul |
258 |
|
ACTB12-FITC |
Monoclonal Anti-Human Beta Actin peptide (non-muscle) IgG-FITC Conjugate |
100 ul |
434 |
|
ACTB12-HRP |
Anti-Human Beta Actin peptide (non-muscle) IgG-HRP Conjugate |
100 ul |
434 |
|
ACTB12-M |
Monoclonal Anti-Human Beta Actin (non-muscle) peptide ascites, ab # 2 |
100 ul |
434 |
|
ACTB12-P |
Human Beta Actin (non-muscle) Control/blocking peptide #2 |
100 ug |
161 |
|
ACTB13-S |
Anti-Human Beta Actin (non-muscle) peptide antiserum #3 |
100 ul |
369 |
|
ACTB15-C |
Rabbit Beta Actin (muscle) protein control for Western |
100 ul |
343 |
|
ACTB15-N |
Purified muscle Actin Protein from Bovine muscle |
100 ug |
200 |
|
ACTB15-N-1 |
Purified (>95%) muscle Actin Protein from muscle (rabbit/bovine) |
1 mg |
434 |
|
ACTB15-S |
Anti-Bovine Beta Actin (muscle) protein antiserum |
100 ul |
369 |
|
ACTB16-N |
Purified human beta-Actin (non-muscle) Protein for ELISA |
100 ug |
369 |
|
ACTB16-N-1 |
Purified human beta-Actin (non-muscle) Protein for ELISA |
1 mg |
824 |
|
ACTB17-S |
Anti-Human Beta Actin (non-muscle) protein antiserum |
100 ul |
369 |
|
ACTB18-C |
Monoclonal Anti-rabbit striated muscle, alpha-sarcomeric
(cardiac/skeletal) actin Protein control for Western |
100 ul |
278 |
|
ACTB18-M |
Monoclonal Anti-rabbit striated muscle, alpha-sarcomeric
(cardiac/skeletal) actin Protein, ascites |
100 ug |
434 |
|
ACTB18-N-100 |
Purified cardiac muscle actin Protein (Bovine) |
100 ug |
200 |
|
ACTB18-N-1000 |
Purified cardiac muscle actin Protein (Bovine) |
1 mg |
434 |
|
ACTB19-C |
Purified smooth muscle actin Protein (chicken gizzard) control for
Western |
100 ul |
278 |
|
ACTB19-M |
Monoclonal Anti-smooth muscle (gamma, alpha, chicken gizzard) IgG,
purified |
100 ug |
434 |
|
ACTB19-N-100 |
Purified smooth muscle actin Protein (chicken gizzard) |
100 ug |
200 |
|
ACTB19-N-1000 |
Purified cardiac muscle actin Protein (Bovine) |
1 mg |
434 |
|
ACTB20-M |
Monoclonal Anti-smooth muscle, pan actin (6-isoforms of actin) IgG,
ascites |
100 ul |
434 |
|
ACTB21-M |
Monoclonal Anti-Plant Actin Pan (ACT1-4, 7, 8, 11, 12) IgG, purified |
100 ul |
434 |
|
ACTB22-A |
Anti-Actin (Pan, alpha, beta, gamma) IgG, aff pure |
100 ug |
434 |
|
ACTB22-P |
Actin (Pan, alpha, beta, gamma) Control/blocking peptide |
100 ug |
161 |
|
ACTB24-BTN |
Anti-Actin (Pan, alpha, beta, gamma)-biotinylated |
50 ul |
434 |
|
ACTB24-Cy3 |
Anti-Actin (Pan, alpha, beta, gamma) IgG-Cy3 conjugate |
100 ul |
434 |
|
ACTB24-FITC |
Anti-Actin (Pan, alpha, beta, gamma) IgG-FITC conjugate |
100 ul |
434 |
|
ACTB24-M |
Anti-Actin (Pan, alpha, beta, gamma) IgG, aff pure |
100 ug |
434 |
|
ADA11-BTN |
Anti-bovine Adenosine deaminase IgG-biotin conjugate |
100 ul |
408 |
|
ADA11-C |
Bovine Adenosine deaminase protein control for Western |
100 ul |
258 |
|
ADA11-HRP |
Anti-bovine Adenosine deaminase IgG-HRP conjugate |
100 ul |
408 |
|
ADA11-S |
Anti-bovine Adenosine deaminase antiserum (IgG) |
100 ul |
369 |
|
ADA15-N |
Bovine Adenosine deaminase protein control, partially pure |
100 U |
239 |
|
ADIPOR11-A |
Anti-Mouse Adiponectin receptor 1 (ADIPOR1), aff pure IgG # 1 |
100 ul |
434 |
|
ADIPOR11-P |
Mouse Adiponectin receptor 1 (ADIPOR1) Control/blocking peptide # 1 |
100 ug |
161 |
|
ADIPOR12-A |
Anti-Mouse Adiponectin receptor 1 (ADIPOR1) aff pure IgG # 2 |
100 ul |
434 |
|
ADIPOR12-P |
Mouse Adiponectin receptor 1 (ADIPOR1) Control/blocking peptide # 2 |
100 ug |
161 |
|
ADIPOR21-A |
Anti-Mouse Adiponectin receptor 2 (ADIPOR2) aff pure IgG # 1 |
100 ul |
434 |
|
ADIPOR21-P |
Mouse Adiponectin receptor 2 (ADIPOR2) Control/blocking peptide # 1 |
100 ug |
161 |
|
ADIPOR22-A |
Anti-Mouse Adiponectin receptor 2 (ADIPOR2) aff pure IgG # 2 |
100 ul |
434 |
|
ADIPOR22-P |
Mouse Adiponectin receptor 2 (ADIPOR2) Control/blocking peptide # 2 |
100 ug |
161 |
|
ADML11-A |
Anti-Human Adrenomedullin IgG, aff. Pure |
100 ug |
434 |
|
ADML11-P |
Human Adrenomedullin Control/blocking peptide |
100 ug |
161 |
|
ADML11-S |
Anti-Human Adrenomedullin antiserum |
100 ul |
369 |
|
ADML15-P |
Human Adrenomedullin Peptide full length (52 aa, 1 disulfide) |
100 ug |
434 |
|
ADN11-A |
Anti-Rat Adipsin/Factor D IgG # 1, aff pure |
100 ug |
434 |
|
ADN11-P |
Rat Adipsin/Factor D control/blocking peptide # 1 |
100 ug |
161 |
|
ADN11-S |
Anti-Rat Adipsin/Factor D antiserum # 1 |
100 ul |
369 |
|
ADN12-A |
Anti-Human Adipsin/Factor D IgG # 2, aff pure |
100 ug |
434 |
|
ADN12-C |
Human Adipsin/Factor D protein Western blot +ve control |
100 ul |
258 |
|
ADN12-P |
Human Adipsin/Factor D control/blocking peptide # 2 |
100 ug |
161 |
|
ADN12-S |
Anti-Human Adipsin/Factor D antiserum # 2 |
100 ul |
369 |
|
ADN13-A |
Anti-Human Adipsin/Factor D protein IgG # 3, aff pure |
100 ug |
434 |
|
ADN15-N |
Human Adipsin/Factor D protein for ELISA or Standards |
5 ug |
278 |
|
ADPR11-C |
Poly-ADP-ribosylated proteins for Western blot |
100 ul |
258 |
|
ADPR12-M |
Monoclonal Anti-Poly-ADP-ribose IgG#2, |
100 ug |
434 |
|
AE11-A |
Anti-Rat Anion Exchanger 1 (AE1) IgG #1, aff pure |
100 ug |
434 |
|
AE11-P |
Rat Anion Exchanger 1 (AE1) Control/blocking peptide #1 |
100 ug |
161 |
|
AE11-S |
Anti-Rat Anion Exchanger 1 (AE1) antiserum #1 |
100 ul |
369 |
|
AE12-M |
Monoclonal Anti-Human Anion Exchanger 1 (AE1) Ab #2, ascites |
100 ul |
434 |
|
AE21-A |
Anti-Rat Anion Exchanger 2 (AE2) IgG #1, aff pure |
100 ug |
434 |
|
AE21-P |
Rat Anion Exchanger 2 (AE2) Control/blocking peptide #2 |
100 ug |
161 |
|
AE21-S |
Anti-Rat Anion Exchanger 2 (AE2) antiserum #2 |
100 ul |
369 |
|
AE31-A |
Anti-Rat Anion Exchanger 3 (AE3) IgG #1, aff pure |
100 ug |
434 |
|
AE31-P |
Rat Anion Exchanger 3 (AE3) Control/blocking peptide #1 |
100 ug |
161 |
|
AE31-S |
Anti-Rat Anion Exchanger 3 (AE3) antiserum #1 |
100 ul |
369 |
|
AE41-A |
Anti-Human Anion Exchanger 4 (AE4) IgG #1, aff pure |
100 ug |
434 |
|
AE41-P |
Human Anion Exchanger 4 (AE4) Control/blocking peptide #1 |
100 ug |
161 |
|
AE41-S |
Anti-Human Anion Exchanger 4 (AE4) antiserum # 1 |
100 ul |
369 |
|
AGO11-A |
Anti-Mouse Agouti IgG, IgG aff pure |
100 ug |
434 |
|
AGO11-P |
Mouse Agouti Control/blocking peptide |
100 ug |
161 |
|
AGO11-S |
Anti-Mouse Agouti antiserum |
100 ul |
369 |
|
AGRP11-A |
Anti-Mouse Agouti related protein (AGRP) IgG aff pure |
100 ug |
434 |
|
AGRP11-P |
Mouse Agouti related protein (AGRP) Control/blocking peptide |
100 ug |
161 |
|
AGRP11-S |
Anti-Mouse Agouti related protein (AGRP) antiserum |
100 ul |
369 |
|
AGRP12-M |
Rat monoclonal Anti-Mouse Agouti related protein (AGRP) IgG aff pure |
100 ug |
434 |
|
AGRP13-C |
Recombinant, purified, Human AGRP protein for WB +ve control |
100 ul |
258 |
|
AIB12-M |
Mouse Monoclonal Anti-Human Activated in Breast Cancer (AIB1/ACTR) IgG
# 2 (ascites) |
100 ug |
434 |
|
AIF11-A |
Anti-Mouse Apoptosis Inducing Factor (AIF) IgG #1, aff pure |
100 ug |
434 |
|
AIF11-P |
Mouse Apoptosis Inducing Factor (AIF) control peptide #1 |
100 ug |
161 |
|
AIF11-S |
Anti-Mouse Apoptosis Inducing Factor (AIF) antiserum #1 |
100 ul |
369 |
|
AIF12-A |
Anti-Human Apoptosis Inducing Factor (AIF) IgG aff pure |
100 ug |
434 |
|
AIF12-C |
Human Apoptosis Inducing Factor (AIF) WB +ve protein control |
100 ul |
258 |
|
AKT12-C |
Recombinant purified, human Akt-1/PKB-alpha (phosphorylated) protein
control for WB |
100 ul |
304 |
|
AKT12-P |
Rat Akt-1 Control/blocking peptide #2 (S472-phosphorylated) |
100 ug |
239 |
|
AKT12-S |
Anti-Rat Akt-1 (phosphorylated) antiserum # 2 |
100 ul |
369 |
|
AKT13-C |
Recombinant purified Human Akt-1/ PKB-alpha (nonphosphorylated) protein
WB +ve control |
100 ul |
304 |
|
AKT13-P |
Rat Akt-1 non-phosphorylated Control/blocking peptide # 3 for ab#2
(Akt12) |
100 ug |
161 |
|
AKT14-A |
Anti-Rat/human Akt-1, IgG # 4, aff pure |
100 ug |
434 |
|
AKT14-P |
Rat/human Akt-1 Control/blocking peptide #4 |
100 ug |
161 |
|
AKT14-S |
Anti-Rat/human Akt-1 antiserum # 4 |
100 ul |
369 |
|
AKT15-R-15 |
Recombinant purified human Akt-1/PKB-alpha protein (active) |
15 ug |
954 |
|
AKT16-R |
Recombinant purified human Akt-1/PKB-alpha protein (PHD deletion 1-116
active) |
1 U |
499 |
|
AKT21-C |
Recombinant purified, human Akt-2/PKB-beta protein control for WB |
100 ul |
258 |
|
AKT21-P |
Rat Akt-2 Control/blocking peptide #1 |
100 ug |
161 |
|
AKT21-S |
Anti-Rat Akt-2 antiserum # 1 |
100 ul |
369 |
|
AKT31-C |
Recombinant purified, human Akt-3/PKB-gamma protein control for WB |
100 ul |
258 |
|
AKT31-P |
Rat Akt-3 Control/blocking peptide #1 |
100 ug |
161 |
|
AKT31-S |
Anti-Rat Akt-3 antiserum # 1 |
100 ul |
369 |
|
ALB11-A |
Anti-Mouse albumin IgG aff pure |
100 ug |
369 |
|
ALB11-BTN |
Anti-Mouse albumin IgG-Biotin Conjugate |
50 ug |
408 |
|
ALB11-C |
Purified Mouse serum albumin protein control for Western blot |
100 ul |
258 |
|
ALB11-FITC |
Anti-Mouse albumin IgG-FITC Conjugate |
100 ug |
369 |
|
ALB12-N-1 |
Purified Mouse serum albumin protein (>96% pure) |
1 mg |
278 |
|
ALBC15-C |
Chicken Serum Albumin protein control for Western blot |
100 ul |
258 |
|
ALBC15-N-1 |
Chicken Serum Albumin protein purified |
1 mg |
213 |
|
ALBC15-N-10 |
Chicken Serum Albumin protein purified |
10 mg |
1.084 |
|
ALBC15-S |
Anti-Chicken Serum Albumin protein antiserum |
100 ul |
369 |
|
ALBH13-A |
Anti-Human albumin IgG aff pure |
100 ug |
369 |
|
ALBH13-C |
Purified Human serum albumin protein control for Western blot |
100 ul |
258 |
|
ALBH13-FITC |
Anti-Human albumin IgG-FITC Conjugate |
100 ug |
369 |
|
ALBH16-R-10 |
Recombinant purified human serum albumin (rHSA) |
10 mg |
564 |
|
ALBH16-R-100 |
Recombinant purified human serum albumin (rHSA) |
100 mg |
2.195 |
|
ALBR12-A |
Anti-rat albumin IgG aff pure |
100 ug |
369 |
|
ALBR12-BTN |
Anti-rat albumin IgG, biotinylated |
50 ug |
408 |
|
ALBR12-C |
Purified rat serum albumin protein control for Western blot |
100 ul |
258 |
|
ALBR12-HRP |
Anti-rat albumin IgG-HRP Conjugate |
100 ul |
369 |
|
ALBR12-N-1 |
Purified rat albumin protein (>98% pure) |
10 mg |
278 |
|
AMPKA11-A |
Anti-Mouse AMP Activated Kinase-a1 (AMPK-a1) IgG, aff pure |
100 ug |
434 |
|
AMPKA11-P |
Mouse AMP Activated Kinase-a1 (AMPK-a1) Control/blocking peptide |
100 ug |
161 |
|
AMPKA11-S |
Anti-Mouse AMP Activated Kinase-a1 (AMPK-a1) antiserum |
100 ul |
369 |
|
AMPKA21-A |
Anti-Rat AMP Activated Kinase-a2 (AMPK-a2) IgG, aff pure |
100 ug |
434 |
|
AMPKA21-P |
Rat AMP Activated Kinase-a2 (AMPK-a2) Control/blocking peptide |
100 ug |
161 |
|
AMPKA21-S |
Anti-Rat AMP Activated Kinase-a2 (AMPK-a2) antiserum |
100 ul |
369 |
|
AMPKB11-A |
Anti-Human AMP Activated Kinase-b1/2 (AMPK-b1/2) IgG, aff pure |
100 ug |
434 |
|
AMPKB11-P |
Human AMP Activated Kinase-b1/2 (AMPK-b1/2) Control/blocking peptide |
100 ug |
161 |
|
AMPT11-M |
Monoclonal Anti-Amphetamine IgG |
1 mg |
434 |
|
AMYL11-P |
Human Amylin (1-37 aa) Control/blocking peptide #1 |
100 ug |
161 |
|
AMYL11-S |
Anti-Human Amylin (1-37 aa) antiserum # 1 |
100 ul |
369 |
|
AMYL12-A |
Anti-Human Amylin IgG # 2, aff pure |
100 ug |
434 |
|
AMYL12-P |
Human Amylin Control/blocking peptide # 2 |
100 ug |
161 |
|
AMYL12-S |
Anti-Human Amylin antiserum # 2 |
100 ul |
369 |
|
AMYL13-A |
Anti-rat Amylin IgG # 3, aff pure |
100 ug |
434 |
|
AMYL13-P |
Rat Amylin Control/blocking peptide # 3 |
100 ug |
161 |
|
AMYL13-S |
Anti-rat Amylin antiserum # 3 |
100 ul |
369 |
|
AMYL14-P |
Human Amylin, 1-37 aa full length (non-oxidized) |
100 ug |
239 |
|
AMYL15-P-100 |
Human Amylin, 1-37 aa full length (non-oxidized), N-terminal Biotin |
100 ug |
304 |
|
AMYL15-P-1000 |
Human Amylin, 1-37 aa full length (non-oxidized), N-terminal Biotin |
1000 ug |
694 |
|
AMYL16-P5 |
Human Amylin, 1-37 aa full length (Cys2-Cys7 oxidized) |
500 ug |
434 |
|
AMYL17-P5 |
Rat Amylin, 1-37 aa full length (Cys2-Cys7 oxidized) |
500 ug |
434 |
|
AMYL18-P5 |
Rat Amylin, 8-37 aa, pure |
500 ug |
434 |
|
AMYL19-P5 |
Human Amylin, 1-13 aa, maide (Cys2-Cys7 oxidized) pure |
500 ug |
239 |
|
AMYL20-P5 |
Human Amylin, 8-37 aa, maide (Cys2-Cys7 oxidized) pure |
500 ug |
278 |
|
ANG11-A |
Anti-Mouse Angiopoietin 1 (Ang-1) IgG #1, aff pure |
100 ug |
434 |
|
ANG11-P |
Mouse Angiopoietin 1 (Ang-1) Control/blocking peptide #1 |
100 ug |
161 |
|
ANG11-S |
Anti-Mouse Angiopoietin 1 (Ang-1) antiserum #1 |
100 ul |
369 |
|
ANG12-C |
Purified Recombinant Human Angiopoietin 1 (Ang-1) protein WB +ve control |
100 ul |
258 |
|
ANG12-P |
Mouse Angiopoietin 1 (Ang-1) Control/blocking peptide #2 |
100 ug |
161 |
|
ANG16-R-10 |
Purified Recombinant Human Angiopoietin 1 (Ang-1) protein (sf9) |
10 ug |
434 |
|
ANG21-A |
Anti-Mouse Angiopoietin 2 (Ang-2) IgG #1, aff pure |
100 ug |
434 |
|
ANG21-P |
Mouse Angiopoietin 2 (Ang-2) Control/blocking peptide #2 |
100 ug |
161 |
|
ANG21-S |
Anti-Mouse Angiopoietin 2 (Ang-2) antiserum #2 |
100 ul |
369 |
|
ANG22-C |
Purified Recombinant Human Angiopoietin 2 (Ang-2) WB +ve control |
100 ul |
258 |
|
ANG26-R-10 |
Purified Recombinant Human Angiopoietin 2 (Ang-2) protein (sf9) |
10 ug |
434 |
|
ANG31-C |
Mouse Angiopoietin 3 (Ang-3) protein control for WB |
100 ul |
258 |
|
ANG41-C |
Human Angiopoietin 4 (Ang-4) protein control for WB |
100 ul |
258 |
|
ANGN108-P |
Human Angiogenin 108-123 aa peptide |
1 mg |
304 |
|
ANGN12-A |
Anti-Human Angiogenin protein IgG #1, IgG aff pure |
100 ug |
434 |
|
ANGN12-C |
Recombinant purified Human Angiogenin protein W. blot +ve control |
100 ul |
258 |
|
ANGN15-R-50 |
Recombinant (E. coli) purified Human Angiogenin protein, biologically
active |
50 ug |
824 |
|
ANKR131-C |
Human Recombinant Angiostatin Kringles 1-3 purified protein W. blot +ve
positive control |
100 ul |
258 |
|
ANKR131-R-250 |
Human Recombinant Angiostatin Kringles 1-3 purified protein biologically
active |
250 ug |
824 |
|
ANKR131-R-50 |
Human Recombinant Angiostatin Kringles 1-3 purified protein biologically
active |
50 ug |
239 |
|
ANKR13-M |
Mouse Monoclonal Anti-human Angiostatin (Kringles 1-3) IgG #3 |
100 ug |
434 |
|
ANST11-R |
Purified Human Angiostatin (Kringles 1-4) protein (>98%), biologically
active |
100 ug |
369 |
|
ANST11-S |
Anti-Human Angiostatin (Kringles 1-4) protein antiserum |
100 ul |
369 |
|
ANST12-C |
Purified Human Angiostatin (Kringles 1-4) protein W. Blot +ve control |
100 ul |
258 |
|
ANST12-M |
Mouse Monoclonal Anti-Human Angiostatin (kringles 1-4) IgG #2 |
100 ug |
434 |
|
ANV-F-100 |
Annexin V-FITC apopotosis kit |
100 tests |
564 |
|
APAF11-A |
Anti-HumanApaf-1 (Apoptosis Protease Activating Factor-1) IgG, aff pure |
100 ug |
434 |
|
APAF11-P |
Human Apaf-1 (Apoptosis Protease Activating Factor-1) Control/blocking
peptide |
100 ug |
161 |
|
APE11-S |
Anti-Human AP Endonuclease (APE/APEX/APE-1) antiserum #1 |
100 ul |
369 |
|
APE12-S |
Anti-Mouse AP Endonuclease (APE/APEX/APE-1) protein antiserum #2 |
100 ul |
369 |
|
APOBEC11-A |
Anti-human APOBEC 1 IgG #1, aff pure |
100 ug |
434 |
|
APOBEC11-P |
Human APOBEC 1 Control/blocking peptide # 1 |
100 ug |
161 |
|
APOE11-C |
Human ApoE protein W. Blot +ve control |
100 ul |
258 |
|
APOE11-S |
Anti-Human ApoE protein antiserum #1 |
100 ul |
369 |
|
APOE12-C |
Human ApoE protein W. Blot +ve control |
100 ul |
258 |
|
APOE12-M |
monoclonal Anti-Human ApoE protein IgG #2 |
100 ug |
434 |
|
APOE15-R |
Human Purified native plasma Apolipoprotein E protein |
25 ug |
369 |
|
APOE25-R |
Recombinant Purified Human Apolipoprotein E2 protein |
25 ug |
369 |
|
APOE31-C |
Human ApoE3 protein W. Blot +ve control |
100 ul |
258 |
|
APOE31-S |
Anti-Human ApoE3 protein antiserum #1 |
100 ul |
369 |
|
APOE35-R |
Recombinant Purified Human Apolipoprotein E3 protein |
25 ug |
369 |
|
APOE36-R |
Recombinant (E coli) Purified Human Apolipoprotein E3 protein |
100 ug |
369 |
|
APOE45-R |
Recombinant Purified Human Apolipoprotein E4 protein |
25 ug |
369 |
|
APOJ11-A |
Anti-Human ApoJ (Clusterin/Apolipoprotein J/Apo J) protein IgG aff pure |
100 ug |
434 |
|
APOJ11-C |
Recombinant purified Human ApoJ (Clusterin/Apolipoprotein J) protein
control for WB |
100 ul |
258 |
|
APOJ35-R-10 |
Recombinant purified Rat ApoJ (Clusterin/Apolipoprotein J) protein for
ELISA |
10 ug |
434 |
|
APOJ36-R-10 |
Recombinant purified Human ApoJ (Clusterin/Apolipoprotein J) protein for
ELISA |
10 ug |
434 |
|
APP11-P |
Human Amyloid precursor protein (APP770) Control/blocking peptide |
100 ug |
161 |
|
APP11-S |
Anti-Human Amyloid precursor protein (APP770) antiserum # 1 |
100 ul |
369 |
|
APP12-P |
Human Amyloid precursor protein (APP) control/blocking peptide #2 |
100 ug |
161 |
|
APP12-S |
Anti-Human Amyloid precursor protein (APP) antiserum #2 |
100 ul |
369 |
|
APP13-M |
Monoclonal Anti-Human Amyloid precursor protein (APP) ab #3 |
100 ug |
434 |
|
APP14-P |
Human Amyloid precursor protein (APP) Control/blocking peptide # 4 |
100 ug |
161 |
|
APP14-S |
Anti-Human Amyloid precursor protein (APP) antiserum #4 |
100 ul |
369 |
|
AQP01-A |
Anti-Human Aquaporin 0 (AQP0) IgG # 1, aff pure |
100 ug |
434 |
|
AQP01-P |
Human Aquaporin 0 (AQP0) Control/blocking peptide # 1 |
100 ug |
161 |
|
AQP01-S |
Anti-Human Aquaporin 0 (AQP0) Antiserum # 1 |
100 ul |
369 |
|
AQP02-P |
Human Aquaporin 0 (AQP0) Control/blocking peptide # 1 |
100 ug |
161 |
|
AQP02-S |
Anti-Rat Aquaporin 0 (AQP0) Antiserum # 2 |
100 ul |
369 |
|
AQP0-9-AP-A |
Anti-AQP1-AQP9 and AQPAP, aff. pure (25 ug each of AQP1-9) |
25 ul x10 |
1.285 |
|
AQP0-9-AP-P |
AQP1-AQP9 and AQPAP control/blocking peptides (25 ug each of AQP1-9) |
25 ug x10 |
1.051 |
|
AQP0-9-AP-S |
Anti-AQP1-AQP9 and AQPAP Antiserum (25 ul each of AQP1-9) |
25 ul x10 |
1.155 |
|
AQP101-A |
Anti-Human Aquaporin 10 (AQP10) IgG, aff pure |
100 ug |
434 |
|
AQP101-P |
Human Aquaporin 10 (AQP10) Control/blocking peptide |
100 ug |
161 |
|
AQP101-S |
Anti-Human Aquaporin 10 (AQP10) Antiserum |
100 ul |
369 |
|
AQP115-A |
Anti-Rat AQP11 IgG, aff pure |
100 ug |
434 |
|
AQP115-P |
Rat AQP11 control/blocking peptide |
100 ug |
161 |
|
AQP115-S |
Anti-Rat AQP11 IgG, aff pure |
100 ug |
369 |
|
AQP11-A |
Anti-Rat Aquaporin 1 (AQP1) IgG #1, aff pure |
100 ug |
434 |
|
AQP11-P |
Rat Aquaporin 1 (AQP1) Control/blocking peptide #1 |
100 ug |
161 |
|
AQP11-S |
Anti-Rat Aquaporin 1 (AQP1) Antiserum #1 |
100 ul |
369 |
|
AQP125-A |
Anti-Mouse AQP12 IgG, aff pure |
100 ug |
434 |
|
AQP125-P |
Mouse AQP12 control/blocking peptide |
100 ug |
161 |
|
AQP126-A |
Anti-Human AQP12 IgG, aff pure |
100 ug |
434 |
|
AQP126-P |
Human AQP12 control/blocking peptide |
100 ug |
161 |
|
AQP12-P |
Rat Aquaporin 1 (AQP1) Control/blocking peptide #1 |
100 ug |
161 |
|
AQP16-PAN-A |
Anti-AQP1-AQP6 IgG (25 ug each of AQP1-6) aff pure |
25 ul x 6 |
499 |
|
AQP16-PAN-P |
AQP1-AQP6 control/blocking peptides (25 ug each of AQP1-6) |
25 ug x6 |
304 |
|
AQP16-PAN-S |
Anti-AQP1-AQP6 Antiserum (25 ul each of AQP1-6) neat serum |
25 ul x 6 |
369 |
|
AQP19-PAN-A |
Anti-AQP1-AQP9 IgG, aff pure (25 ug each of AQP1-9) |
25 ug x9 |
1.084 |
|
AQP19-PAN-P |
AQP1-AQP9 control/blocking peptides (25 ug each of AQP1-9) |
25 ug x9 |
369 |
|
AQP19-PAN-S |
Anti-AQP1-AQP9 Antiserum (25 ul each of AQP1-9) |
25 ul x9 |
954 |
|
AQP21-A |
Anti-Rat Aquaporin 2 (AQP2) IgG #1, aff pure |
100 ug |
434 |
|
AQP21-P |
Rat Aquaporin 2 (AQP2) Control/blocking peptide #1 |
100 ug |
161 |
|
AQP21-S |
Anti-Rat Aquaporin 2 (AQP2) Antiserum #1 |
100 ul |
369 |
|
AQP23-A |
Anti-mouse/rat Aquaporin 2 (AQP2) IgG # 3, aff pure |
100 ug |
434 |
|
AQP23-P |
Mouse/rat Aquaporin 2 (AQP2) Control/blocking peptide # 3 |
100 ug |
161 |
|
AQP23-S |
Anti-Mouse/rat Aquaporin 2 (AQP2) Antiserum # 3 |
100 ul |
369 |
|
AQP31-A |
Anti-Rat Aquaporin 3 (AQP3) IgG, aff pure |
100 ug |
434 |
|
AQP31-P |
Rat Aquaporin 3 (AQP3) Control/blocking peptide |
100 ug |
161 |
|
AQP31-S |
Anti-Rat Aquaporin 3 (AQP3) Antiserum |
100 ul |
369 |
|
AQP41-A |
Anti-Rat Aquaporin 4 (AQP4) IgG #1, aff pure |
100 ug |
434 |
|
AQP41-P |
Rat Aquaporin 4 (AQP4) Control/blocking peptide #1 |
100 ug |
161 |
|
AQP41-S |
Anti-Rat Aquaporin 4 (AQP4) Antiserum #1 |
100 ul |
369 |
|
AQP51-A |
Anti-Rat Aquaporin 5 (AQP5) IgG #1, aff pure |
100 ug |
434 |
|
AQP51-P |
Rat Aquaporin 5 (AQP5) Control/blocking peptide #1 |
100 ug |
161 |
|
AQP51-S |
Anti-Rat Aquaporin 5 (AQP5) Antiserum #1 |
100 ul |
369 |
|
AQP61-A |
Anti-Human Aquaporin 6 (AQP6) IgG # 1, aff pure |
100 ug |
434 |
|
AQP61-P |
Human Aquaporin 6 (AQP6) Control/blocking peptide # 1 |
100 ug |
161 |
|
AQP61-S |
Anti-Human Aquaporin 6 (AQP6) Antiserum # 1 |
100 ul |
369 |
|
AQP62-P |
Human Aquaporin 6 (AQP6) Control/blocking peptide # 2 |
100 ug |
161 |
|
AQP62-S |
Anti-Human Aquaporin 6 (AQP6) Antiserum # 2 |
100 ul |
369 |
|
AQP71-A |
Anti-Rat Aquaporin 7 (AQP7) IgG # 1, aff pure |
100 ug |
434 |
|
AQP71-P |
Rat Aquaporin 7 (AQP7) Control/blocking peptide # 1 |
100 ug |
161 |
|
AQP71-S |
Anti-Rat Aquaporin 7 (AQP7) Antiserum # 1 |
100 ul |
369 |
|
AQP72-P |
Rat Aquaporin 7 (AQP7)Control/blocking peptide # 2 |
100 ug |
161 |
|
AQP72-S |
Anti-Rat Aquaporin 7 (AQP7) Antiserum # 2 |
100 ul |
369 |
|
AQP81-A |
Anti-Rat Aquaporin 8 (AQP8) IgG # 1, aff pure |
100 ug |
434 |
|
AQP81-P |
Rat Aquaporin 8 (AQP8) Control/blocking peptide #1 |
100 ug |
161 |
|
AQP81-S |
Anti-Rat Aquaporin 8 (AQP8) Antiserum # 1 |
100 ul |
369 |
|
AQP82-P |
Rat Aquaporin 8 (AQP8) Control/blocking peptide # 2 |
100 ug |
161 |
|
AQP82-S |
Anti-Rat Aquaporin 8 (AQP8) Antiserum # 2 |
100 ul |
369 |
|
AQP91-A |
Anti-Rat Aquaporin 9 (AQP9) IgG # 1, aff pure |
100 ug |
434 |
|
AQP91-P |
Rat Aquaporin 9 (AQP9) Control/blocking peptide #1 |
100 ug |
161 |
|
AQP91-S |
Anti-Rat Aquaporin 9 (AQP9) Antiserum # 1 |
100 ul |
369 |
|
AQP92-P |
Rat Aquaporin 9 (AQP9) Control/blocking peptide # 2 |
100 ug |
161 |
|
AQP92-S |
Anti-Rat Aquaporin 9 (AQP9) Antiserum # 2 |
100 ul |
369 |
|
AQPAP11-A |
Anti-Human AQPAP IgG # 1, aff pure |
100 ug |
434 |
|
AQPAP11-P |
Human AQPAP Control/blocking peptide # 1 |
100 ug |
161 |
|
AQPAP11-S |
Anti-Human AQPAP Antiserum # 1 |
100 ul |
369 |
|
AQPAP12-P |
Human AQPAP Control/blocking peptide # 2 |
100 ug |
161 |
|
AQPAP12-S |
Anti-Human AQPAP Antiserum # 2 |
100 ul |
369 |
|
AR11-A |
Anti-Rat Androgen Receptor (AR) IgG #1, aff pure |
100 ug |
434 |
|
AR11-P |
Rat Androgen Receptor (AR) Control/blocking peptide #1 |
100 ug |
161 |
|
AR11-S |
Anti-Rat Androgen Receptor (AR) antiserum #1 |
100 ul |
369 |
|
AR13-M |
Mouse Monoclonal Anti-Human Androgen Receptor (AR) IgG #3 |
100 ug |
434 |
|
ASIC11-A |
Anti-Rat Acid sensitive Ion channel (ASIC1/BNaC2) IgG #1, Aff. Pure |
100 ug |
434 |
|
ASIC11-P |
Rat Acid sensitive Ion channel (ASIC1/BNaC2) ab #1 Control/blocking
peptide #1 |
100 ug |
161 |
|
ASIC11-S |
Anti-Rat Acid sensitive Ion channel (ASIC1/BNaC2) ab #1 |
100 ul |
369 |
|
ASIC41-A |
Anti-Rat ASIC4/BNAC4/SPASIC IgG, aff pure |
100 ug |
434 |
|
ASIC41-P |
Rat ASIC4/BNAC4/SPASIC Control/blocking peptide |
100 ug |
161 |
|
ASIC41-S |
Anti-Rat ASIC4/BNAC4/SPASIC Antiserum |
100 ul |
369 |
|
ASICB12-A |
Anti-Rat Acid sensitive Ion channel (ASIC1-beta) Ab #1, Aff. Pure |
100 ug |
434 |
|
ASICB12-P |
Rat Acid sensitive Ion channel (ASIC1-beta) Control/blocking peptide #1 |
100 ug |
161 |
|
ASICB12-S |
Anti-Rat Acid sensitive Ion channel (ASIC1-beta) Antiserum #1 |
100 ul |
369 |
|
ASIC-PAN-51A |
Anti-Rat Acid sensitive Ion channels 1-3 mixture of 5 aff pure IgGs |
100 ug |
434 |
|
ASIC-PAN-51P |
Rat Acid sensitive Ion channels 1-3, mixture of 5 Control/blocking
peptides |
100 ug |
174 |
|
ASIC-PAN-51S |
Anti-Rat Acid sensitive Ion channels 1-3, mixture of 5 antisera |
100 ul |
369 |
|
ASP11-S |
Discontd:Anti-Aspartate antiserum (alternate item # ASP51-A) |
100 ul |
369 |
|
ASP51-A |
Anti-Aspartate IgG, aff pure |
100 ug |
434 |
|
ASP51-N-100 |
Aspartate-BSA Protein conjugate (blocking antigen) |
100 ug |
265 |
|
AT11-A |
Anti-Rat ATII, Type 1 receptor IgG #1, aff pure |
100 ug |
434 |
|
AT11-P |
Rat ATII, Type 1 receptor Control/blocking peptide # 1 |
100 ug |
161 |
|
AT11-S |
Anti-Rat ATII, Type 1 receptor Antiserum #1 |
100 ul |
369 |
|
AT12-A |
Anti-Rat ATII, Type 1 receptor IgG #2, aff pure |
100 ug |
434 |
|
AT12-P |
Rat ATII, Type 1 receptor Control/blocking peptide # 2 |
100 ug |
161 |
|
AT12-S |
Anti-Rat ATII, Type 1 receptor Antiserum #2 |
100 ul |
369 |
|
AT21-A |
Anti-Human ATII, Type 2 receptor IgG #1, aff pure |
100 ug |
434 |
|
AT21-BTN |
Anti-Human ATII, Type 2 receptor IgG-biotinylated |
50 ug |
434 |
|
AT21-P |
Human ATII, Type 2 receptor Control/blocking peptide #1 |
100 ug |
161 |
|
AT21-S |
Anti-Human AT2 Type 2 receptorAntiserum #1 |
100 ul |
369 |
|
AT22-A |
Anti-Human ATII, Type 2 receptor IgG #2, aff pure |
100 ug |
434 |
|
AT22-P |
Human ATII, Type 2 receptor Control/blocking peptide # 2 |
100 ug |
161 |
|
AT22-S |
Anti-Human ATII, Type 2 receptor Antiserum #2 |
100 ul |
369 |
|
AT51-M |
Monoclonal Anti-Human Angiotensin I IgG, aff pure |
100 ug |
434 |
|
AT52-A |
Anti-Human Angiotensin I IgG, aff pure |
100 ug |
434 |
|
AT55-P-5 |
Human Angiotensin I, pure (bioactive) |
5 mg |
148 |
|
AT56-P-1 |
Rat/Canine Angiotensin I, pure (bioactive) |
1 mg |
148 |
|
AT61-M |
Monoclonal Anti-Human Angiotensin II IgG, aff pure |
100 ug |
434 |
|
AT62-A |
Anti-Human Angiotensin II IgG, aff pure |
100 ug |
434 |
|
AT65-P-5 |
Human Angiotensin II, pure (bioactive) |
5 mg |
148 |
|
AT66-P-5 |
Human Angiotensin II (1-4), pure (bioactive) |
5 mg |
148 |
|
AT67-P-5 |
Human Angiotensin II (3-8), pure (bioactive) |
5 mg |
148 |
|
AT68-P-5 |
Human Angiotensin II (4-8), pure (bioactive) |
5 mg |
148 |
|
AT69-P-5 |
Human Angiotensin II (5-8), pure (bioactive) |
5 mg |
148 |
|
AT75-P-5 |
Human Angiotensin III, pure (bioactive) |
5 mg |
148 |
|
ATR11-A |
Anti-human Anthrax Toxin Receptor 1, aff pure IgG # 1 |
100 ug |
434 |
|
ATR11-P |
Human Anthrax toxin receptor protein Control/blocking peptide # 1 |
100 ug |
161 |
|
ATR12-A |
Anti-human Anthrax Toxin Receptor 1, aff pure IgG # 2 |
100 ug |
434 |
|
ATR12-P |
Human Anthrax toxin receptor 1 protein Control/blocking peptide # 2 |
100 ug |
161 |
|
ATR31-A |
Anti-human Anthrax Toxin Receptor 3, aff pure IgG #1 |
100 ug |
434 |
|
ATR31-P |
Human Anthrax toxin receptor 3 protein Control/blocking peptide # 1 |
100 ug |
161 |
|
AVEN11-A |
Anti-Human Aven IgG # 1, aff. pure |
100 ug |
434 |
|
AVEN11-P |
Human Aven Control/blocking peptide # 1 |
100 ug |
161 |
|
AVEN11-S |
Anti-Human Aven antiserum # 1 |
100 ul |
369 |
|
AVEN12-A |
Anti-Mouse Aven IgG # 2, aff. pure |
100 ug |
434 |
|
AVEN12-P |
Mouse Aven Control/blocking peptide # 2 |
100 ug |
161 |
|
AVEN12-S |
Anti-Human Aven antiserum # 2 |
100 ul |
369 |
|
AVP1A11-A |
Anti-Rat AVP V1a IgG #1, aff pure |
100 ug |
434 |
|
AVP1A11-P |
Rat AVP V1a Control/blocking peptide # 1 |
100 ug |
161 |
|
AVP1A11-S |
Anti-Rat AVP V1a Antiserum #1 |
100 ul |
369 |
|
AVP1A12-A |
Anti-Rat AVP V1a IgG #2, aff pure |
100 ug |
434 |
|
AVP1A12-P |
Rat AVP V1a Control/blocking peptide # 2 |
100 ug |
161 |
|
AVP1A12-S |
Anti-Rat AVP V1a Antiserum #2 |
100 ul |
369 |
|
AVP1B13-A |
Anti-Rat AVP V1b IgG, aff pure |
100 ug |
434 |
|
AVP1B13-P |
Rat AVP V1b Control/blocking peptide |
100 ug |
161 |
|
AVP1B13-S |
Anti-Rat AVP V1b Antiserum |
100 ul |
369 |
|
AVPV21-A |
Anti-Rat AVP-V2 IgG, aff pure |
100 ug |
434 |
|
AVPV21-P |
Rat AVP-V2 Control/blocking peptide |
100 ug |
161 |
|
AVPV21-S |
Anti-Rat AVP-V2 Antiserum |
100 ul |
369 |
|
B2GP11-C |
Human beta-2 glycoprotein (B2-GP or Apolipoprotein H/ApoH) W. Blot +ve
control |
100 ul |
258 |
|
B2GP11-M |
monoclonal Anti-Human beta-2 glycoprotein (B2-GP or Apolipoprotein
H/ApoH) IgG |
100 ug |
434 |
|
B2GP15-N-25 |
Purified human beta-2 glycoprotein (B2-GP or Apolipoprotein H/ApoH)
protein for ELISA |
25 ug |
265 |
|
B2M11-C |
Purified Human beta-2 microglobulin (B2M) WB +ve control |
100 ul |
258 |
|
B2M11-S |
Anti-Human beta-2 microglobulin (B2M) antiserum # 1 |
100 ul |
369 |
|
B2M12-M |
Monoclonal Anti-Human beta-2 microglobulin (B2M) ascites |
100 ul |
434 |
|
B2M15-N |
Purified Human beta-2 microglobulin (B2M) protein for ELISA/Standards |
50 ug |
343 |
|
B3AR11-P |
Human beta-3 Adrenergic receptor Control/blocking peptide # 1 |
100 ug |
161 |
|
B3AR12-A |
Anti-Human beta-3 Adrenergic receptor IgG # 2, aff. Pure |
100 ug |
434 |
|
B3AR12-P |
Human beta-3 Adrenergic receptor Control/blocking peptide # 2 |
100 ug |
161 |
|
B3AR12-S |
Anti-Human beta-3 Adrenergic receptor antiserum # 2 |
100 ul |
369 |
|
B3AR13-A |
Anti-Mouse beta-3 Adrenergic receptor IgG # 3, aff. Pure |
100 ul |
434 |
|
B3AR13-P |
Mouse beta-3 Adrenergic receptor Control/blocking peptide # 3 |
100 ug |
161 |
|
B3AR13-S |
Anti-Mouse beta-3 Adrenergic receptor antiserum # 3 |
100 ul |
369 |
|
BACE11-A |
Anti-Human beta-site APP cleaving enzyme (BACE/Asp2) IgG #1, aff. pure |
100 ug |
434 |
|
BACE11-P |
Human beta-site APP cleaving enzyme (BACE/Asp2) Control/blocking
peptide #1 |
100 ug |
161 |
|
BACE11-S |
Anti-Human beta-site APP cleaving enzyme (BACE/Asp2) antiserum #1 |
100 ul |
369 |
|
BACE12-A |
Anti-Human beta-site APP cleaving enzyme (BACE/Asp2) IgG #2, aff. pure |
100 ug |
434 |
|
BACE12-C |
Purified, recombinant Human BACE1 control protein (EC domain 1-460 aa)
for WB |
100 ul |
258 |
|
BACE12-P |
Human beta-site APP cleaving enzyme (BACE/Asp2) Control/blocking
peptide #2 |
100 ug |
161 |
|
BACE12-S |
Anti-Human beta-site APP cleaving enzyme (BACE/Asp2) antiserum #2 |
100 ul |
369 |
|
BACE13-M |
Mouse Monoclonal Anti-Human beta-site APP cleaving enzyme protein
(BACE/Asp2) IgG #3, aff. Pure |
100 ug |
434 |
|
BACE15-R-50 |
Purified recombinant Human BACE1 protein (EC domain 1-460 aa) for ELISA |
50 ug |
824 |
|
BACE21-A |
Anti-Human beta-site APP cleaving enzyme (BACE2/Asp1) IgG #1, aff. Pure |
100 ug |
434 |
|
BACE21-P |
Human beta-site APP cleaving enzyme (BACE2/Asp1) Control/blocking
peptide #1 |
100 ug |
161 |
|
BACE21-S |
Anti-Human beta-site APP cleaving enzyme (BACE2/Asp1) antiserum #1 |
100 ul |
369 |
|
BACE-SS |
Human BACE/Asp2 substrate (Swedish type) APP590-603 |
100 ug |
148 |
|
BACE-SW |
Human BACE/Asp2 substrate (wild type) APP590-603 |
100 ug |
148 |
|
BAM2535-1 |
Human beta-Amyloid 25-35 fragment |
1 mg |
239 |
|
BAM400-P |
Human beta-Amyloid 1-40 (full length) peptide |
100 ug |
174 |
|
BAM400-P1000 |
Human beta-Amyloid 1-40 (full length) peptide |
1000 ug |
369 |
|
BAM401-A |
Anti-Human Beta-Amyloid 1-40 IgG #1, aff pure |
100 ug |
434 |
|
BAM401-P |
Beta-Human Amyloid 1-40 (C-terminal, 8 aa) Control/blocking peptide # 1 |
100 ug |
161 |
|
BAM401-S |
Anti-Human Beta-Amyloid 1-40 antiserum #1 |
100 ul |
369 |
|
BAM402-P |
Human Beta-Amyloid 1-40 Control/blocking peptide |
100 ug |
161 |
|
BAM402-S |
Anti-Human Beta-Amyloid 1-40/42 antiserum |
100 ul |
369 |
|
BAM403-M |
Monoclonal Anti-Human Beta-Amyloid 1-40/42 Ab, Neat ascites |
100 ul |
434 |
|
BAM404-P |
Human beta amyloid 10-24 aa Control/blocking peptide # 4 |
100 ug |
161 |
|
BAM404-S |
Anti-Human Beta-Amyloid 1-40/42 (10-24 aa) antiserum |
100 ul |
369 |
|
BAM421-A |
Anti-Human Beta-Amyloid 1-42 IgG # 1, aff pure |
100 ug |
434 |
|
BAM421-P |
Beta-Human Amyloid 1-42 (C-terminal, 8 aa) Control/blocking peptide # 1 |
100 ug |
161 |
|
BAM421-S |
Anti-Human Beta-Amyloid 1-42 antiserum # 1 |
100 ul |
369 |
|
BAM422-P |
Human beta-Amyloid 1-42 (full length) peptide |
100 ug |
174 |
|
BAM422-P1000 |
Human beta-Amyloid 1-42 (full length) peptide |
1000 ug |
369 |
|
BDNF11-C |
Purified Human Brain Derived Neurotrophic Factor (BDNF) Protein Control
for Western |
100 ul |
258 |
|
BDNF11-M |
Monoclonal Anti-Human Brain Derived Neurotrophic Factor (BDNF) IgG #1,
aff. Pure |
100 ug |
434 |
|
BDNF11-R |
Recombinant Human Brain Derived Neurotrophic Factor (BDNF) Protein |
5 ug |
499 |
|
BGAL11-C |
Beta-Galactosidase (E. Coli) Protein for Western Blot |
100 ul |
258 |
|
BGAL11-M |
Monoclonal Anti-beta-Galactosidase (E. Coli) ascites |
100 ul |
434 |
|
BGAL12-A |
Anti Beta-Galactosidase (E. Coli) IgG |
1 mg |
434 |
|
BGAL12-BTN |
Anti Beta-Galactosidase (E. Coli) IgG-Biotin conjugate |
100 ul |
408 |
|
BGAL12-FITC |
Anti Beta-Galactosidase (E. Coli) IgG-FITC conjugate |
100 ul |
369 |
|
BGAL12-HRP |
Anti Beta-Galactosidase (E. Coli) IgG-HRP conjugate |
100 ul |
369 |
|
BGAL12-S |
Anti Beta-Galactosidase (E. Coli) antiserum |
100 ul |
369 |
|
BGAL15-AS |
Anti Beta-Galactosidase (E. Coli) IgG-Agarose (aff matrix) |
0.5 ml |
369 |
|
BGAL15-R |
Recombinant purified Beta-Galactosidase (E. Coli) Protein for ELISA |
100 ug |
278 |
|
BGT11-A |
Anti-Rat Betaine GABA Transp. (BGT-1) IgG #1, aff pure |
100 ug |
434 |
|
BGT11-P |
Rat Betaine GABA Transp. (BGT-1) Control/blocking peptide #1 |
100 ug |
161 |
|
BGT11-S |
Anti-Rat Betaine GABA Transp. (BGT-1) antiserum # 1 |
100 ul |
369 |
|
BHSD11-A |
Anti-Mouse 11-beta hydroxysteroid dehydrogenase-1 (11 beta-HSD-1) IgG,
aff pure |
100 ug |
434 |
|
BHSD11-P |
Mouse 11-beta hydroxysteroid dehydrogenase-1 (11 beta-HSD-1)
Control/blocking peptide |
100 ug |
161 |
|
BHSD11-S |
Anti-Mouse 11-beta hydroxysteroid dehydrogenase-1 (11 beta-HSD-1)
antiserum |
100 ul |
369 |
|
BHSD21-A |
Anti-Rat 11-beta hydroxysteroid dehydrogenase-2 (11 beta-HSD-2) IgG # 1,
aff pure |
100 ug |
434 |
|
BHSD21-P |
Rat 11-beta hydroxysteroid dehydrogenase-2 (11 beta-HSD-2)
Control/blocking peptide # 1 |
100 ug |
161 |
|
BHSD21-S |
Anti-Rat 11-beta hydroxysteroid dehydrogenase-2 (11 beta-HSD-2)
antiserum # 1 |
100 ul |
369 |
|
BHSD22-A |
Anti-Mouse 11-beta hydroxysteroid dehydrogenase-2 (11 beta-HSD-2) IgG
#2, aff pure |
100 ug |
434 |
|
BHSD22-P |
Mouse 11-beta hydroxysteroid dehydrogenase-2 (11 beta-HSD-2)
Control/blocking peptide #2 |
100 ug |
161 |
|
BHSD22-S |
Anti-Mouse 11-beta hydroxysteroid dehydrogenase-2 (11 beta-HSD-2)
antiserum #2 |
100 ul |
369 |
|
BHSD23-A |
Anti-Human 11-beta hydroxysteroid dehydrogenase-2 (11 beta-HSD-2) IgG
#3, aff pure |
100 ug |
434 |
|
BHSD23-P |
Human 11-beta hydroxysteroid dehydrogenase-2 (11 beta-HSD-2)
Control/blocking peptide #3 |
100 ug |
161 |
|
BHSD23-S |
Anti-Human 11-beta hydroxysteroid dehydrogenase-2 (11 beta-HSD-2)
antiserum #3 |
100 ul |
369 |
|
BIN1B11-A |
Anti-Rat Bin1b IgG #1, aff pure |
100 ug |
434 |
|
BIN1B11-P |
Rat Bin 1b Control/blocking peptide #1 |
100 ug |
161 |
|
BMALD11-A |
Anti-Drosophila BMAL IgG #1, aff pure |
100 ug |
434 |
|
BMALD11-P |
Drosophila BMAL Control/blocking peptide # 1 |
100 ug |
161 |
|
BMALD11-S |
Anti-Drosophila BMAL Antiserum #1 |
100 ul |
369 |
|
BMP12-A |
Anti-Bone Morphogenetic protein 1 (BMP1) peptide (NT) IgG #2, aff pure |
100 ug |
434 |
|
BMP12-C |
Human recombinant purified BMP-1 protein control for WB |
100 ul |
258 |
|
BMP12-P |
Human Bone Morphogenetic protein 1 (BMP-1) Control/blocking peptide # 2 |
100 ug |
161 |
|
BMP131-C |
Human recombinant, purified BMP-13 (CDMP-2/GDF-6) protein control for WB |
100 ul |
258 |
|
BMP131-S |
Anti-Human BMP-13 (CDMP-2/GDF-6) protein antiserum |
100 ul |
369 |
|
BMP135-R-10 |
Purified Recombinant Human BMP-13 (CDMP-2/GDF-6), Biologically active,
Carrier free |
10 ug |
434 |
|
BMP135-R-50 |
Purified Recombinant Human BMP-13 (CDMP-2/GDF-6), Biologically active,
Carrier free |
50 ug |
954 |
|
BMP141-C |
Human recombinant, purified BMP-14 (CDMP-1/GDF-5) protein control for WB |
100 ul |
258 |
|
BMP141-S |
Anti-Human BMP-14 (CDMP-1/GDF-5) antiserum |
100 ul |
369 |
|
BMP145-R-10 |
Purified Recombinant Human BMP-14 (CDMP-1/GDF-5), Biologically active,
Carrier free |
10 ug |
434 |
|
BMP145-R-50 |
Purified Recombinant Human BMP-14 (CDMP-1/GDF-5), Biologically active,
Carrier free |
50 ug |
954 |
|
BMP21-C |
Human recombinant, purified BMP2 protein Western blot +ve control |
100 ul |
258 |
|
BMP21-M |
Mouse Monoclonal Anti-Human Bone Morphogenetic protein 2 (BMP2), IgG #
1, aff pure |
100 ug |
434 |
|
BMP22-S |
Anti-Human Bone Morphogenic Protein 2 (BMP-2) antiserum |
100 ul |
369 |
|
BMP25-R-10 |
Purified Recombinant Human BMP2 protein, Biologically active, Carrier
free |
10 ug |
954 |
|
BMP31-C |
Human recombinant, purified BMP3 protein Western blot +ve control |
100 ul |
258 |
|
BMP32-M |
Mouse Monoclonal Anti-Bone Morphogenetic protein 3 (BMP3), IgG # 1, aff
pure |
100 ug |
434 |
|
BMP3b11-A |
Anti-Human Bone Morphogenetic protein 3b (BMP3b) IgG #1, aff pure |
100 ug |
434 |
|
BMP3b11-P |
Human Bone Morphogenetic protein 3b (BMP3b) Control/blocking peptide # 1 |
100 ug |
161 |
|
BMP3b12-A |
Anti-Human Bone Morphogenetic protein 3b (BMP3b) IgG #2, aff pure |
100 ug |
434 |
|
BMP3b12-P |
Human Bone Morphogenetic protein 3b (BMP3b) Control/blocking peptide # 2 |
100 ug |
161 |
|
BMP41-C |
Human recombinant, purified BMP4 protein Western blot +ve control |
100 ul |
258 |
|
BMP41-M |
Mouse Monoclonal Anti- Human Bone Morphogenetic protein 4 (BMP4), IgG #
1, aff pure |
100 ug |
434 |
|
BMP45-R-10 |
Purified Recombinant Human BMP4 protein, Biologically active, |
10 ug |
954 |
|
BMP45-R-5 |
Purified Recombinant Human BMP4 protein, Biologically active |
5 ug |
564 |
|
BMP51-C |
Human recombinant, purified BMP5 protein Western blot +ve control |
100 ul |
258 |
|
BMP51-M |
Mouse Monoclonal Anti- Human Bone Morphogenetic protein 5 (BMP5), IgG #
1, aff pure |
100 ug |
434 |
|
BMP61-C |
Human recombinant, purified BMP6 protein Western blot +ve control |
100 ul |
258 |
|
BMP61-M |
Mouse Monoclonal Anti- Human Bone Morphogenetic protein 6 (BMP6), IgG #
1, aff pure |
100 ug |
434 |
|
BMP65-R-10 |
Purified Recombinant Human BMP6 protein, Biologically active |
10 ug |
564 |
|
BMP65-R-20 |
Purified Recombinant Human BMP6 protein, Biologically active |
20 ug |
954 |
|
BMP71-C |
Human recombinant, purified BMP7 protein Western blot +ve control |
100 ul |
304 |
|
BMP71-M |
Mouse Monoclonal Anti- Human Bone Morphogenetic protein 7 (BMP7), IgG #
1, aff pure |
100 ug |
434 |
|
BMP72-A |
Anti- Human Bone Morphogenetic protein 7 (BMP7) IgG #2, aff pure |
100 ug |
434 |
|
BMP72-P |
Human Bone Morphogenetic protein 7b (BMP7), Control/blocking peptide # 2 |
100 ug |
161 |
|
BMP72-S |
Anti-Human Bone Morphogenic Protein 7 (BMP7) antiserum #1 |
100 ul |
369 |
|
BMP75-R-10 |
Purified Recombinant Human BMP7 protein, Biologically active |
10 ug |
954 |
|
BMP76-R-10 |
Purified Recombinant Human BMP7 protein, non-glycosylated (E. coli) |
10 ug |
694 |
|
BMP76-R-5 |
Purified Recombinant Human BMP7 protein, non-glycosylated (E. coli) |
5 ug |
434 |
|
BMP81-M |
Mouse Monoclonal Anti- Human Bone Morphogenetic protein 8 (BMP8), IgG #
1, aff pure |
100 ug |
434 |
|
bNOS11-C |
Purified recombinant human brain Nitric Oxide Synthase (bNOS/NOS-1)
protein Western blot +ve control |
100 ul |
258 |
|
bNOS12-M |
Monoclonal anti-Rat brain Nitric Oxide Synthase (bNOS/NOS-1), ascites |
100 ul |
434 |
|
bNOS13-P |
Rat brain Nitric Oxide Synthase (bNOS/NOS-1) Control/blocking peptide #
3 |
100 ug |
161 |
|
bNOS13-S |
anti-rat brain Nitric Oxide Synthase (bNOS/NOS-1) IgG # 3 |
100 ul |
369 |
|
bNOS14-C |
Rat brain Nitric Oxide Synthase (bNOS/NOS-1) protein WB +ve protein
control |
100 ul |
258 |
|
bNOS14-P |
Rat brain Nitric Oxide Synthase (bNOS/NOS-1) Control/blocking peptide #
4 |
100 ug |
161 |
|
bNOS14-S |
Anti-Rat brain Nitric Oxide Synthase (bNOS/NOS-1) IgG # 4 |
100 ul |
369 |
|
bNOS71-D |
Rat bNOS (nNOS/cNOS) cDNA probe |
1 ug |
369 |
|
bNOS-A |
Anti-Human brain Nitric Oxide Synthase (bNOS/NOS-1) IgG # 1, aff pure |
100 ug |
434 |
|
bNOS-P |
Human brain Nitric Oxide Synthase (bNOS/NOS-1) Control/blocking peptide
# 1 |
100 ug |
161 |
|
bNOS-S |
Anti-Human brain Nitric Oxide Synthase (bNOS/NOS-1) Antiserum # 1 |
100 ul |
369 |
|
BOM11-P |
Human Bombesin 1-14 aa full length peptide |
1 mg |
109 |
|
BRS31-A |
Anti-Human Bombesin Receptor Subtype-3 (BRS-3) IgG # 1, aff pure |
100 ug |
434 |
|
BRS31-P |
Human Bombesin Receptor Subtype-3 (BRS-3) Control/blocking peptide # 1 |
100 ug |
161 |
|
BRS31-S |
Anti-Human Bombesin Receptor Subtype-3 (BRS-3) antiserum # 1 |
100 ul |
369 |
|
BRTN11-A |
Anti-Human Human Barttin IgG, aff pure |
100 ug |
434 |
|
BRTN11-P |
Human Barttin Control/blocking peptide |
100 ug |
161 |
|
BRTN11-S |
Anti-Human Barttin antiserum |
100 ul |
369 |
|
BSA11-AS |
Anti-Bovine Serum albumin (BSA)-agarose (aff matrix) |
0.5 ml |
239 |
|
C1Q11-C |
Purified Human C1q protein Western blot +ve control |
100 ul |
258 |
|
C1Q11-S |
Anti-Human C1q protein antiserum |
100 ul |
369 |
|
C1Q12-M |
Monoclonal Anti-Human C1q protein IgG |
100 ug |
434 |
|
C1Q12-MB |
Monoclonal Anti-Human C1q protein IgG biotinylated |
100 ug |
434 |
|
C1Q13-M |
Monoclonal Anti-Mouse C1q protein IgG |
100 ug |
434 |
|
C1Q13-MB |
Monoclonal Anti-Mouse C1q protein IgG biotinylated |
100 ug |
434 |
|
C1Q15-N |
Purified Human C1q protein for ELISA or Standards |
100 ug |
265 |
|
C1Q15-N-1000 |
Purified Human C1q protein for ELISA or Standards |
1000 ug |
889 |
|
C28R21-A |
Anti-Human C28R2 (Ca-pump inhibitory peptide) IgG # 2, aff. Pure |
100 ug |
434 |
|
C28R21-P |
Human C28R2 (Ca-pump inhibitory peptide) Control/blocking peptide #1 |
100 ug |
161 |
|
C28R21-S |
Anti-Human C28R2 (Ca-pump inhibitory peptide) Antiserum # 1 |
100 ul |
369 |
|
C311-A |
Anti-Mouse C3 IgG, aff pure |
100 ug |
434 |
|
C311-BTN |
Anti-Mouse C3 IgG-biotin conjugate |
50 ug |
408 |
|
C311-S |
Anti-Mouse C3 antiserum |
100 ul |
369 |
|
C312-A |
Anti-Rat C3 IgG, aff pure |
100 ug |
434 |
|
C312-BTN |
Anti-Rat C3 IgG-biotin conjugate |
50 ug |
408 |
|
C312-S |
Anti-Rat C3 antiserum |
100 ul |
369 |
|
C313-A |
Anti-Dog C3 IgG, aff pure |
100 ug |
434 |
|
C313-BTN |
Anti-Dog C3 IgG-biotin conjugate |
50 ug |
408 |
|
C313-S |
Anti-Dog C3 antiserum |
100 ul |
369 |
|
C314-N-100 |
Purified Human serum C3 protein |
100 ug |
304 |
|
C314-S |
Anti-Human C3 antiserum |
100 ul |
369 |
|
C3A15-N-25 |
Purified Human serum C3a protein |
25 ug |
304 |
|
C3A16-N-25 |
Purified Human serum C3a des-Arg protein |
25 ug |
304 |
|
C3B17-N-100 |
Purified Human serum C3b protein |
100 ug |
304 |
|
C3B19-N-100 |
Purified Human serum iC3b protein |
100 ug |
304 |
|
C3D18-N-25 |
Purified Human C3d protein |
25 ug |
304 |
|
CA1531-M |
Monoclonal Anti-Human cancer associated antigen CA153 (CA15-3) IgG #1 |
1 mg |
1.019 |
|
CA1532-M |
Monoclonal Anti-Human cancer associated antigen CA153 (CA15-3) IgG #2 |
1 mg |
1.019 |
|
CA153-N-10 |
Human cancer associated antigen CA153 (CA15-3) purified |
10 KU |
694 |
|
CA1991-M |
Monoclonal Anti-Human Cancer Antigen 19-9 (CA199 or CA19-9) IgG # 1, aff
pure |
1 mg |
759 |
|
CACH11-P |
Human Cachectic Factor Control/blocking peptide #1 |
100 ug |
161 |
|
CACH11-S |
Human Cachectic Factor peptide antiserum # 1 |
100 ul |
369 |
|
CACH12-S |
Human Cachectic Factor protein antiserum #2 |
100 ul |
369 |
|
CALN11-A |
Anti-bovine Calcineurin (A+B subunits) protein, IgG, aff pure |
100 ug |
434 |
|
CALN11-C |
Purified Bovine Calcineurin protein (A+B subunits) WB +Ve control |
100 ul |
258 |
|
CALNA12-A |
Anti-Human Calcineurin A-subunit IgG aff pure |
100 ug |
434 |
|
CALNA12-C |
Human Calcineurin A-subunit protein WB +Ve control |
100 ul |
258 |
|
CALNA12-P |
Human Calcineurin A-subunit Control/blocking peptide |
100 ug |
161 |
|
CALNA13-M |
Monoclonal Anti-Human Calcineurin A-subunit ascites |
100 ul |
434 |
|
CALNA15-R |
Human Calcineurin A-subunit protein biologically active |
1000 U |
369 |
|
CALNB21-C |
Human Calcineurin B -subunit protein WB +Ve control |
100 ul |
258 |
|
CALNB21-S |
Anti-Mouse Calcineurin B subunit antiserum |
100 ul |
369 |
|
CALS11-A |
Anti-Mouse Calsarcin-1/Myozenin-2 IgG, aff pure |
100 ug |
434 |
|
CALS11-P |
Mouse Calsarcin-1/Myozenin-2 Control/blocking peptide |
100 ug |
161 |
|
CALS11-S |
Anti-Mouse Calsarcin-1/Myozenin-2 antiserum |
100 ul |
369 |
|
CALS21-A |
Anti-Mouse Calsarcin-2/Myozenin-1 IgG, aff pure |
100 ug |
434 |
|
CALS21-P |
Mouse Calsarcin-2/Myozenin-1 Control/blocking peptide |
100 ug |
161 |
|
CALS21-S |
Anti-Mouse Calsarcin-2/Myozenin-1 antiserum |
100 ul |
369 |
|
CART11-A |
Anti-Mouse Cocaine Amphetamine Rel. Transcript (CART, 55-102) IgG # 1,
aff pure |
100 ug |
434 |
|
CART11-P |
Mouse Cocaine Amphetamine Rel. Transcript (CART, 55-102)
Control/blocking peptide # 1 |
100 ug |
304 |
|
CART11-S |
Anti-Mouse Cocaine Amphetamine Rel. Transcript (CART) Antiserum #1 |
100 ul |
369 |
|
CART12-P |
Mouse Cocaine Amphetamine Rel. Transcript (CART, 55-102)
Control/blocking peptide #2 |
100 ug |
304 |
|
CART12-S |
Anti-Mouse Cocaine Amphetamine Rel. Transcript (CAR 55-102T) Antiserum
#2 |
100 ul |
369 |
|
CART13-P1 |
Mouse Cocaine Amphetamine Rel. Transcript (CART) 55-102 aa (cyclized) |
100 ug |
434 |
|
CART14-P1 |
Biotinylated-Mouse Cocaine Amphetamine Rel. Transcript (CART) 55-102 aa
(cyclized) |
100 ug |
434 |
|
CART51-P |
Human/Rat Cocaine Amphetamine Rel. Transcript (CART) 1-39aa |
100 ug |
304 |
|
CART52-P |
Human Cocaine Amphetamine Rel. Transcript (CART) 55-102aa |
100 ug |
304 |
|
CART53-P |
Human Cocaine Amphetamine Rel. Transcript (CART) 62-102aa |
100 ug |
304 |
|
CART54-P |
Human Cocaine Amphetamine Rel. Transcript (CART) 62-76aa |
500 ug |
239 |
|
CASP111-A |
Anti-Mouse Caspase 11 (ICH-3 Protease) IgG #1, aff pure |
100 ug |
434 |
|
CASP111-P |
Mouse Caspase 11 (ICH-3 Protease) Control/blocking peptide |
100 ug |
161 |
|
CASP111-S |
Anti-Mouse Caspase 11 (ICH-3 Protease) antiserum #1 |
100 ul |
369 |
|
CASP31-S |
Anti-Mouse Caspase-3 (ICE-3/LICE/Yama/CASP-3) antiserum #1 |
100 ul |
369 |
|
CASP61-A |
Anti-Human Caspase-6 (ICE-6/MCH-2, CASP-6) IgG #1, aff. pure |
100 ug |
434 |
|
CASP81-A |
Anti-Mouse Caspase 8 (ICE8/MACH/FLICE) IgG #1, aff pure |
100 ug |
434 |
|
CASP81-P |
Mouse Caspase 8 (ICE8/MACH/FLICE) Control/blocking peptide #1 |
100 ug |
161 |
|
CASP81-S |
Anti-Mouse Caspase 8 (ICE8/MACH/FLICE) antiserum #1 |
100 ul |
369 |
|
CASP82-A |
Anti-Mouse Caspase 8 (ICE8/MACH/FLICE) IgG #1, aff pure |
100 ug |
434 |
|
CASP82-P |
Human Caspase 8 (ICE8/MACH/FLICE) Control/blocking peptide #2 |
100 ug |
161 |
|
CASP82-S |
Anti-Human Caspase 8 (ICE8/MACH/FLICE) antiserum #1 |
100 ul |
369 |
|
CASP91-A |
Anti-Human Caspase 9 (ICE9/Pro-Mch6) p35 subunit IgG #1, aff. pure |
100 ug |
434 |
|
CASP91-P |
Human Caspase 9 (ICE9/Pro-Mch6) p35 subunit Control/blocking peptide # 1 |
100 ug |
161 |
|
CASP91-S |
Anti-Human Caspase 9 (ICE9/Pro-Mch6) p35 subunit antiserum #1 |
100 ul |
369 |
|
CASP92-A |
Anti-Human Caspase 9 (ICE9/Pro-Mch6) IgG #2, aff. pure |
100 ug |
434 |
|
CASP92-P |
Human Caspase 9 (ICE9/Pro-Mch6) Control/blocking peptide #2 |
100 ug |
161 |
|
CASP92-S |
Anti-Human Caspase 9 (ICE9/Pro-Mch6) antiserum #2 |
100 ul |
369 |
|
CASP93-P |
Human Caspase 9 (ICE9/Pro-Mch6) Control/blocking peptide #3 |
100 ug |
161 |
|
CASP93-S |
Anti-Human Caspase 9 (ICE9/Pro-Mch6) antiserum #3 |
100 ul |
369 |
|
CASR11-A |
Anti-Human Ca-Sensing Receptor 1 (CaSR) IgG #1, aff pure |
100 ug |
434 |
|
CASR11-P |
Human Ca-Sensing Receptor 1 (CaSR) Control/blocking peptide #1 |
100 ug |
161 |
|
CASR11-S |
Anti-Human Ca-Sensing Receptor 1 (CaSR) Antiserum #1 |
100 ul |
369 |
|
CAT11-A |
Anti-Rat Calcium transporter 1 (Cat-1/ECAC2 ) IgG #1, aff pure |
100 ug |
434 |
|
CAT11-P |
Rat Calcium transporter 1 (Cat-1/ECAC2 ) Control/blocking peptide #1 |
100 ug |
161 |
|
CAT11-S |
Anti- Rat Calcium transporter 1 (Cat-1/ECAC2 ) Antiserum #1 |
100 ul |
369 |
|
CAT21-A |
Anti-Rat Calcium transporter 2 (Cat-2/ECAC1 ) IgG #1, aff pure |
100 ug |
434 |
|
CAT21-P |
Rat Calcium transporter 2 (Cat-2/ECAC1 ) Control/blocking peptide #1 |
100 ug |
161 |
|
CAT21-S |
Anti-Rat Calcium transporter 2 (Cat-2/ECAC1 ) Antiserum #1 |
100 ul |
369 |
|
CATL11-A |
Anti-human Catalase (CATL) protein IgG |
100 ul |
434 |
|
CATL11-C |
Purified human Catalase (CATL) protein control for WB |
100 ul |
258 |
|
CB11-A |
Anti-Human Cannabinoid receptor (CB1) IgG # 1, aff. pure |
100 ug |
434 |
|
CB11-P |
Human Cannabinoid receptor (CB1) Control/blocking peptide # 1 |
100 ug |
161 |
|
CB11-S |
Anti-Human Cannabinoid receptor (CB1) antiserum # 1 |
100 ul |
369 |
|
CB12-A |
Anti-Rat Cannabinoid receptor (CB1) IgG #2, aff. pure |
100 ug |
434 |
|
CB12-P |
Rat Cannabinoid receptor (CB1) Control/blocking peptide # 2 |
100 ug |
161 |
|
CB12-S |
Anti-Rat Cannabinoid receptor (CB1) antiserum #2 |
100 ul |
369 |
|
CB21-A |
Anti-Human Cannabinoid receptor (CB2) IgG # 1, aff pure |
100 ug |
434 |
|
CB21-P |
Human Cannabinoid receptor (CB2) Control/blocking peptide # 1 |
100 ug |
161 |
|
CB21-S |
Anti-Human Cannabinoid receptor (CB2) antiserum # 1 |
100 ul |
369 |
|
CB22-A |
Anti-Rat Cannabinoid receptor (CB2) IgG # 2, aff pure |
100 ug |
434 |
|
CB22-P |
Rat Cannabinoid receptor (CB2) Control/blocking peptide # 2 |
100 ug |
161 |
|
CB22-S |
Anti-Rat Cannabinoid receptor (CB2) antiserum # 2 |
100 ul |
369 |
|
CBFA11-A |
Anti-Human Core-binding factor alpha (CBFA1) aff pure IgG #1 |
100 ug |
434 |
|
CBFA11-P |
Human Core-binding factor alpha (CBFA1) Control/blocking peptide #1 |
100 ug |
161 |
|
CBFA11-S |
Anti-Human Core-binding factor alpha (CBFA1) antiserum #1 |
100 ul |
369 |
|
CBFA12-A |
Anti-mouse Core-binding factor alpha 1 (CBFA1) aff pure IgG # 2 |
100 ul |
434 |
|
CBFA12-P |
Mouse Core-binding factor alpha 1 (CBFA1) Control/blocking peptide # 2 |
100 ug |
161 |
|
CBFA21-A |
Anti-human Core-binding factor alpha 2 (CBFA2) aff pure IgG # 1 |
100 ul |
434 |
|
CBFA21-P |
Human Core-binding factor alpha 2 (CBFA2) Control/blocking peptide # 1 |
100 ug |
161 |
|
CBFA31-A |
Anti-human Core-binding factor alpha 3 (CBFA3) aff pure IgG # 1 |
100 ul |
434 |
|
CBFA31-P |
Human Core-binding factor alpha 3 (CBFA3) Control/blocking peptide # 1 |
100 ug |
161 |
|
CCR7-PC-100 |
Monoclonal Anti-Human CCR7 (CD197) PE-Cy7 conjugate |
100 tests |
603 |
|
CCS11-A |
Anti-Mouse Copper chaperone superoxide (CCS) dismutase IgG aff pure |
100 ug |
434 |
|
CCS11-P |
Copper chaperone superoxide dismutase control/blocking peptide |
100 ug |
161 |
|
CD81-M |
Monoclonal Anti-Human CD81 (TAPA-1) IgG,unconjugated |
100 ug |
434 |
|
CD81-PE-100 |
Monoclonal Anti-Human CD81 (TAPA-1)-PE Conjugate |
100 tests |
564 |
|
CD8-PC-50 |
Monoclonal Anti-Human CD8-PerCP-Cy5.5 conjugate |
50 tests |
603 |
|
CECA15-C |
Chicken Egg Conalbumin (ovotransferrin) protein control for Western |
100 ul |
239 |
|
CECA15-S |
Anti-Chicken Egg Conalbumin (ovotransferrin) protein |
100 ul |
369 |
|
CECA16-N |
Chicken Egg White Conalbumin (ovotransferrin) protein |
10 mg |
239 |
|
CEGT11-C |
Chicken Egg proteins total (whole egg) control for Western |
100 ul |
239 |
|
CEGT11-S |
Anti-Chicken Egg protein total (whole egg) antiserum |
100 ul |
369 |
|
CEGT15-N |
Chicken Egg proteins total (whole egg) |
10 mg |
239 |
|
CEGW12-C |
Chicken Egg white proteins total control for Western |
100 ul |
239 |
|
CEGW12-S |
Anti-Chicken Egg white proteins total |
100 ul |
369 |
|
CEGW15-N |
Chicken Egg white proteins total |
10 mg |
239 |
|
CELY14-C |
Chicken Egg white lysozyme (muramidase) protein control for Western |
100 ul |
239 |
|
CELY14-S |
Anti-Chicken Egg white lysozyme (muramidase) protein antiserum |
100 ul |
369 |
|
CELY15-N |
Chicken Egg white lysozyme (muramidase) protein |
100 mg |
239 |
|
CGRP11-A |
Anti-Human Calcitonin Gene Related Peptide (CGRP) IgG #1, aff pure |
100 ug |
434 |
|
CGRP11-P |
Anti-Human Calcitonin Gene Related Peptide (CGRP) Control/blocking
peptide #1 |
100 ug |
161 |
|
CGRP11-S |
Anti-Human Calcitonin Gene Related Peptide (CGRP) antiserum #1 |
100 ul |
369 |
|
CGRP12-A |
Anti-Human Calcitonin Gene Related Peptide (CGRP) IgG #2, aff pure |
100 ug |
434 |
|
CGRP12-P |
Human Calcitonin Gene Related Peptide (CGRP) Control/blocking peptide #2 |
100 ug |
161 |
|
CGRP12-S |
Anti-Human Calcitonin Gene Related Peptide (CGRP) antiserum #2 |
100 ul |
369 |
|
CGRP15-P-5 |
Human Calcitonin Gene Related Peptide (CGRP, 1-37) peptide |
500 ug |
434 |
|
CGRP16-P-5 |
Rat Calcitonin Gene Related Peptide (CGRP, 1-37) peptide |
500 ug |
434 |
|
ChREBP11-A |
Anti-rat Carbohydrate responsive element binding protein (CHREBP) IgG 1
(aff pure) |
100ug |
434 |
|
ChREBP11-P |
Anti-rat Carbohydrate responsive element binding protein (CHREBP) IgG 1
(aff pure) |
100ug |
161 |
|
ChREBP12-A |
Anti-human Carbohydrate responsive element binding protein (CHREBP) IgG
1 (aff pure) |
100ug |
434 |
|
ChREBP12-P |
Anti-human Carbohydrate responsive element binding protein (CHREBP) IgG
1 (aff pure) |
100ug |
161 |
|
CIP11-A |
Anti-Mouse p/CIP/p300 IgG # 1, aff pure |
100 ug |
434 |
|
CIP11-P |
Mouse p/CIP/p300 Control/blocking peptide # 1 |
100 ug |
161 |
|
CIP11-S |
Anti-Mouse p/CIP/p300 antiserum # 1 |
100 ul |
369 |
|
CIP12-A |
Anti-Mouse p/CIP/p300 IgG #2, aff pure |
100 ug |
434 |
|
CIP12-P |
Mouse p/CIP/p300 Control/blocking peptide # 2 |
100 ug |
161 |
|
CIP12-S |
Anti-Mouse p/CIP/p300 antiserum # 2 |
100 ul |
369 |
|
CISY11-A |
Anti-Mouse/Human Citrate synthase (CS) aff pure IgG |
100 ul |
434 |
|
CISY11-P |
Mouse/Human Citrate synthase (CS) Control/blocking peptide |
100 ug |
161 |
|
CISY11-S |
Anti-Mouse/Human Citrate synthase (CS) antiserum |
100 ul |
369 |
|
CISY13-S |
Anti-Pig Citrate synthase (CS) protein antiserum |
100 ul |
369 |
|
CISY14-M |
Mouse monoclonal Anti-Pig Citrate synthase (CS) protein IgG |
100 ug |
434 |
|
CLC11-A |
Anti-Rat Chloride channel 1 (CLC1) IgG #1, aff pure |
100 ug |
434 |
|
CLC11-P |
Rat Chloride channel 1 (CLC1) Control/blocking peptide # 1 |
100 ug |
161 |
|
CLC11-S |
Anti-Rat Chloride channel 1 (CLC1) Antiserum # 1 |
100 ul |
369 |
|
CLC12-A |
Anti-Rat Chloride channel 1 (CLC1) IgG #2, aff pure |
100 ug |
434 |
|
CLC12-P |
Rat Chloride channel 1 (CLC1) Control/blocking peptide # 2 |
100 ug |
161 |
|
CLC12-S |
Anti-Rat Chloride channel 1 (CLC1) Antiserum #2 |
100 ul |
369 |
|
CLC21-A |
Anti-Rat Chloride channel 2 (CLC2) IgG # 1, aff pure |
100 ug |
434 |
|
CLC21-P |
Rat Chloride channel 2 (CLC2) Control/blocking peptide # 1 |
100 ug |
161 |
|
CLC21-S |
Anti-Rat Chloride channel 2 (CLC2) Antiserum #1 |
100 ul |
369 |
|
CLC31-A |
Anti-Rat Chloride channel 3 (CLC3) IgG #1, aff pure |
100 ug |
434 |
|
CLC31-P |
Rat Chloride channel 3 (CLC3) Control/blocking peptide #1 |
100 ug |
161 |
|
CLC31-S |
Anti-Rat Chloride channel 3 (CLC3) Antiserum #1 |
100 ul |
369 |
|
CLC41-A |
Anti-Rat Chloride channel 4 (CLC4) IgG #1, aff pure |
100 ug |
434 |
|
CLC41-P |
Rat Chloride channel 4 (CLC4) Control/blocking peptide #1 |
100 ug |
161 |
|
CLC41-S |
Anti-Rat Chloride channel 4 (CLC4) Antiserum #1 |
100 ul |
369 |
|
CLC51-A |
Anti-Rat Chloride channel 5 (CLC5) IgG #1, aff pure |
100 ug |
434 |
|
CLC51-P |
Rat Chloride channel 5 (CLC5) Control/blocking peptide #1 |
100 ug |
161 |
|
CLC51-S |
Anti-Rat Chloride channel 5 (CLC5) Antiserum #1 |
100 ul |
369 |
|
CLC61-A |
Anti-Rat Chloride channel 6 (CLC6) IgG , aff pure |
100 ug |
434 |
|
CLC61-P |
Rat Chloride channel 6 (CLC6) Control/blocking peptide #1 |
100 ug |
161 |
|
CLC61-S |
Anti-Rat Chloride channel 6 (CLC6) Antiserum #1 |
100 ul |
369 |
|
CLC71-A |
Anti-Rat Chloride channel 7 (CLC7) IgG #1, aff pure |
100 ug |
434 |
|
CLC71-P |
Rat Chloride channel 7 (CLC7) Control/blocking peptide #1 |
100 ug |
161 |
|
CLC71-S |
Anti-Rat Chloride channel 7 (CLC7) Antiserum #1 |
100 ul |
369 |
|
CLC72-A |
Anti-Human Chloride channel 7 (CLC7) IgG #2, aff pure |
100 ug |
434 |
|
CLC72-P |
Human Chloride channel 7 (CLC7) Control/blocking peptide #2 |
100 ug |
161 |
|
CLC72-S |
Anti-Human Chloride channel 7 (CLC7) Antiserum #2 |
100 ul |
369 |
|
CLCK11-A |
Anti-Rat Chloride channel K1/2 (CLCK1/K2) IgG #1, aff pure |
100 ug |
434 |
|
CLCK11-P |
Rat Chloride channel K1/2 (CLCK1/K2)Control/blocking peptide #1 |
100 ug |
161 |
|
CLCK11-S |
Anti-Rat Chloride channel K1/2 (CLCK1/K2) Antiserum #1 |
100 ul |
369 |
|
CLO11-A |
Anti-Mouse Clock IgG #1, aff pure |
100 ug |
434 |
|
CLO11-P |
Mouse Clock Control/blocking peptide # 1 |
100 ug |
161 |
|
CLO11-S |
Anti-Mouse Clock Antiserum # 1 |
100 ul |
369 |
|
CLO12-A |
Anti-Human Clock IgG #2, aff pure |
100 ug |
434 |
|
CLO12-P |
Human Clock Control/blocking peptide # 2 |
100 ug |
161 |
|
CLO12-S |
Anti-Human Clock Antiserum #2 |
100 ul |
369 |
|
CLO13-A |
Anti-Drosophila Clock IgG #1, aff pure |
100 ug |
434 |
|
CLO13-P |
Drosophila Clock Control/blocking peptide # 1 |
100 ug |
161 |
|
CLO13-S |
Anti-Drosophila Clock Antiserum #1 |
100 ul |
369 |
|
CNG11-A |
Anti-Rat Cyclic Nucleotide Channel 1 (CNG1) Ab #1, aff pure |
100 ug |
434 |
|
CNG11-P |
Rat Cyclic Nucleotide Gated Channel 1 (CNG1) Control/blocking peptide #
1 |
100 ug |
161 |
|
CNG11-S |
Anti-Rat Cyclic Nucleotide Gated Channel 1 (CNG1) Ab #1 |
100 ul |
369 |
|
CNG12-A |
Anti-Human Cyclic Nucleotide Gated Channel 1 (CNG1) IgG #2, aff pure |
100 ug |
434 |
|
CNG12-P |
Human Cyclic Nucleotide Gated Channel 1 (CNG1) Control/blocking peptide
# 2 |
100 ug |
161 |
|
CNG12-S |
Anti-Human Cyclic Nucleotide Gated Channel 1 (CNG1) Ab #2 |
100 ul |
369 |
|
CNG21-A |
Anti-Rat Cyclic Nucleotide Gated Channel 2 (CNG2) IgG #1, aff pure |
100 ug |
434 |
|
CNG21-P |
Rat Cyclic Nucleotide Gated Channel 2 (CNG2) Control/blocking peptide
# 1 |
100 ug |
161 |
|
CNG21-S |
Anti-Rat Cyclic Nucleotide Gated Channel 2 (CNG2) Antiserum #1 |
100 ul |
369 |
|
CNG22-A |
Anti-Rat Cyclic Nucleotide Gated Channel 2 (CNG2) IgG #2, aff pure |
100 ug |
434 |
|
CNG22-P |
Rat Cyclic Nucleotide Gated Channel 2 (CNG2) Control/blocking peptide #
2 |
100 ug |
161 |
|
CNG22-S |
Anti-Rat Cyclic Nucleotide Gated Channel 2 (CNG2) Antiserum #2 |
100 ul |
369 |
|
CNG31-A |
Anti-Rat Cyclic Nucleotide Gated Channel 3 (CNG3) IgG #1, aff pure |
100 ug |
434 |
|
CNG31-P |
Rat Cyclic Nucleotide Gated Channel 3 (CNG3) Control/blocking peptide #
1 |
100 ug |
161 |
|
CNG31-S |
Anti-Rat Cyclic Nucleotide Gated Channel 3 (CNG3) Antiserum #1 |
100 ul |
369 |
|
CNG32-A |
Anti-Rat Cyclic Nucleotide Gated Channel 3 (CNG3) IgG #2, aff pure |
100 ug |
434 |
|
CNG32-P |
Rat Cyclic Nucleotide Gated Channel 3 (CNG3) Control/blocking peptide #
2 |
100 ug |
161 |
|
CNG32-S |
Anti-Rat Cyclic Nucleotide Gated Channel 3 (CNG3) Antiserum #2 |
100 ul |
369 |
|
CNG41-A |
Anti-Rat Cyclic Nucleotide Gated Channel 4 (CNG4) IgG #1, aff pure |
100 ug |
434 |
|
CNG41-P |
Rat Cyclic Nucleotide Gated Channel 4 (CNG4) Control/blocking peptide #1 |
100 ug |
161 |
|
CNG41-S |
Anti-Rat Cyclic Nucleotide Gated Channel 4 (CNG4) Antiserum #1 |
100 ul |
369 |
|
COVM13-C |
Chicken Ovomucoid (trypsin inhibitor) protein control for Western |
100 ul |
239 |
|
COVM13-S |
Anti-Chicken Ovomucoid (trypsin inhibitor) protein antiserum |
100 ul |
369 |
|
COVM15-N |
Chicken Ovomucoid (trypsin inhibitor) protein |
10 mg |
239 |
|
COX11-A |
Anti-Ram Cyclooxygenase (Cox-1) IgG #1 |
100 ul |
434 |
|
COX11-C |
Purified Ram Cyclooxygenase (Cox-1) Western blot +ve control |
100 ul |
258 |
|
COX11-D |
Mouse Cyclooxygenase (Cox-1) cDNA probe |
1 ug |
369 |
|
COX12-D |
Human Cyclooxygenase (Cox-1) cDNA probe |
2 ug |
499 |
|
COX12-D |
Human Cyclooxygenase (Cox-1) cDNA probe |
1 ug |
369 |
|
COX14-M |
Monoclonal Anti-Ovine Cyclooxygenase 1 (Cox-1) protein IgG # 4, aff pure |
100 ug |
434 |
|
COX21-A |
Anti-Human Cyclooxygenase (Cox-2) IgG # 1 |
100 ug |
434 |
|
COX21-C |
Purified Ram Cyclooxygenase (Cox-2) Western blot +ve control |
100 ul |
258 |
|
COX21-D |
Mouse Cyclooxygenase (Cox-2) cDNA probe |
1 ug |
369 |
|
COX21-P |
Human Cyclooxygenase (Cox-2) Control/blocking peptide # 1 |
100 ug |
161 |
|
COX21-S |
Anti-Human Cyclooxygenase (Cox-2) antiserum # 1 |
100 ul |
369 |
|
COX22-C |
Purified, Ovine Cyclooxygenase 2 (Cox-2) Protein WB +ve control |
100 ul |
258 |
|
COX22-D |
Human Cyclooxygenase (Cox-2) cDNA probe |
1 ug |
369 |
|
COX22-P |
Rat Cyclooxygenase 2 (Cox-2) Control/blocking peptide # 2 |
100 ug |
161 |
|
COX23-C |
Human Recombinant Cyclooxygenase 2 (Cox-2) Protein WB +ve control |
100 ul |
258 |
|
COX23-M |
Monoclonal Anti-Human Cyclooxygenase 2 (Cox-2) protein IgG # 3, aff pure |
100 ug |
434 |
|
COX31-A |
Anti-Mouse Cyclooxygenase 3 (Cox-3) IgG # 1, aff pure |
100 ug |
434 |
|
COX31-P |
Mouse Cyclooxygenase 3 (Cox-3) Control/blocking peptide # 1 |
100 ug |
161 |
|
COX32-A |
Anti-Human Cyclooxygenase 3 (Cox-3) IgG # 2, aff pure |
100 ug |
434 |
|
COX32-P |
Human Cyclooxygenase 3 (Cox-3) Control/blocking peptide # 2 |
100 ug |
161 |
|
CP11-C |
Purified Human ceruloplasmin (Cp) WB +ve control |
100 ul |
258 |
|
CP11-S |
Anti-Human ceruloplasmin (Cp) antiserum |
100 ul |
369 |
|
CP12-A |
Anti-Human ceruloplasmin (Cp) IgG #2, aff pure |
100 ug |
434 |
|
CP15-N |
Purified Human ceruloplasmin (Cp) protein for ELISA/standards |
100 ug |
343 |
|
CPT1L12-A |
Anti-Mouse Carnitine Palmitoyl Transferase-1: Liver (CPT1-L) IgG, aff
pure |
100 ug |
434 |
|
CPT1L12-P |
Mouse Carnitine Palmitoyl Transferase-1: Liver (CPT1-L) Control/blocking
peptide |
100 ug |
161 |
|
CPT1L12-S |
Anti-Mouse Carnitine Palmitoyl Transferase-1: Liver (CPT1-L) antiserum |
100 ul |
369 |
|
CPT1M11-A |
Anti-Mouse Carnitine Palmitoyl Transferase-1: Muscle (CPT1-M) IgG, aff
pure |
100 ug |
434 |
|
CPT1M11-P |
Mouse Carnitine Palmitoyl Transferase-1: Muscle (CPT1-M)
Control/blocking peptide |
100 ug |
161 |
|
CPT1M11-S |
Anti-Mouse Carnitine Palmitoyl Transferase-1: Muscle (CPT1-M) antiserum |
100 ul |
369 |
|
CPT21-A |
Anti-Mouse Carnitine Palmitoyl Transferase-2 (CPT-2) IgG, aff pure |
100 ug |
434 |
|
CPT21-P |
Mouse Carnitine Palmitoyl Transferase-2 (CPT-2) Control/blocking peptide |
100 ug |
161 |
|
CPT21-S |
Anti-Mouse Carnitine Palmitoyl Transferase-2 (CPT-2) antiserum |
100 ul |
369 |
|
CRLR11-A |
Anti-Rat Calcitonin Receptor Like receptor (CRLR) IgG aff pure |
100 ug |
434 |
|
CRLR11-P |
Rat Calcitonin Receptor Like receptor (CRLR) Control/blocking peptide |
100 ug |
161 |
|
CRLR11-S |
Anti-Rat Calcitonin Receptor Like receptor (CRLR) antiserum |
100 ul |
369 |
|
CRN11-S |
Anti-Rat Calretinin (CR/CLB2/D29K) Antiserum #1 |
100 ul |
369 |
|
CRN12-M |
Monoclonal Anti-Calretinin (CR/CLB2/D29K) IgG #2 |
100 ul |
434 |
|
CRP11-A |
Anti-human C-Reactive Protein (CRP) IgG, aff pure |
100 ug |
434 |
|
CRP11-FITC |
Anti-human C-Reactive Protein (CRP)-FITC Conjugate, aff pure |
100 ug |
434 |
|
CRP11-HRP |
Anti-human C-Reactive Protein (CRP)-HRP Conjugate, aff pure |
100 ug |
434 |
|
CRP12-C |
Purified Human C-Reactive Protein (CRP) control for WB |
100 ul |
258 |
|
CRP12-M |
Monoclonal Anti-human C-Reactive Protein (CRP) IgG # 2, aff pure |
100 ug |
434 |
|
CRP15-N-100 |
Human C-Reactive Protein (CRP) protein, purified |
100 ug |
200 |
|
CRP15-N-500 |
Human C-Reactive Protein (CRP) protein, purified |
500 ug |
369 |
|
CRP16-A |
Anti-rat C-Reactive Protein (CRP) IgG, aff pure |
100 ug |
434 |
|
CRP16-C |
Purified Rat C-Reactive Protein (CRP) control for WB |
100 ul |
258 |
|
CRP16-HRP |
Anti-rat C-Reactive Protein (CRP) IgG-HRP Conjugate, aff pure |
100 ug |
434 |
|
CRP16-N-10 |
Rat C-Reactive Protein (CRP) protein, purified |
10 ug |
369 |
|
CRP17-A |
Anti-rat C-Reactive Protein (CRP) IgG, aff pure |
100 ug |
434 |
|
CRP17-HRP |
Anti-rat C-Reactive Protein (CRP) IgG-HRP Conjugate, aff pure |
100 ug |
434 |
|
CRP18-C |
Purified Dog C-Reactive Protein (CRP) control for WB |
100 ul |
258 |
|
CRP18-R-20 |
Purified Dog C-Reactive Protein (CRP) for ELISA |
20 ug |
369 |
|
CRP21-A |
Anti-Mouse C-Reactive Protein (CRP) IgG, aff pure |
100 ug |
434 |
|
CRP21-P |
Mouse C-Reactive Protein (CRP) control peptide |
100 ug |
161 |
|
CRP24-A |
Anti-Mouse C-Reactive Protein (CRP) IgG, aff pure |
100 ug |
434 |
|
CRP24-BTN |
Anti-Mouse C-Reactive Protein (CRP) IgG-biotin conjugate |
50 ug |
408 |
|
CRT11-A |
Anti-Human Creatine Transporter (CRT) IgG #1, aff pure |
100 ug |
434 |
|
CRT11-P |
Human Creatine Transporter (CRT) Control/blocking peptide #1 |
100 ug |
161 |
|
CRT11-S |
Anti-Human Creatine Transporter (CRT) antiserum #1 |
100 ul |
369 |
|
CRY11-A |
Anti-Mouse Cryptochrome 1 (CRY1) IgG # 1, aff pure |
100 ug |
434 |
|
CRY11-P |
Mouse Cryptochrome 1 (CRY1) Control/blocking peptide # 1 |
100 ug |
161 |
|
CRY11-S |
Anti-Mouse Cryptochrome 1 (CRY1) antiserum # 1 |
100 ul |
369 |
|
CRY21-A |
Anti-Mouse Cryptochrome 2 (CRY2) IgG #1, aff pure |
100 ug |
434 |
|
CRY21-P |
Mouse Cryptochrome 2 (CRY2) Control/blocking peptide #1 |
100 ug |
161 |
|
CRY21-S |
Anti-Mouse Cryptochrome 2 (CRY2) antiserum #1 |
100 ul |
369 |
|
CRYD13-A |
Anti-Drosophila Cryptochrome (dCRY) IgG # 1, aff pure |
100 ug |
434 |
|
CRYD13-P |
Drosophila Cryptochrome (dCRY) Control/blocking peptide # 1 |
100 ug |
161 |
|
CRYD13-S |
Anti-Drosophila Cryptochrome (dCRY) antiserum # 1 |
100 ul |
369 |
|
CT11-P |
Human Calcitonin (CT) Control/blocking peptide |
100 ug |
161 |
|
CT12-M |
monoclonal anti-Human Calcitonin (CT) IgG |
100 ug |
434 |
|
CT13-M |
monoclonal anti-Human Calcitonin (CT) IgG #2 |
100 ug |
434 |
|
CT15-P-1000 |
Human Calcitonin (CT 1-32 aa amide) full length pure |
1 mg |
239 |
|
CT16-P-1000 |
Human Calcitonin (CT 1-7 aa) peptide pure |
1 mg |
148 |
|
CT17-P-1000 |
Chicken Calcitonin (CT 1-32 aa amide) full length pure |
1 mg |
239 |
|
CT18-P-1000 |
Rat Calcitonin (CT 1-32 aa amide) full length pure |
1 mg |
239 |
|
CT19-P-1000 |
Salmon Calcitonin (CT 1-32 aa amide) full length pure |
1 mg |
239 |
|
CTMP11-A |
Anti-Human Carboxyl Terminal Modulator Protein (CTMP) IgG, aff pure |
100 ug |
434 |
|
CTMP11-C |
Recombinant purified Human Carboxyl Terminal Modulator Protein (CTMP)
protein for Western blot |
100 ul |
258 |
|
CTMP11-P |
Human Carboxyl Terminal Modulator Protein (CTMP) Control/blocking
peptide |
100 ug |
161 |
|
CTMP11-S |
Anti-Human Carboxyl Terminal Modulator Protein (CTMP) antiserum |
100 ul |
369 |
|
CTMP12-S |
Anti-Human Carboxyl Terminal Modulator Protein (CTMP) antiserum |
100 ul |
369 |
|
CUGBP11-M |
Monoclonal Anti-rat CUGBP1 protein IgG # 1 |
100 ug |
434 |
|
CUGBP21-A |
Anti-human CUGBP2/ NAPOR IgG #1, aff pure |
100 ug |
434 |
|
CUGBP21-P |
Human CUGBP2/ NAPOR Control/blocking peptide # 1 |
100 ug |
161 |
|
CWBA-1 |
Cell wall, sermi pure (B. Anthracis) |
1 mg |
213 |
|
CWBA-5 |
Cell wall, sermi pure (B. Anthracis) |
5 mg |
564 |
|
Cx2409-P-1 |
Human, mouse, rat connexin 32 hemi-channel-blocking peptide (GAP24
domain) |
1 mg |
278 |
|
Cx2409-P-5 |
Human, mouse, rat connexin 32 hemi-channel-blocking peptide (GAP24
domain) |
5 mg |
824 |
|
Cx2410-PS-1 |
Human, mouse, rat connexin 32 hemi-channel-Scrambled peptide (GAP24
domain) |
1 mg |
278 |
|
Cx2410-PS-5 |
Human, mouse, rat connexin 32 hemi-channel-Scrambled peptide (GAP24
domain) |
5 mg |
824 |
|
Cx2601-P-1 |
Human, mouse, rat connexin 37/40 hemi-channel blocking peptide; GAP26
domain |
1 mg |
278 |
|
Cx2601-P-5 |
Human, mouse, rat connexin 37/40 hemi-channel blocking peptide; GAP26
domain |
5 mg |
824 |
|
Cx2602-PS-1 |
Human, mouse, rat connexin 37/40 hemi-channel Scrambled peptide (GAP26
domain) |
1 mg |
278 |
|
Cx2602-PS-5 |
Human, mouse, rat connexin 37/40 hemi-channel Scrambled peptide (GAP26
domain) |
5 mg |
824 |
|
Cx2605-P-1 |
Human, mouse, rat connexin 43 hemi-channel-blocking peptide (GAP26
domain) |
1 mg |
278 |
|
Cx2605-P-5 |
Human, mouse, rat connexin 43 hemi-channel-blocking peptide (GAP26
domain) |
5 mg |
824 |
|
Cx2606-PS-1 |
Human, mouse, rat connexin 43 hemi-channel-Scrambled peptide (GAP26
domain) |
1 mg |
278 |
|
Cx2606-PS-5 |
Human, mouse, rat connexin 43 hemi-channel-Scrambled peptide (GAP26
domain) |
5 mg |
824 |
|
CX26-A |
Anti-Mouse Connexin 26 (Cx26) IgG # 1, aff pure |
100 ug |
434 |
|
CX26-P |
Mouse Connexin 26 (Cx26) Control/blocking peptide # 1 |
100 ug |
161 |
|
CX26-S |
Anti-Mouse Connexin 26 (Cx26) antiserum # 1 |
100 ul |
369 |
|
Cx2703-P-1 |
Human, mouse, rat connexin 43 and 37 hemi-channel blocking peptide
(GAP27 domain with conserved sequence SRPTEK) |
1 mg |
278 |
|
Cx2703-P-5 |
Human, mouse, rat connexin 43 and 37 hemi-channel blocking peptide
(GAP27 domain with conserved sequence SRPTEK) |
5 mg |
824 |
|
Cx2704-PS-1 |
Human, mouse, rat connexin 43 and 37 scrambled peptide (GAP27 domain) |
1 mg |
278 |
|
Cx2704-PS-5 |
Human, mouse, rat connexin 43 and 37 scrambled peptide (GAP27 domain) |
5 mg |
824 |
|
Cx2707-P-1 |
Human, mouse, rat connexin 40 hemi-channel-blocking peptide (GAP27
domain) |
1 mg |
278 |
|
Cx2707-P-5 |
Human, mouse, rat connexin 40 hemi-channel-blocking peptide (GAP27
domain) |
5 mg |
824 |
|
Cx2708-PS-1 |
Human, mouse, rat connexin 40 hemi-channel-Scrambled peptide (GAP27
domain) |
1 mg |
278 |
|
Cx2708-PS-5 |
Human, mouse, rat connexin 40 hemi-channel-Scrambled peptide (GAP27
domain) |
5 mg |
824 |
|
CX303-A |
Anti-Rat Connexin 30.3 (Cx30.3) IgG, aff pure |
100 ug |
434 |
|
CX303-P |
Rat Connexin 30.3 (Cx30.3) Control/blocking peptide |
100 ug |
161 |
|
CX303-S |
Anti-Rat Connexin 30.3 (Cx30.3) antiserum |
100 ul |
369 |
|
CX311-A |
Anti-Rat Connexin 31.1 (Cx31.1) IgG, aff pure |
100 ug |
434 |
|
CX311-P |
Rat Connexin 31.1 (Cx31.1) Control/blocking peptide |
100 ug |
161 |
|
CX311-S |
Anti-Rat Connexin 31.1 (Cx31.1) antiserum |
100 ul |
369 |
|
CX31-A |
Anti-Mouse Connexin 31 (Cx31) IgG #1, aff pure |
100 ug |
434 |
|
CX31-P |
Mouse Connexin 31 (Cx31) Control/blocking peptide #1 |
100 ug |
161 |
|
CX31-S |
Anti-Mouse Connexin 31 (Cx31) antiserum #1 |
100 ul |
369 |
|
Cx3211-P-1 |
Human, mouse, rat connexin 32 hemi-channel-blocking peptide |
1 mg |
278 |
|
Cx3211-P-5 |
Human, mouse, rat connexin 32 hemi-channel-blocking peptide |
5 mg |
824 |
|
Cx3212-PS-1 |
Human, mouse, rat connexin 32 hemi-channel-scrambled peptide |
1 mg |
278 |
|
Cx3212-PS-5 |
Human, mouse, rat connexin 32 hemi-channel-scrambled peptide |
5 mg |
824 |
|
CX32A11-A |
Anti-Rat Connexin 32 (Cx32) IgG # 1, aff pure |
100 ug |
434 |
|
CX32A11-P |
Rat Connexin 32 (Cx32) Control/blocking peptide # 1 |
100 ug |
161 |
|
CX32A11-S |
Anti-Rat Connexin 32 (Cx32) antiserum #1 |
100 ul |
369 |
|
CX32B12-A |
Anti-Rat Connexin 32 (Cx32) IgG # 2, aff pure |
100 ug |
434 |
|
CX32B12-P |
Rat Connexin 32 (Cx32) Control/blocking peptide # 2 |
100 ug |
161 |
|
CX32B12-S |
Anti-Rat Connexin 32 (Cx32) Antiserum # 2 |
100 ul |
369 |
|
CX32C13-M |
Monoclonal Anti-Rat Connexin 32 (Cx32) ascites |
100 ul |
434 |
|
CX32C13-P |
Rat Connexin 32 (Cx32) Control/blocking peptide # 3 |
100 ug |
161 |
|
CX33-A |
Anti-Rat Connexin 33 (Cx33) IgG #1, aff pure |
100 ug |
434 |
|
CX33-P |
Rat Connexin 33 (Cx33) antiserum #1 Control/blocking peptide 31 |
100 ug |
161 |
|
CX33-S |
Anti-Rat Connexin 33 (Cx33) antiserum #1 |
100 ul |
369 |
|
CX37A11-A |
Anti-Mouse Connexin 37 (Cx37) IgG #1, aff pure |
100 ug |
434 |
|
CX37A11-P |
Mouse Connexin 37 (Cx37) Control/blocking peptide # 1 |
100 ug |
161 |
|
CX37A11-S |
Anti-Mouse Connexin 37 (Cx37) Antiserum # 1 |
100 ul |
369 |
|
Cx37B12-A |
Anti-Rat Connexin 37 (Cx37) IgG # 2, aff pure |
100 ug |
434 |
|
Cx37B12-P |
Rat Connexin 37 (Cx37) Control/blocking peptide # 2 |
100 ug |
161 |
|
Cx37B12-S |
Anti-Rat Connexin 37 (Cx37) Antiserum # 2 |
100 ul |
369 |
|
Cx40-A |
Anti-Mouse Connexin 40 (Cx40) IgG #1, aff pure |
100 ug |
434 |
|
Cx40B12-A |
Anti-Rat Connexin 40 (Cx40) IgG #2, aff pure |
100 ug |
434 |
|
Cx40B12-P |
Rat Connexin 40 (Cx40) Control/blocking peptide #2 |
100 ug |
161 |
|
Cx40B12-S |
Anti-Rat Connexin 40 (Cx40) Antiserum #2 |
100 ul |
369 |
|
Cx40-P |
Mouse Connexin 40 (Cx40) Control/blocking peptide #1 |
100 ug |
161 |
|
Cx40-S |
Anti-Mouse Connexin 40 (Cx40) Antiserum #1 |
100 ul |
369 |
|
Cx43A11-A |
Anti-Mouse Connexin 43 (Cx43) IgG #1, aff pure |
100 ug |
434 |
|
Cx43A11-P |
Mouse Connexin 43 (Cx43) Control/blocking peptide # 1 |
100 ug |
161 |
|
Cx43A11-S |
Anti-Mouse Connexin 43 (Cx43) Antiserum #1 |
100 ul |
369 |
|
Cx43B12-A |
Anti-Mouse Connexin 43 (Cx43) IgG # 2, aff pure |
100 ug |
434 |
|
Cx43B12-P |
Mouse Connexin 43 (Cx43) Control/blocking peptide # 2 |
100 ug |
161 |
|
Cx43B12-S |
Anti-Mouse Connexin 43 (Cx43) Antiserum # 2 |
100 ul |
369 |
|
Cx43C13-M |
Monoclonal Anti-Connexin 43 (Cx43) ab # 3, ascites |
100 ul |
434 |
|
Cx43C13-P |
Mouse Connexin 43 (Cx43) Control/blocking peptide # 3 |
100 ug |
304 |
|
Cx45-A |
Anti-Mouse Connexin 45 (Cx45) IgG #1, aff pure |
100 ug |
434 |
|
Cx45B12-A |
Anti-Human Connexin 45 (Cx45) IgG #2, aff pure |
100 ug |
434 |
|
Cx45B12-P |
Human Connexin 45 (Cx45) Control/blocking peptide #2 |
100 ug |
161 |
|
Cx45B12-S |
Anti-Human Connexin 45 (Cx45) antiserum #2 |
100 ul |
369 |
|
Cx45-P |
Mouse Connexin 45 (Cx45) Control/blocking peptide # 1 |
100 ug |
161 |
|
Cx45-S |
Anti-Mouse Connexin 45 (Cx45) Antiserum #1 |
100 ul |
369 |
|
Cx46-A |
Anti-Rat Connexin 46 (Cx46) IgG #1, aff pure |
100 ug |
434 |
|
Cx46-P |
Rat Connexin 46 (Cx46) Control/blocking peptide #1 |
100 ug |
161 |
|
Cx46-S |
Anti-Rat Connexin 46 (Cx46) Antiserum #1 |
100 ul |
369 |
|
Cx50-A |
Anti-Mouse Connexin 50 (Cx50) IgG #1, aff pure |
100 ug |
434 |
|
Cx50-P |
Mouse Connexin 50 (Cx50) Control/blocking peptide #1 |
100 ug |
161 |
|
Cx50-S |
Anti-Mouse Connexin 50 (Cx50) Antiserum #1 |
100 ul |
369 |
|
CYP1B11-A |
Anti-human CYP1B1 IgG, aff pure |
100 ug |
434 |
|
CYP1B11-P |
Human CYP1B1 control/blocking peptide |
100 ug |
161 |
|
CYP1B11-S |
Anti-human CYP1B1 antiserum |
100 ul |
369 |
|
CYP1B12-A |
Anti-Mouse CYP1B1 peptide IgG, aff pure |
100 ug |
434 |
|
CYP1B12-P |
Mouse CYP1B1 control/blocking peptide |
100 ug |
161 |
|
CYP1B12-S |
Anti-Mouse CYP1B1 peptide antiserum #2 |
100 ul |
369 |
|
CYP26A11-A |
Anti-human CYP26A1 IgG, aff pure# 1 |
100 ug |
434 |
|
CYP26A11-P |
Human CYP26A1 control/blocking peptide #1 |
100 ug |
161 |
|
CYP26A12-A |
Anti-human CYP26A1 IgG, aff pure #2 |
100 ug |
434 |
|
CYP26A12-P |
Human CYP26A1 control/blocking peptide #2 |
100 ug |
161 |
|
CYTC11-C |
Rat Cytochrome-C (Cyt-c) protein WB +ve control |
100 ul |
258 |
|
CYTC11-S |
Anti-Cytochrome-C (Cyt-c) protein antiserum #1 |
100 ul |
369 |
|
CYTC12-S |
Anti-bovine Cytochrome-C (Cyt-c) protein antiserum #2 |
100 ul |
369 |
|
CYTC13-M |
Monoclonal Anti-horse Cytochrome-C (Cyt-c) protein ascites #3 |
100 ul |
434 |
|
D1IP11-A |
Anti-mouse Dopamine receptor D1 interacting protein (D1IP) IgG 1(aff
pure) #1 |
100ug |
434 |
|
D1IP11-A |
Anti-Mouse Dopamine receptor D1 interacting protein - Calcyon (D1IP) IgG
# 1, aff pure |
100 ug |
434 |
|
D1IP11-P |
Dopamine receptor D1 interacting protein - Calcyon (D1IP)
control/blcokgin peptide #1 |
100 ug |
161 |
|
D1IP11-P |
Anti-mouse Dopamine receptor D1 interacting protein (D1IP) Control
Peptide |
100ug |
161 |
|
D1IP12-A |
Anti-Human Dopamine receptor D1 interacting protein - Calcyon (D1IP) IgG
# 2, aff pure |
100 ug |
434 |
|
D1IP12-A |
Anti-human Dopamine receptor D1 interacting protein (D1IP) IgG 1(aff
pure) #1 |
100ug |
434 |
|
D1IP12-P |
Anti-human Dopamine receptor D1 interacting protein (D1IP) Control
Peptide |
100ug |
161 |
|
D1IP12-P |
Dopamine receptor D1 interacting protein - Calcyon (D1IP)
control/blcokgin peptide #2 |
100 ug |
161 |
|
D1R11-A |
Anti-Rat Dopamine Receptor 1(D1R) IgG # 1, aff pure |
100 ug |
434 |
|
D1R11-P |
Rat Dopamine Receptor 1(D1R) Control/blocking peptide # 1 |
100 ug |
161 |
|
D1R11-S |
Anti-Rat Dopamine Receptor 1(D1R) Antiserum # 1 |
100 ul |
369 |
|
D1R12-A |
Anti-Rat Dopamine Receptor 1(D1R) IgG # 2, aff pure |
100 ug |
434 |
|
D1R12-P |
Rat Dopamine Receptor 1(D1R) Control/blocking peptide # 2 |
100 ug |
161 |
|
D1R12-S |
Anti-Rat Dopamine Receptor 1(D1R) Antiserum # 2 |
100 ul |
369 |
|
D28K11-A |
Anti-Mouse CABP28K (Calbindin 1/CALB1/Spot35 protein/Cholecalcin) IgG
#1, aff pure |
100 ug |
434 |
|
D28K11-P |
Mouse CABP28K (Calbindin 1/CALB1/Spot35 protein/Cholecalcin)
Control/blocking peptide #1 |
100 ug |
161 |
|
D28K12-M |
Monoclonal ant-bovine CABP28K (Calbindin 1/CALB1/Spot35
protein/Cholecalcin), ascites #2 |
100 ul |
434 |
|
D2R11-A |
Anti-Rat Dopamine Receptor 2 (D2R) (L/S) IgG # 1, aff pure |
100 ug |
434 |
|
D2R11-P |
Rat Dopamine Receptor 2 (D2R) (L/S) Control/blocking peptide # 1 |
100 ug |
148 |
|
D2R11-S |
Anti-Rat Dopamine Receptor 2 (D2R) (L/S) Antiserum # 1 |
100 ul |
369 |
|
D2R12-A |
Anti-Rat Dopamine Receptor 2 (D2R) (L) IgG # 2, aff pure |
100 ug |
434 |
|
D2R12-P |
Rat Dopamine Receptor 2 (D2R) (L) Control/blocking peptide # 2 |
100 ug |
161 |
|
D2R12-S |
Anti-Rat Dopamine Receptor 2 (D2R) (L) Antiserum # 2 |
100 ul |
369 |
|
D2R13-A |
Anti-Human Dopamine Receptor 2 (D2R) (L/S) IgG # 3, aff pure |
100 ug |
434 |
|
D2R13-P |
Human Dopamine Receptor 2 (D2R) (L/S) Control/blocking peptide # 3 |
100 ug |
161 |
|
D2R13-S |
Anti-Human Dopamine Receptor 2 (D2R) (L/S) Ab # 3 |
100 ul |
369 |
|
D2R14-P |
Human Dopamine Receptor 2 (D2R) (L) Control/blocking peptide # 4 |
100 ug |
161 |
|
D3R11-A |
Anti-Human Dopamine Receptor 3 (D3R) IgG # 1, aff pure |
100 ug |
434 |
|
D3R11-P |
Human Dopamine Receptor 3 (D3R) Control/blocking peptide # 1 |
100 ug |
161 |
|
D3R11-S |
Anti-Human Dopamine Receptor 3 (D3R) Antiserum # 1 |
100 ul |
369 |
|
D3R12-A |
Anti-Rat Dopamine Receptor 3 (D3R) IgG # 2, aff pure |
100 ug |
434 |
|
D3R12-P |
Rat Dopamine Receptor 3 (D3R) Control/blocking peptide # 2 |
100 ug |
161 |
|
D3R12-S |
Anti-Rat Dopamine Receptor 3 (D3R) Antiserum # 2 |
100 ul |
369 |
|
D4R11-A |
Anti-Mouse Dopamine Receptor 4 (D4R) IgG # 1, aff pure |
100 ug |
434 |
|
D4R11-P |
Mouse Dopamine Receptor 4(D4R) Control/blocking peptide # 1 |
100 ug |
161 |
|
D4R11-S |
Anti-Mouse Dopamine Receptor 4 (D4R) Antiserum # 1 |
100 ul |
369 |
|
D4R12-A |
Anti-Human Dopamine Receptor 4 (D4R) IgG # 2, aff pure |
100 ug |
434 |
|
D4R12-P |
Human Dopamine Receptor 4 (D4R) Control/blocking peptide # 2 |
100 ug |
161 |
|
D4R12-S |
Anti-Human Dopamine Receptor 4 (D4R) Antiserum # 2 |
100 ul |
369 |
|
D5R12-P |
Rat Dopamine Receptor 5 (D5R) Control/blocking peptide # 2 |
100 ug |
161 |
|
D9K11-A |
Anti-Mouse CABP9K (D9K/CALB3 or CABP1) IgG #1, aff pure |
100 ug |
434 |
|
D9K11-P |
Mouse CABP9K (D9K/CALB3 or CABP1) Control/blocking peptide #1 |
100 ug |
161 |
|
D9K11-S |
Anti-Mouse CABP9K (D9K/CALB3 or CABP1) antiserum #1 |
100 ul |
369 |
|
D9K12-A |
Anti-Human CABP9K (D9K/CALB3 or CABP1) IgG #2, aff pure |
100 ug |
434 |
|
D9K12-C |
Purified, Porcine CABP9K (D9K/CALB3 or CABP1) protein control for WB |
100 ul |
258 |
|
D9K12-P |
Human CABP9K (D9K/CALB3 or CABP1) Control/blocking peptide #2 |
100 ug |
161 |
|
D9K12-S |
Anti-Human CABP9K (D9K/CALB3 or CABP1) antiserum #2 |
100 ul |
369 |
|
DAT11-A |
Anti-Rat Dopamine Transporter IgG # 1, aff pure |
100 ug |
434 |
|
DAT11-P |
Rat Dopamine Transporter Control/blocking peptide # 1 |
100 ug |
161 |
|
DAT11-S |
Anti-Rat Dopamine Transporter Antiserum # 1 |
100 ul |
369 |
|
DAT13-A |
Anti-Human Dopamine Transporter IgG # 3, aff pure |
100 ug |
434 |
|
DAT13-P |
Human Dopamine Transporter Control/blocking peptide # 3 |
100 ug |
161 |
|
DAT13-S |
Anti-Human Dopamine Transporter Antiserum # 3 |
100 ul |
369 |
|
DAT14-A |
Anti-Mouse Dopamine Transporter IgG # 4, aff pure |
100 ug |
434 |
|
DAT14-P |
Mouse Dopamine Transporter Control/blocking peptide # 4 |
100 ug |
161 |
|
DAT15-A |
Anti-Human Dopamine Transporter IgG # 4, aff pure |
100 ug |
434 |
|
DAT15-P |
Human Dopamine Transporter Control/blocking peptide # 4 |
100 ug |
161 |
|
DBH11-M |
monoclonal Anti-Bovine Dopamine beta hydroxylase (DBH), Ab # 1, ascites |
100 ul |
434 |
|
DBH12-A |
Anti-Human Dopamine beta hydroxylase (DBH), IgG # 2, aff. pure |
100 ug |
434 |
|
DBH12-P |
Human Dopamine beta hydroxylase (DBH) Control/blocking peptide # 2 |
100 ug |
161 |
|
DCYTB11-A |
Anti-Mouse Duodenal cytochrome B (Dcytb) aff pure IgG |
100 ug |
434 |
|
DCYTB11-P |
Mouse Duodenal cytochrome B (Dcytb) Control/blocking peptide |
100 ug |
161 |
|
DCYTB11-S |
Anti-Mouse Duodenal cytochrome B (Dcytb) antiserum |
100 ul |
369 |
|
DDC11-M |
Monoclonal Anti-Human Dopamine Decarboxylase (DDC) ab#1, ascites |
100 ul |
434 |
|
DDC11-P |
Human Dopamine Decarboxylase (DDC) control peptide |
100 ug |
161 |
|
DDC12-A |
Anti-Human Dopamine Decarboxylase (DDC) IgG # 2, aff pure |
100 ug |
434 |
|
DDC12-P |
Human Dopamine Decarboxylase (DDC) control peptide # 2 |
100 ug |
161 |
|
DDC12-S |
Anti-Human Dopamine Decarboxylase (DDC) antiserum # 2 |
100 ul |
369 |
|
DINE11-A |
Anti-Rat damage-induced neuronal endopeptidase (DINE) IgG (aff pure) |
100 ug |
434 |
|
DINE11-P |
Rat damage-induced neuronal endopeptidase (DINE) Control/blocking
peptide |
100 ug |
161 |
|
DINE11-S |
Anti-Rat damage-induced neuronal endopeptidase (DINE) antiserum |
100 ul |
369 |
|
DNA11-M |
Monoclonal Anti-dsDNA IgG # 1, aff pure |
100 ug |
434 |
|
DNAL11-M |
Monoclonal Anti-bovine DNA ligase I protein IgG # 1 |
100 ug |
434 |
|
DNASE11-A |
Anti-Bovine DNAse 1 IgG (replaces cat # DNASE11-G) |
100 ug |
369 |
|
DNASE11-C |
Bovine DNAse 1 Protein Western blot +ve control |
100 ul |
258 |
|
DNASE21-A |
Anti-Human Deoxyribonuclease II (Dnase II) IgG #1, aff pure |
100 ug |
434 |
|
DNASE21-P |
Human Deoxyribonuclease II (Dnase II) Control/blocking peptide # 1 |
100 ug |
161 |
|
DNASE21-S |
Anti-Human Deoxyribonuclease II (Dnase II) antiserum # 1 |
100 ul |
369 |
|
DNASE22-A |
Anti-Mouse Deoxyribonuclease II (Dnase II) IgG #2, aff pure |
100 ug |
434 |
|
DNASE22-P |
Mouse Deoxyribonuclease II (Dnase II) Control/blocking peptide # 2 |
100 ug |
161 |
|
DNASE22-S |
Anti-Mouse Deoxyribonuclease II (Dnase II) antiserum # 2 |
100 ul |
369 |
|
DNP11-S |
Anti-Dinitrophenol (DNP) antiserum |
100 ul |
369 |
|
DNP13-A |
Anti-Dinitrophenol (DNP) aff pure |
100 ug |
434 |
|
DNP14-M |
Anti-Dinitrophenol (DNP IgE, aff pure |
100 ug |
434 |
|
DNP15-M |
Anti-Dinitrophenol (DNP IgG1, aff pure |
100 ug |
434 |
|
DNP25-N-10 |
Dinitrophenol (DNP)-KLH protein Conjugate |
10 mg |
265 |
|
DNP35-N-10 |
Dinitrophenol (DNP)-BSA protein Conjugate |
10 mg |
265 |
|
DNPB11-M |
Monoclonal Anti-Rat DNA polymerase beta antibody # 1 |
100 ug |
434 |
|
DNPD11-P |
Human DNA Polymerase Delta, catalytic subunit (Pol D) Control/blocking
peptide |
100 ug |
161 |
|
DNPD11-S |
Anti-Human DNA Polymerase Delta, catalytic subunit (Pol D) antiserum |
100 ul |
369 |
|
DNPE12-M |
Monoclonal Anti-Human DNA Polymerase epsilon antibody # 1 |
100 ug |
434 |
|
DNPG13-M |
Monoclonal Anti-Human DNA Polymerase gamma antibody # 1 |
100 ug |
434 |
|
DNPR13-A |
Anti-Mouse DNA primase subunit p49, aff pure IgG |
100 ug |
434 |
|
DNPR14-A |
Anti-Mouse DNA primase subunit p58, aff pure IgG |
100 ug |
434 |
|
DOP11-S |
Anti-Dopamine antiserum # 1 |
100 ul |
369 |
|
DOP12-M |
Monoclonal Anti-Dopamine IgG # 2 |
100 ug |
434 |
|
DRASIC31-A |
Anti-Rat DRASIC/ASIC3 IgG #1, aff pure |
100 ug |
434 |
|
DRASIC31-P |
Rat DRASIC/ASIC3 Control/blocking peptide #1 |
100 ug |
161 |
|
DRASIC31-S |
Anti-Rat DRASIC/ASIC3 Antiserum #1 |
100 ul |
369 |
|
EAAC11-A |
Anti-Rat EAAC1/EAAT3 IgG #1, aff pure |
100 ug |
434 |
|
EAAC11-P |
Rat EAAC1/EAAT3 Control/blocking peptide #1 |
100 ug |
161 |
|
EAAC11-S |
Anti-Rat EAAC1/EAAT3 antiserum #1 |
100 ul |
369 |
|
EAAT41-A |
Anti-Rat EAAT4 IgG #1, aff pure |
100 ug |
434 |
|
EAAT41-P |
Rat EAAT4 Control/blocking peptide #1 |
100 ug |
161 |
|
EAAT41-S |
Anti-Rat EAAT4 antiserum #1 |
100 ul |
369 |
|
EAAT51-A |
Anti-Human EAAT5 IgG #1, aff pure |
100 ug |
434 |
|
EAAT51-P |
Human EAAT5 Control/blocking peptide #1 |
100 ug |
161 |
|
EAAT51-S |
Anti-Human EAAT5 antiserum #1 |
100 ul |
369 |
|
EAT45-A |
Anti-EAT-4 (C. elegans) IgG #1, aff pure |
100 ug |
434 |
|
EAT45-P |
EAT-4 (C. elegans) control/blocking peptide # 1 |
100 ug |
161 |
|
EAT45-S |
Anti-EAT-4 (C. elegans) antiserum #1 |
100 ul |
369 |
|
EC11-G |
E. Coli Proteins-Sepharose affinity gel for removing E. coli antibodies |
1 ml |
304 |
|
EF11-A |
Anti-Edema factor (B Anthracis) IgG |
100 ug |
369 |
|
EF25-R |
Purified Recombinant Anthrax toxin Edema Factor protein |
50 ug |
759 |
|
EGFP16-R |
Enhanced Green Fluorescent Proteins (EGFP) protein for ELISA or
Standards |
10 ug |
265 |
|
EGFP16-R-100 |
Enhanced Green Fluorescent Proteins (EGFP) protein for ELISA or
Standards |
100 ug |
824 |
|
ENACa11-A |
Anti-Rat Epithelial Na Channel alpha (ENAC-a) IgG #1, Aff. Pure |
100 ug |
434 |
|
ENACa11-P |
Rat Epithelial Na Channel alpha (ENAC-a) Control/blocking peptide #1 |
100 ug |
161 |
|
ENACa11-S |
Anti-Rat Epithelial Na Channel alpha (ENAC-a) antiserum #1 |
100 ul |
369 |
|
ENACb21-A |
Anti-Rat Epithelial Na Channel beta (ENAC-b) IgG # 1, Aff. Pure |
100 ug |
434 |
|
ENACb21-P |
Rat Epithelial Na Channel beta (ENAC-b) Control/blocking peptide #1 |
100 ug |
161 |
|
ENACb21-S |
Anti-Rat Epithelial Na Channel beta (ENAC-b) antiserum # 1 |
100 ul |
369 |
|
ENACd41-A |
Anti-Human Epithelial Na Channel delta (ENAC-d) IgG #1, Aff. Pure |
100 ug |
434 |
|
ENACd41-P |
Human Epithelial Na Channel delta (ENAC-d) Control/blocking peptide #1 |
100 ug |
161 |
|
ENACd41-S |
Anti-Human Epithelial Na Channel delta (ENAC-d) antiserum # 1 |
100 ul |
369 |
|
ENACg31-A |
Anti-Rat Epithelial Na Channel gamma (ENAC-g) IgG #1, Aff. Pure |
100 ug |
434 |
|
ENACg31-P |
Rat Epithelial Na Channel gamma (ENAC-g) Control/blocking peptide #1 |
100 ug |
161 |
|
ENACg31-S |
Anti-Rat Epithelial Na Channel gamma (ENAC-g) antiserum # 1 |
100 ul |
369 |
|
eNOS32-A |
Anti-Bovine Endothelial Nitric Oxide Synthase (eNOS/NOS-III) IgG # 2 |
100 ul |
434 |
|
eNOS32-C |
Purified recombinant Bovine eNOS (NOS-III) protein WB +Ve control |
100 ul |
258 |
|
eNOS32-P |
Bovine Endothelial Nitric Oxide Synthase (eNOS/NOS-III) Control/blocking
peptide # 2 |
100 ug |
161 |
|
eNOS41-C |
Purified, recombinant Bovine eNOS (NOS-III) protein WB +Ve control |
100 ul |
258 |
|
eNOS41-M |
Mouse Monoclonal Anti-Bovine Endothelial Nitric Oxide Synthase
(eNOS/NOS-III) antibody #4 |
100 ul |
434 |
|
eNOS41-P |
Bovine Endothelial Nitric Oxide Synthase (eNOS/NOS-III) Control/blocking
peptide # 2 |
100 ug |
161 |
|
eNOS51-D-2 |
Human eNOS cDNA probe |
2 ug |
473 |
|
eNOS-A |
Anti-Human Endothelial Nitric Oxide Synthase (eNOS/NOS-III) IgG # 1, aff
pure |
100 ug |
434 |
|
eNOS-C |
Purified, recombinant human eNOS (NOS-III) protein WB +Ve control |
100 ul |
258 |
|
eNOS-P |
Human Endothelial Nitric Oxide Synthase (eNOS/NOS-III) Control/blocking
peptide # 1 |
100 ug |
161 |
|
eNOS-S |
Anti-Human Endothelial Nitric Oxide Synthase (eNOS/NOS-III) antiserum #
1 |
100 ul |
369 |
|
ENST11-A |
Anti-Human Endostatin IgG, aff pure |
100 ug |
434 |
|
ENST11-C |
Recombinant purified Human Endostatin protein W. Blot Positive control |
100 ul |
258 |
|
ENST11-S |
Anti-Human Endostatin antiserum |
100 ul |
369 |
|
ENST12-C |
Recombinant purified Mouse Endostatin protein W. Blot Positive control |
100 ul |
258 |
|
ENST13-R-100 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically
active |
100 ug |
499 |
|
ENST13-R-1000 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically
active |
1000 ug |
1.734 |
|
ENST13-R-250 |
Recombinant purified Human Endostatin protein (P. Pastoris) biologically
active |
250 ug |
759 |
|
ENST15-R-100 |
Recombinant purified Mouse Endostatin protein (P. Pastoris) biologically
active |
100 ug |
499 |
|
ENST15-R-1000 |
Recombinant purified Mouse Endostatin protein (P. Pastoris) biologically
active |
1000 ug |
1.734 |
|
ENST15-R-250 |
Recombinant purified Mouse Endostatin protein (P. Pastoris) biologically
active |
250 ug |
759 |
|
ENST16-M |
Rat Monoclonal Anti-Mouse Endostatin IgG #2 |
100 ug |
434 |
|
EP11-A |
Anti-Mouse Prostaglandin E receptor 1 (EP1) IgG #1, aff pure |
100 ug |
434 |
|
EP11-P |
Mouse Prostaglandin E receptor 1 (EP1) control (blocking) peptide #1 |
100 ug |
161 |
|
EP11-S |
Anti-Mouse Prostaglandin E receptor 1 (EP1) antiserum #1 |
100 ul |
369 |
|
EP21-A |
Anti-Rat Prostaglandin E receptor 2 (EP2) IgG #1, aff pure |
100 ug |
434 |
|
EP21-P |
Rat Prostaglandin E receptor 2 (EP2) control (blocking) peptide #1 |
100 ug |
161 |
|
EP21-S |
Anti-Rat Prostaglandin E receptor 2 (EP2) antiserum #1 |
100 ul |
369 |
|
EP22-A |
Anti-Human Prostaglandin E receptor 2 (EP2) IgG #2, aff pure |
100 ug |
434 |
|
EP22-P |
Human Prostaglandin E receptor 2 (EP2) control (blocking) peptide #2 |
100 ug |
161 |
|
EP22-S |
Anti-Human Prostaglandin E receptor 2 (EP2) antiserum #2 |
100 ul |
369 |
|
EP31-A |
Anti-Rat Prostaglandin E receptor 3 (EP3) IgG #1, aff pure |
100 ug |
434 |
|
EP31-P |
Rat Prostaglandin E receptor 3 (EP3) control (blocking) peptide # 1 |
100 ug |
161 |
|
EP31-S |
Anti-Rat Prostaglandin E receptor 3 (EP3) antiserum #1 |
100 ul |
369 |
|
EP32-A |
Anti-Human Prostaglandin E receptor 3 (EP3) IgG #2, aff pure |
100 ug |
434 |
|
EP32-P |
Human Prostaglandin E receptor 3 (EP3) control (blocking) peptide #2 |
100 ug |
161 |
|
EP32-S |
Anti-Human Prostaglandin E receptor 3 (EP3) antiserum #2 |
100 ul |
369 |
|
EP41-A |
Anti-Human Prostaglandin E receptor 4 (EP4) IgG #1, aff pure |
100 ug |
434 |
|
EP41-P |
Human Prostaglandin E receptor 4 (EP4) control (blocking) peptide # 1 |
100 ug |
161 |
|
EP41-S |
Anti-Human Prostaglandin E receptor 4 (EP4) antiserum #1 |
100 ul |
369 |
|
EP42-A |
Anti-Human Prostaglandin E receptor 4 (EP4) IgG #2, aff pure |
100 ug |
434 |
|
EP42-P |
Human Prostaglandin E receptor 4 (EP4) control (blocking) peptide # 2 |
100 ug |
161 |
|
EP42-S |
Anti-Human Prostaglandin E receptor 4 (EP4) antiserum #2 |
100 ul |
369 |
|
EPR11-A |
Anti-Human Effector Cell Protease Receptor-1 (EPR-1) IgG, aff pure |
100 ug |
434 |
|
EPR11-P |
Human Effector Cell Protease Receptor-1 (EPR-1) Control/blocking peptide |
100 ug |
161 |
|
EPR11-S |
Anti-Human Effector Cell Protease Receptor-1 (EPR-1) antiserum |
100 ul |
369 |
|
ERA11-M |
Monoclonal Anti-bovine Estrogen Receptor alpha (ER-a) Protein ascites |
100 ul |
434 |
|
ERAB11-A |
Anti-Human Endopl. Ret. Amyloid-beta binding protein (ERAB) IgG# 1, aff.
Pure |
100 ug |
434 |
|
ERAB11-P |
Human Endopl. Ret. Amyloid-beta binding protein (ERAB) Control/blocking
peptide #1 |
100 ug |
161 |
|
ERAB11-S |
Anti-Human Endopl. Ret. Amyloid-beta binding protein (ERAB) antiserum #1 |
100 ul |
369 |
|
ERAB12-A |
Anti-Human Endopl. Ret. Amyloid-beta binding protein (ERAB) IgG # 2,
aff. Pure |
100 ug |
434 |
|
ERAB12-P |
Human Endopl. Ret. Amyloid-beta binding protein (ERAB) Control/blocking
peptide #2 |
100 ug |
161 |
|
ERAB12-S |
Anti-Human Endopl. Ret. Amyloid-beta binding protein (ERAB) antiserum #
2 |
100 ul |
369 |
|
ERB11-A |
Anti-Mouse Estrogen Receptor-beta (ER-b) 1/2 IgG # 1, aff pure |
100 ug |
434 |
|
ERB11-P |
Mouse Estrogen Receptor-beta (ER-b) 1/2Control/blocking peptide #1 |
100 ug |
161 |
|
ERB11-S |
Anti-Mouse Estrogen Receptor-beta (ER-b) 1/2 antiserum # 1 |
100 ul |
369 |
|
ERB12-A |
Anti-Rat Estrogen Receptor-beta (ER-b) 1/2 IgG # 2, aff pure |
100 ug |
434 |
|
ERB12-P |
Rat ER Beta 1/2 Control/blocking peptide #2 |
100 ug |
161 |
|
ERB12-S |
Anti-Rat Estrogen Receptor-beta (ER-b) 1/2 antiserum # 2 |
100 ul |
369 |
|
ERB13-A |
Anti-Human Estrogen Receptor-beta (ER-b) 1/2 IgG # 3, aff pure |
100 ug |
434 |
|
ERB13-P |
Human Estrogen Receptor-beta (ER-b) 1/2 Control/blocking peptide #3 |
100 ug |
161 |
|
ERB13-S |
Anti-Human Estrogen Receptor-beta (ER-b) 1/2 antiserum # 3 |
100 ul |
369 |
|
ERB14-A |
Anti-Human Estrogen Receptor-beta (ER-b) 1/2 IgG # 4, aff pure |
100 ug |
434 |
|
ERB14-P |
Human Estrogen Receptor-beta (ER-b) 1/2 Control/blocking peptide #4 |
100 ug |
161 |
|
ERB14-S |
Anti-Human Estrogen Receptor-beta (ER-b) 1/2 antiserum #4 |
100 ul |
369 |
|
ERB15-A |
Anti-Human/Rat Estrogen Receptor-beta (ER-b) 1/2 IgG # 5, aff pure |
100 ug |
434 |
|
ERB15-P |
Human/Rat Estrogen Receptor-beta (ER-b) 1/2 Control/blocking peptide # 5 |
100 ug |
161 |
|
ERB21-A |
Anti-Rat Estrogen Receptor-beta 2 (ER-b) IgG #1, aff pure |
100 ug |
434 |
|
ERB21-P |
Rat Estrogen Receptor-beta 2 (ER-b) Control/blocking peptide #1 |
100 ug |
161 |
|
ERB21-S |
Anti-Rat Estrogen Receptor-beta 2 (ER-b) antiserum #1 |
100 ul |
369 |
|
ERCC11-M |
Monoclonal Anti-human Exchange repair cross complementing (ERCC1)
protein IgG |
100 ug |
434 |
|
EST21-A |
Anti-Human Telomerase/EST2 IgG # 1, aff pure |
100 ug |
434 |
|
EST21-P |
Human Telomerase/EST2 Control/blocking peptide # 1 |
100 ug |
161 |
|
EST21-S |
Anti-Human Telomerase/EST2 antiserum # 1 |
100 ul |
369 |
|
EST22-A |
Anti-Human Telomerase/EST2 IgG # 2, aff pure |
100 ug |
434 |
|
EST22-P |
Human Telomerase/EST2 Control/blocking peptide # 2 |
100 ug |
161 |
|
EST22-S |
Anti-Human Telomerase/EST2 antiserum # 2 |
100 ul |
369 |
|
EST23-A |
Anti-Mouse Telomerase/EST2 IgG # 3, aff pure |
100 ug |
434 |
|
EST23-P |
Mouse Telomerase/EST2 Control/blocking peptide # 3 |
100 ug |
161 |
|
EST23-S |
Anti-Mouse Telomerase/EST2 antiserum # 3 |
100 ul |
369 |
|
EST24-A |
Anti-Yeast Telomerase/EST2 IgG # 4, aff pure |
100 ug |
434 |
|
EST24-P |
Yeast Telomerase/EST2 Control/blocking peptide # 4 |
100 ug |
161 |
|
EST24-S |
Anti-Yeast Telomerase/EST2 antiserum # 4 |
100 ul |
369 |
|
EST25-P |
Yeast Telomerase/EST2 Control/blocking peptide # 5 |
100 ug |
161 |
|
EST25-S |
Anti-Yeast Telomerase/EST2 antiserum # 5 |
100 ul |
369 |
|
FAAH11-A |
Anti-Human Fatty Acid Amide Synthase (FAAH) IgG #1, aff pure |
100 ug |
434 |
|
FAAH11-P |
Human Fatty Acid Amide Synthase (FAAH) Control/blocking peptide # 1 |
100 ug |
369 |
|
FAAH11-S |
Anti-Human Fatty Acid Amide Synthase (FAAH) antiserum #1 |
100 ul |
369 |
|
FABP11-A |
Anti-Human (heart/adipocyte) Fatty acid binding protein (FABP) IgG #1,
aff pure |
100 ug |
434 |
|
FABP11-C |
Human Heart Fatty acid binding protein (FABP) purified, WB +Ve control |
100 ul |
258 |
|
FABP11-P |
Human FABP (heart/adipocyte) Control/blocking peptide #1 |
100 ug |
161 |
|
FABP11-S |
Anti-Human FABP (heart/adipocyte) antiserum #1 |
100 ul |
369 |
|
FABP12-C |
Mouse Heart Fatty acid binding protein (FABP) purified WB +Ve control |
100 ul |
258 |
|
FABP12-S |
Anti-Rat FABP (FABP/FABP4/ALBP/A-FABP) peptide antiserum #2 |
100 ul |
369 |
|
FABP13-C |
Rat Heart Fatty acid binding protein (FABP) purified WB +Ve control |
100 ul |
258 |
|
FABP13-M |
Monoclonal Anti-Human heart Fatty acid binding protein (FABP) IgG # 3,
aff pure |
100 ug |
434 |
|
FABP14-C |
Monkey Heart Fatty acid binding protein (FABP) purified WB +Ve control |
100 ul |
258 |
|
FABP15-C |
Rabbit Heart Fatty acid binding protein (FABP) purified WB +Ve control |
100 ul |
258 |
|
FABP15-R-100 |
Mouse Heart Fatty acid binding protein (FABP) protein |
100 ug |
1.214 |
|
FABP15-R-25 |
Mouse Heart Fatty acid binding protein (FABP) purified WB +Ve control |
25 ug |
434 |
|
FABP16-C |
Dog Heart Fatty acid binding protein (FABP) purified WB +Ve control |
100 ul |
258 |
|
FABP16-R-100 |
Rat Heart Fatty acid binding protein (FABP) purified protein |
100 ug |
1.214 |
|
FABP16-R-25 |
Rat Heart Fatty acid binding protein (FABP) purified protein |
25 ug |
434 |
|
FABP17-C |
Pig Heart Fatty acid binding protein (FABP) purified WB +Ve control |
100 ul |
258 |
|
FABP21-C |
Mouse Liver Fatty acid binding protein (FABP) purified WB +Ve control |
100 ul |
258 |
|
FABP22-C |
Rat Liver Fatty acid binding protein (FABP) purified WB +Ve control |
100 ul |
258 |
|
FADS11-A |
Anti-Human Fatty acid desaturase 1 (FADS1) IgG #1 (aff pure) |
100 ug |
434 |
|
FADS11-P |
Anti-Human Fatty acid desaturase 1 (FADS1) Control peptide |
100ug |
161 |
|
FADS12-A |
Anti-Mouse Fatty acid desaturase 1 (FADS1) IgG #2 (aff pure) |
100 ug |
434 |
|
FADS12-P |
Anti-Mouse Fatty acid desaturase 1 (FADS1) Control peptide |
100ug |
161 |
|
FADS21-A |
Anti-Mouse Fatty acid desaturase 2 (FADS2/delta-6 desaturase) IgG aff
pure |
100 ug |
434 |
|
FADS21-P |
Mouse Fatty acid desaturase 2 (FADS2/delta-6 desaturase)
Control/blocking peptide |
100 ug |
161 |
|
FADS22-A |
Anti-Mouse Fatty acid desaturase 1 (FADS2) IgG #1 (aff pure) |
100 ug |
434 |
|
FADS22-P |
Anti-Mouse Fatty acid desaturase 1 (FADS2) Control peptide |
100ug |
161 |
|
FADS32-A |
Anti-Human Fatty acid desaturase 3 (FADS3) IgG #1 (aff pure) |
100 ug |
434 |
|
FADS32-P |
Anti-Human Fatty acid desaturase 3 (FADS3) Control peptide |
100ug |
161 |
|
FASL11-A |
Anti-Rat FAS Ligand IgG # 1, aff pure |
100 ug |
434 |
|
FASL11-C |
Rat FAS Ligand Recombinant protein for Western |
100 ul |
258 |
|
FASL11-P |
Rat FAS Ligand Control/blocking peptide #1 |
100 ug |
161 |
|
FASL11-S |
Anti-Rat FAS Ligand Antiserum # 1 |
100 ul |
369 |
|
FASL12-A |
Anti-Human FAS Ligand IgG # 2, aff pure |
100 ug |
434 |
|
FASL12-C |
Human soluble FAS Ligand (FASL/CD95L) Recombinant protein for Western |
100 ul |
258 |
|
FASL12-P |
Human FAS Ligand Control/blocking peptide #2 |
100 ug |
161 |
|
FASL12-S |
Anti-Human FAS Ligand Antiserum # 2, |
100 ul |
369 |
|
FASL15-R-10 |
Recombinant purified (>98%) Human FAS Ligand Protein (carrier free) |
10 ug |
629 |
|
FASL15-R-2 |
Recombinant purified (>98%) Human FAS Ligand Protein (carrier free) |
2 ug |
369 |
|
FASN11-A |
Anti-Human Fatty acid synthase (FASN) IgG #1 (aff pure) #1 |
100 ug |
434 |
|
FASN11-P |
Anti-Human Fatty acid synthase (FASN) Control peptide |
100ug |
161 |
|
FASN12-A |
Anti-Mouse Fatty acid synthase (FASN) IgG #2 (aff pure) |
100 ug |
434 |
|
FASN12-P |
Anti-Mouse Fatty acid synthase (FASN) Control peptide |
100ug |
161 |
|
FERH13-A |
Anti-Human Ferritin (H-chain) IgG # 3, aff pure |
100 ug |
434 |
|
FERH13-C |
Human Ferritin (H-chain) recombinant protein WB +ve control |
100 ul |
258 |
|
FERH13-P |
Human Ferritin (H-chain) control/blocking peptide # 3 |
100 ug |
161 |
|
FERH13-S |
Anti-Human Ferritin (H-chain) antiserum # 3 |
100 ul |
369 |
|
FERH16-R |
Human Ferritin (H-chain) recombinant protein |
10 ug |
369 |
|
FERL14-A |
Anti-Human Ferritin (L-chain) IgG # 4, aff pure |
100 ug |
434 |
|
FERL14-C |
Human Ferritin (L-chain) recombinant protein WB +ve control |
100 ul |
258 |
|
FERL14-P |
Human Ferritin (L-chain) control/blocking peptide # 4 |
100 ug |
161 |
|
FERL14-S |
Anti-Human Ferritin (L-chain) antiserum # 4 |
100 ul |
369 |
|
FERL15-R |
Human Ferritin (L-chain) recombinant protein |
10 ug |
369 |
|
FERT11-C |
Human Spleen Ferritin protein Western blot +ve control |
100 ul |
258 |
|
FERT11-S |
Anti-Human Spleen Ferritin antiserum |
100 ul |
369 |
|
FERT12-C |
Human Liver Ferritin protein Western blot +ve control |
100 ul |
258 |
|
FERT12-M |
Monoclonal Anti-Human Liver Ferritin IgG, aff pure |
100 ug |
434 |
|
FERT13-C |
Horse Spleen Ferritin protein Western blot +ve control |
100 ul |
258 |
|
FERT14-R-100 |
Human Spleen Ferritin purified protein |
100 ug |
369 |
|
FERT16-C |
Human Heart Ferritin WB +ve protein control |
100 ul |
258 |
|
FERT16-R-50 |
Human Heart Ferritin purified |
50 ug |
369 |
|
FERT16-S |
Anti-Human Heart Ferritin antiserum |
100 ul |
369 |
|
FERT17-A |
Anti-Human Liver Ferritin IgG |
100 ug |
434 |
|
FERT17-C |
Human Liver Ferritin WB +ve protein control |
100 ul |
258 |
|
FERT17-R-100 |
Human Liver Ferritin purified |
100 ug |
239 |
|
FERT17-R-1000 |
Human Liver Ferritin purified |
1 mg |
694 |
|
FLAG12-C |
Recombinant purified FLAG tag-Protein (~9 kda) control WB +ve control |
100 ul |
258 |
|
FLAG15-R |
Recombinant purified FLAG tag-Protein (~9 kda) control for ELISA |
100 ug |
239 |
|
FLASH11-A |
Anti-Mouse FLASH (FLICE-associated huge' protein) IgG #1, aff. pure |
100 ug |
434 |
|
FLASH11-P |
Mouse FLASH (FLICE-associated huge' protein) Control/blocking peptide #1 |
100 ug |
161 |
|
FLASH11-S |
Anti-Mouse FLASH (FLICE-associated huge' protein) antiserum #1 |
100 ul |
369 |
|
FLASH12-A |
Anti-Human FLASH (FLICE-associated huge' protein) IgG #2, aff. pure |
100 ug |
434 |
|
FLASH12-P |
Human FLASH (FLICE-associated huge' protein) Control/blocking peptide #2 |
100 ug |
161 |
|
FLASH12-S |
Anti-Human FLASH (FLICE-associated huge' protein) antiserum #2 |
100 ul |
369 |
|
FLK11-A |
Anti-Mouse FLK-1/VEGFR-2 IgG #1, aff pure |
100 ug |
434 |
|
FLK11-P |
Mouse FLK-1/VEGFR-2 control/blocking peptide # 1 |
100 ug |
161 |
|
FLK13-MB |
Biotinylated-Mouse Monoclonal Anti-Human FLK-1/VEGFR-2 IgG # 3 |
100 ug |
434 |
|
FLT11-A |
Anti-human FLT-1/VEGFR-1 IgG #1, aff pure |
100 ul |
434 |
|
FLT11-P |
Human FLT-1/VEGFR-1 Control/blocking peptide #1 |
100 ug |
161 |
|
FLT12-M |
Mouse Monoclonal Anti-human FLT-1/VEGFR-1 IgG, aff pure |
100 ug |
434 |
|
FLT41-A |
Anti-Mouse FLT-4/VEGFR-3 IgG #1, aff pure |
100 ug |
434 |
|
FLT41-P |
Mouse FLT-4/VEGFR-3 Control/blocking peptide #1 |
100 ug |
161 |
|
FLT42-A |
Anti-Human FLT-4/VEGFR-3 IgG #2, aff pure |
100 ug |
434 |
|
FLT42-P |
Human FLT-4/VEGFR-3 control/blocking peptide #2 |
100 ug |
161 |
|
FOD11-A |
Anti-Human Fodrin-alpha (spectrin-alpha) IgG, aff pure |
100 ug |
434 |
|
FOD11-P |
Human Fodrin-alpha (spectrin-alpha) control/blocking peptide |
100 ug |
161 |
|
FOD11-S |
Anti-Human Fodrin-alpha (spectrin-alpha) antiserum |
100 ul |
369 |
|
FXN11-A |
Anti-Mouse Frataxin (FXN) IgG, Aff pure |
100 ug |
434 |
|
FXN11-P |
Mouse Frataxin (FXN) control peptide |
100 ug |
161 |
|
FXN11-S |
Anti-Mouse Frataxin (FXN) antiserum |
100 ul |
369 |
|
G3PDH11-C |
Purified Glyceraldehyde-3-Phosphate Dehydrogenase G3PDH (rabbit) protein
control for WB |
100 ul |
258 |
|
G3PDH11-M |
Monoclonal Anti-Glyceraldehyde-3-Phosphate Dehydrogenase GAPDH (rabbit)
IgG |
100 ug |
434 |
|
G3PDH12-S |
Anti-Rabbit muscle Glyceraldehyde-3-Phosphate Dehydrogenase G3PDH IgG #2 |
100 ul |
369 |
|
GAA11-A |
Anti-Human GABAa Receptor alpha 1 (GAA1) IgG #1, aff pure |
100 ug |
434 |
|
GAA11-P |
Human GABAa Receptor alpha 1 (GAA1) Control/blocking peptide #1 |
100 ug |
161 |
|
GAA11-S |
Anti-Human GABAa Receptor alpha 1 (GAA1) Antiserum #1 |
100 ul |
369 |
|
GAA12-A |
Anti-Rat GABAa Receptor alpha 1 (GAA1) IgG #2, aff pure |
100 ug |
434 |
|
GAA12-P |
Rat GABAa Receptor alpha 1 (GAA1) Control/blocking peptide #2 |
100 ug |
161 |
|
GAA12-S |
Anti-Rat GABAa Receptor alpha 1 (GAA1) Antiserum #2 |
100 ul |
369 |
|
GAA13-M |
Monoclonal anti-bovine GABAa Receptor alpha 1 (1-269aa) IgG #3, aff pure |
100 ug |
434 |
|
GAA14-A |
Anti-Human GABAa Receptor alpha 1 (166-269aa) IgG #1, aff pure |
100 ug |
434 |
|
GAA16-A |
Anti-Rat GABAa Receptor alpha 6 (GAA6) IgG, aff pure |
100 ug |
434 |
|
GAA16-P |
Rat GABAa Receptor alpha 6 (GAA6) Control/blocking peptide #1 |
100 ug |
161 |
|
GAA16-S |
Anti-Rat GABAa Receptor alpha 6 (GAA6) Antiserum |
100 ul |
369 |
|
GAA21-A |
Anti-Human GABAa Receptor alpha 2 (GAA2) IgG, aff. Pure |
100 ug |
434 |
|
GAA21-P |
Human GABAa Receptor alpha 2 (GAA2) Control/blocking peptide |
100 ug |
161 |
|
GAA31-A |
Anti-Human/Rat GABAa Receptor alpha 3 (GAA3) IgG, aff pure |
100 ug |
434 |
|
GAA31-P |
Human/Rat GABAa Receptor alpha 3 (GAA3) Control/blocking peptide #1 |
100 ug |
161 |
|
GAB21-A |
Anti-Rat GABAa Receptor beta 2 (GAB2) IgG #1, aff. pure |
100 ug |
434 |
|
GAB21-P |
Rat GABAa Receptor beta 2 (GAB2) Control/blocking peptide #1 |
100 ug |
161 |
|
GAB21-S |
Anti-Rat GABAa Receptor beta 2 (GAB2) Antiserum #1 |
100 ul |
369 |
|
GABA11-A |
Anti-Gamma Amino butyric acid (GABA) IgG, aff pure |
100 ug |
434 |
|
GABARAP11-A |
Anti-Human GABA Receptor Associated Protein (GABARAP) IgG #1, aff. pure |
100 ug |
434 |
|
GABARAP11-P |
Human GABA Receptor Associated Protein Control/blocking peptide #1 |
100 ug |
161 |
|
GABARAP11-S |
Anti-Human GABA Receptor Associated Protein (GABARAP) antiserum #1 |
100 ul |
369 |
|
GAD41-A |
Anti-Mouse/Rat GABAa Receptor delta (GABRD) IgG #1, aff. pure |
100 ug |
434 |
|
GAD41-P |
Mouse/Rat GABAa Receptor delta (GAD) Control/blocking peptide #1 |
100 ug |
161 |
|
GAD41-S |
Anti-Mouse/Rat GABAa Receptor delta (GAD) Antiserum #1 |
100 ul |
369 |
|
GAD6567-A |
Anti-Glutamic acid decarboxylase (GAD65/67) IgG #3 |
100 ug |
434 |
|
GAD6567-P |
Rat Glutamic acid decarboxylase (GAD6567) Control/blocking peptide #1 |
100 ug |
161 |
|
GAD65-M |
Monoclonal Anti-Rat Glutamic acid decarboxylase (GAD65) IgG # 1, aff
pure |
100 ul |
434 |
|
GAD65-P |
Rat Glutamic acid decarboxylase (GAD65) Control/blocking peptide # 1 |
100 ug |
161 |
|
GAD67-A |
Anti-Rat Glutamic acid decarboxylase (GAD67) IgG #1, aff pure |
100 ug |
434 |
|
GAD67-P |
Rat Glutamic acid decarboxylase (GAD67) Control/blocking peptide # 1 |
100 ug |
161 |
|
GAD67-S |
Anti-Rat Glutamic acid decarboxylase (GAD67) antiserum #1 |
100 ul |
369 |
|
GAG21-A |
Anti-rat/Human GABAa Receptor Gamma 2 (GAG2) IgG #1, aff. Pure |
100 ug |
434 |
|
GAG21-P |
Rat/Human GABAa Receptor Gamma 2 (GAG2) Control/blocking peptide #1 |
100 ug |
161 |
|
GAG21-S |
Anti-Rat/Human GABAa Receptor Gamma 2 (GAG2) Antiserum #1 |
100 ul |
369 |
|
GAG22-A |
Anti-Human GABAa Receptor Gamma 2 (189-299aa) IgG #2, aff. pure |
100 ug |
434 |
|
GAL51-A |
Anti-Human Galanin IgG # 1, aff. Pure |
100 ug |
434 |
|
GAL51-P |
Human Galanin Control/blocking peptide # 1 |
100 ug |
161 |
|
GAL51-S |
Anti-Human Galanin antiserum # 1 |
100 ul |
369 |
|
GAL61-P |
Human Galanin 1-30 aa full length |
1 mg |
291 |
|
GALR11-A |
Anti-Mouse Galanin Receptor 1 (GALR1) IgG # 1, aff. Pure |
100 ug |
434 |
|
GALR11-P |
Mouse Galanin Receptor 1 (GALR1) Control/blocking peptide # 1 |
100 ug |
161 |
|
GALR11-S |
Anti-Mouse Galanin Receptor 1 (GALR1) antiserum # 1 |
100 ul |
369 |
|
GALR21-A |
Anti-Mouse Galanin Receptor 2 (GALR2) IgG # 1, aff. Pure |
100 ug |
434 |
|
GALR21-P |
Mouse Galanin Receptor 2 (GALR2) Control/blocking peptide # 1 |
100 ug |
161 |
|
GALR21-S |
Anti-Mouse Galanin Receptor 2 (GALR2) antiserum # 1 |
100 ul |
369 |
|
GALR31-A |
Anti-Mouse Galanin Receptor 3 (GALR3) IgG # 1, aff. Pure |
100 ug |
434 |
|
GALR31-P |
Mouse Galanin Receptor 3 (GALR3) Control/blocking peptide # 1 |
100 ug |
161 |
|
GALR31-S |
Anti-Mouse Galanin Receptor 3 (GALR3) antiserum # 1 |
100 ul |
369 |
|
GAT11-A |
Anti-Rat GABA Transporter (GAT1) IgG #1, aff pure |
100 ug |
434 |
|
GAT11-P |
Rat GABA Transporter (GAT1) Control/blocking peptide #1 |
100 ug |
161 |
|
GAT11-S |
Anti-Rat GABA Transporter (GAT1) antiserum #1 |
100 ul |
369 |
|
GAT21-A |
Anti-Rat GABA Transporter (GAT2) IgG #1, aff pure |
100 ug |
434 |
|
GAT21-P |
Rat GABA Transporter (GAT2) Control/blocking peptide #1 |
100 ug |
161 |
|
GAT21-S |
Anti-Rat GABA Transporter (GAT2) antiserum #1 |
100 ul |
369 |
|
GAT31-A |
Anti-Rat GABA Transporter (GAT3) IgG #1, aff pure |
100 ug |
434 |
|
GAT31-P |
Rat GABA Transporter (GAT3) Control/blocking peptide #1 |
100 ug |
161 |
|
GAT31-S |
Anti-Rat GABA Transporter (GAT3) antiserum #1 |
100 ul |
369 |
|
GBR1A11-A |
Anti-Rat GABAb-R1a (GBR1a) IgG #1, aff pure |
100 ug |
434 |
|
GBR1A11-P |
Rat GABAb-R1a (GBR1a) Control/blocking peptide #1 |
100 ug |
161 |
|
GBR1A11-S |
Anti-Rat GABAb-R1a (GBR1a) Antiserum #1 |
100 ul |
369 |
|
GBR1B11-A |
Anti-Rat GABAb-R1b (GBR1b) IgG #1, aff pure |
100 ug |
434 |
|
GBR1B11-P |
Rat GABAb-R1b (GBR1b) Control/blocking peptide #1 |
100 ug |
161 |
|
GBR1B11-S |
Anti-Rat GABAb-R1b (GBR1b) Antiserum #1 |
100 ul |
369 |
|
GBR21-P |
Rat GABAb-R2 (GBR2) Control/blocking peptide #1 |
100 ug |
161 |
|
GBR22-A |
Anti-Rat GABAb-R2 (GBR2) IgG #2, aff pure |
100 ug |
434 |
|
GBR22-P |
Rat GABAb-R2 (GBR2) Control/blocking peptide #2 |
100 ug |
161 |
|
GBR22-S |
Anti-Rat GABAb-R2 (GBR2) Antiserum #2 |
100 ul |
369 |
|
GCSF11-A |
Anti-Mouse GCSF protein IgG, aff pure |
100 ug |
434 |
|
GCSF11-C |
Recombinant Mouse GCSF protein control for Western |
100 ul |
278 |
|
GCSF12-A |
Anti-Human GCSF protein IgG, aff pure |
100 ug |
434 |
|
GCSF12-C |
Recombinant Human GCSF protein control for Western |
100 ul |
278 |
|
GCSF13-M |
Monoclonal Anti-Mouse GCSF protein IgG, aff pure |
100 ug |
434 |
|
GCSF15-R |
Recombinant purified Mouse GCSF protein, active |
10 ug |
408 |
|
GCSF15-R |
Recombinant purified Human GCSF protein, active |
10 ug |
408 |
|
GCSFR14-C |
Human GCSF receptor protein control for Western |
100 ul |
278 |
|
GCSFR14-M |
Monoclonal Anti-Human GCSF receptor protein IgG, aff pure |
100 ug |
434 |
|
GCSFR25-R |
Recombinant Human GCSF receptor protein, active |
10 ug |
408 |
|
GDNF11-R-10 |
Recombinant Human Glial Derived Neurotrophic Factor (GDNF) |
10 ug |
538 |
|
GDNF11-R-2 |
Recombinant Human Glial Derived Neurotrophic Factor (GDNF) |
2 ug |
369 |
|
GELB11-N-10 |
Bovine skin gelatin, type B |
10 g |
109 |
|
GELB11-S |
Anti-Bovine gelatin antiserum |
100 ul |
369 |
|
GELF14-N-50 |
Fish gelatin |
50 ml |
109 |
|
GELF14-S |
Anti-Fish gelatin antiserum |
100 ul |
369 |
|
GELM13-N-10 |
Moss (Seaweeds Plant) gelatin (type A) |
10 g |
109 |
|
GELM13-S |
Anti-Moss (Seaweeds Plant) gelatin antiserum |
100 ul |
369 |
|
GELP12-N-10 |
Porcine skin gelatin (type A) |
10 g |
109 |
|
GELP12-S |
Anti-Porcine gelatin antiserum |
100 ul |
369 |
|
GFP11-A |
Anti-Green Fluorescent Proteins (GFP) protein, IgG |
100 ug |
369 |
|
GFP11-AP |
Anti-Green Fluorescent Proteins (GFP) protein IgG-Alk Phos (AP)
conjugate |
100 ug |
369 |
|
GFP11-BTN |
Anti-Green Fluorescent Proteins (GFP) protein IgG-Biotin conjugate |
100 ug |
408 |
|
GFP11-C |
Green Fluorescent Proteins (GFP) protein for WB control |
100 ul |
258 |
|
GFP11-FITC |
Anti-Green Fluorescent Proteins (GFP) protein IgG-FITC conjugate |
100 ug |
369 |
|
GFP11-HRP |
Anti-Green Fluorescent Proteins (GFP) protein IgG-HRP conjugate |
100 ug |
369 |
|
GFP12-M |
Monoclonal Anti-Green Fluorescent Proteins (GFP) IgG |
100 ug |
434 |
|
GFP15-R |
Green Fluorescent Proteins (GFP) protein for ELISA or Standards |
10 ug |
265 |
|
GFP15-R-100 |
Green Fluorescent Proteins (GFP) protein for ELISA or Standards |
100 ug |
1.084 |
|
GHS11-A |
Anti-Human Ghrelin IgG # 1, aff pure |
100 ug |
434 |
|
GHS11-P |
Human Ghrelin control/blocking peptide # 1 |
100 ug |
161 |
|
GHS11-S |
Anti-Human Ghrelin antiserum # 1 |
100 ul |
369 |
|
GHS12-A |
Anti-Human Ghrelin IgG # 2, aff pure |
100 ug |
434 |
|
GHS12-P |
Human Ghrelin control/blocking peptide # 2 |
100 ug |
161 |
|
GHS12-S |
Anti-Human Ghrelin antiserum # 2 |
100 ul |
369 |
|
GHS13-M |
Monoclonal Anti-Human Ghrelin IgG # 3, aff pure |
100 ug |
434 |
|
GHS41-P |
Purified Rat ghrelin (28 aa, Ser3 acylated) |
100 ug |
239 |
|
GHS45-P |
Purified Rat ghrelin (28 aa, Ser3 not acylated) |
100 ug |
239 |
|
GHS50-P |
Purified Human ghrelin (28 aa, Ser3 acylated) |
1 mg |
694 |
|
GHS51-P |
Purified Human ghrelin (28 aa, Ser3 acylated) |
100 ug |
239 |
|
GHS52-P |
Purified Human ghrelin (28 aa, Ser3 NOT acylated) |
1 mg |
564 |
|
GHS53-P |
Purified Human ghrelin (28 aa, Ser3 NOT acylated) |
100 ug |
174 |
|
GHS60-P |
Purified human des-ghrelin (27 aa, Ser3 acylated) |
1 mg |
694 |
|
GHS61-P |
Purified human des-ghrelin (27 aa, Ser3 acylated) |
100 ug |
239 |
|
GHS62-P |
Purified human des-ghrelin (27 aa, Ser3 NOT acylated) |
1 mg |
564 |
|
GHS63-P |
Purified human des-ghrelin (27 aa, Ser3 NOT acylated) |
100 ug |
174 |
|
GHSR11-A |
Anti-Rat ghrelin receptor (GHS-R) IgG # 1, aff pure |
100 ug |
434 |
|
GHSR11-P |
Rat ghrelin receptor (GHS-R) Control/blocking peptide # 1 |
100 ug |
161 |
|
GHSR11-S |
Anti-Rat ghrelin receptor (GHS-R) antiserum # 1 |
100 ul |
369 |
|
GIP71-A |
Anti-human Gastric inhibitory peptide (GIP) IgG #1, aff pure |
100 ug |
434 |
|
GIP71-P |
Human Gastric inhibitory peptide (GIP) Control/blocking peptide #1 |
100 ug |
161 |
|
GIP75-P |
Human Gastric inhibitory peptide (GIP) full length peptide (42 aa) |
500 ug |
304 |
|
GKRP11-A |
Anti-Mouse glucokinase regulatory protein (GKRP/GCKR) IgG, aff pure |
100 ug |
434 |
|
GKRP11-P |
Mouse glucokinase regulatory protein (GKRP/GCKR) control/blocking
peptide |
100 ug |
161 |
|
GLAST11-A |
Anti-Rat Glutamate Transporter (GLAST/EAAT1) IgG #1, aff pure |
100 ug |
434 |
|
GLAST11-P |
Rat Glutamate Transporter (GLAST/EAAT1) Control/blocking peptide #1 |
100 ug |
161 |
|
GLAST11-S |
Anti-Rat Glutamate Transporter (GLAST/EAAT1) antiserum #1 |
100 ul |
369 |
|
GLGN11-A |
Anti-human Glucagon (GLGN) IgG #1, aff pure |
100 ug |
434 |
|
GLGN11-P |
Human Glucagon (GLGN) Control/blocking peptide #1 |
100 ug |
161 |
|
GLM22-M |
Monoclonal Anti-Glutamate antibody #2, Neat ascites |
100 ul |
434 |
|
GLM23-A |
Anti-Glutamate IgG, aff pure |
100 ug |
434 |
|
GLM23-N-100 |
Glutamate-BSA Protein conjugate (blocking antigen) |
100 ug |
265 |
|
GLN55-A |
Anti-Glutamine IgG, aff pure |
100 ug |
434 |
|
GLN55-N-100 |
Glutamine-BSA Protein conjugate (blocking antigen) |
100 ug |
265 |
|
GLP15-A |
Anti-human Glucagon like peptide 1 (GLP1) IgG #1, aff pure |
100 ug |
434 |
|
GLP15-P |
Human Glucagon like peptide 1(GLP1) Control/blocking peptide #1 |
100 ug |
161 |
|
GLP16-P-500 |
Human Glucagon like peptide 1 (1-36) amide |
500 ug |
343 |
|
GLP17-P-500 |
Human Glucagon like peptide 1 (7-36) amide |
500 ug |
304 |
|
GLP18-P-500 |
Human Glucagon like peptide 1, (Ser8, 7-36) amide |
500 ug |
369 |
|
GLP19-P-500 |
Human Glucagon like peptide 1 (7-37) |
500 ug |
304 |
|
GLP1R11-A |
Anti-mouse Glucagon like peptide 1 receptor (GLP1R) IgG #1, aff pure |
100 ug |
434 |
|
GLP1R11-P |
Mouse Glucagon like peptide 1 receptor (GLP1R) Control/blocking peptide
#1 |
100 ug |
161 |
|
GLP20-P-500 |
Human Glucagon like peptide 1 (1-37) |
500 ug |
304 |
|
GLP25-A |
Anti-human Glucagon like peptide 2 (GLP2) IgG #1, aff pure |
100 ug |
434 |
|
GLP25-P |
Human Glucagon like peptide 2 (GLP2) Control/blocking peptide #1 |
100 ug |
161 |
|
GLP26-P-500 |
Human Glucagon like peptide 2, (1-33) amide |
500 ug |
343 |
|
GLP27-P-500 |
Rat Glucagon like peptide 2, (1-33) amide |
500 ug |
343 |
|
GLP2R11-A |
Anti-human Glucagon like peptide 2 receptor(GLP2R) IgG #1, aff pure |
100 ug |
434 |
|
GLP2R11-P |
Human Glucagon like peptide 2 receptor (GLP2R) Control/blocking peptide
#1 |
100 ug |
161 |
|
GLP2R12-A |
Anti-human Glucagon like peptide 2 receptor(GLP2R) IgG #2, aff pure |
100 ug |
434 |
|
GLP2R12-P |
Human Glucagon like peptide 2 receptor (GLP2R) Control/blocking peptide
#2 |
100 ug |
161 |
|
GLP2R13-A |
Anti-human Glucagon like peptide 2 receptor(GLP2R) IgG #3, aff pure |
100 ug |
434 |
|
GLP2R13-P |
Human Glucagon like peptide 2 receptor (GLP2R) Control/blocking peptide
#3 |
100 ug |
161 |
|
GLT11-A |
Anti-Rat Glutamate Transporter (GLT1/EAAT2) IgG #1, aff pure |
100 ug |
434 |
|
GLT11-P |
Rat Glutamate Transporter (GLT1/EAAT2) Control/blocking peptide #1 |
100 ug |
161 |
|
GLT11-S |
Anti-Rat Glutamate Transporter (GLT1/EAAT2) antiserum #1 |
100 ul |
369 |
|
GLTN11-S |
Anti-Wheat Gluten antiserum |
100 ul |
369 |
|
GLYC52-A |
Anti-Glycine IgG, aff pure |
100 ug |
434 |
|
GLYC52-N-100 |
Glycine-BSA Protein conjugate (blocking antigen) |
100 ug |
265 |
|
GLYT11-A |
Anti-Rat Glycine Transporter 1 (GLYT1) IgG #1, aff pure |
100 ug |
434 |
|
GLYT11-P |
Rat Glycine Transporter 1 (GLYT1) Control/blocking peptide #1 |
100 ug |
161 |
|
GLYT11-S |
Anti-Rat Glycine Transporter 1 (GLYT1) antiserum #1 |
100 ul |
369 |
|
GLYT12-P |
Rat Glycine Transporter 1 (GLYT1) Control/blocking peptide # 2 |
100 ug |
161 |
|
GLYT12-S |
Anti-Rat Glycine Transporter 1 (GLYT1) antiserum # 2 |
100 ul |
369 |
|
GLYT21-A |
Anti-Rat Glycine Transporter 2 (GLYT2) IgG #1, aff pure |
100 ug |
434 |
|
GLYT21-P |
Rat Glycine Transporter 2 (GLYT2) Control/blocking peptide #1 |
100 ug |
161 |
|
GLYT21-S |
Anti-Rat Glycine Transporter 2 (GLYT2) antiserum #1 |
100 ul |
369 |
|
GLYT22-P |
Rat Glycine Transporter 2 (GLYT2) Control/blocking peptide #2 |
100 ug |
161 |
|
GLYT22-S |
Anti-Rat Glycine Transporter 2 (GLYT2) antiserum #2 |
100 ul |
369 |
|
GPR14-A |
Anti-Rat Urotensin 2 Receptor (GPR14) IgG # 1, aff pure |
100 ug |
434 |
|
GPR14-P |
Rat Urotensin 2 Receptor (GPR14) Control/blocking peptide #1 |
100 ug |
161 |
|
GPR14-S |
Anti-Rat Urotensin 2 Receptor (GPR14) antiserum # 1 |
100 ul |
369 |
|
GPR391-A |
Anti-Mouse GPR39 IgG #1 aff pure |
100 ug |
434 |
|
GPR391-P |
Mouse GPR39 control antigen peptide #1 |
100 ug |
161 |
|
GPR391-S |
Anti-Mouse GPR39 peptide (NT) antiserum #1 |
100 ul |
369 |
|
GPR392-A |
Anti-Human GPR39 peptide IgG #2 aff pure |
100 ug |
434 |
|
GPR392-P |
Human GPR39 control antigen peptide #2 |
100 ug |
161 |
|
GPR392-S |
Anti-Human GPR39 peptide (NT) antiserum #2 |
100 ul |
369 |
|
GPX11-A |
Anti-human Glutathione Peroxidase (GPX) IgG |
100 ul |
434 |
|
GPX11-C |
Purified human erythrocyte Glutathione Peroxidase (GPX) protein control
for WB |
100 ul |
258 |
|
GRB14-P |
Rat Grb14 (Growth receptor bound protein 14) Control/blocking peptide #1 |
100 ug |
161 |
|
GRB14-S |
Anti-Rat Grb14 (Growth receptor bound protein 14) Antiserum #1 |
100 ul |
369 |
|
GRF11-A |
Anti-human Growth Hormone-releasing factor (GRF) IgG #1, aff pure |
100 ug |
434 |
|
GRF11-P |
Human Growth Hormone-releasing factor (GRF) Control/blocking peptide #1 |
100 ug |
161 |
|
GRF12-A |
Anti-rat Growth Hormone-releasing factor (GRF) IgG #2, aff pure |
100 ug |
434 |
|
GRF12-P |
Rat Growth Hormone-releasing factor (GRF) Control/blocking peptide #2 |
100 ug |
161 |
|
GSH11-A |
Anti-Glutathione IgG |
100 ul |
434 |
|
GSH12-M |
Anti-Glutathione IgG |
100 ul |
434 |
|
GSH15-N-100 |
Anti-Glutathione-Ovalbumin conjugate for ELISA |
100 ug |
278 |
|
GSSH15-AS |
Glutathione-Agarose (Aff matrix) |
1 ml |
239 |
|
GST11-A |
Anti-Glutathione Transferase (GST, E. coli) IgG# 1, aff pure |
100 ug |
434 |
|
GST11-AP |
Anti-Glutathione Transferase (GST, E. coli) IgG-AP conjugate |
100 ul |
434 |
|
GST11-C |
Recombinant purified Glutathione Transferase, GST (E. coli), WB +ve
control |
100 ul |
258 |
|
GST11-R |
Purified Recombinant Glutathione Transferase (E. coli) protein |
100 ug |
369 |
|
GST11-S |
Anti-Glutathione Transferase, GST (E. coli) antiserum # 1 |
100 ul |
369 |
|
GST12-C |
Recombinant purified Glutathione Transferase (GST)-Protein (~27 kda)
control WB +ve control |
100 ul |
258 |
|
GST12-M |
Monoclonal Anti-Glutathione Transferase, GST (E. coli), ascites |
100 ul |
434 |
|
GST13-A |
Anti-Glutathione Transferase (GST, S. japonicum) IgG# 3 |
1 mg |
369 |
|
GST13-AS |
Anti-Glutathione Transferase (GST, S. japonicum) IgG-Agarose (Aff
matrix) |
0.5 ml |
369 |
|
GST13-BTN |
Anti-Glutathione Transferase (GST, S. japonicum) IgG-Biotin Conjugate |
100 ul |
408 |
|
GST13-FITC |
Anti-Glutathione Transferase (GST, S. japonicum) IgG-FITC Conjugate |
100 ul |
369 |
|
GST13-HRP |
Anti-Glutathione Transferase (GST, S. japonicum) IgG-HRP Conjugate |
100 ul |
369 |
|
GST13-R |
Purified Recombinant Glutathione Transferase-His(x6) tag (GST-His)
protein |
50 ug |
278 |
|
GST14-R |
Purified Recombinant Glutathione Transferase-Ubiquitin fusion (GST-Ub)
protein |
100 ug |
369 |
|
GST15R-AS |
Glutathione Transferase (GST) Protein-Agarose (Aff matrix) |
0.50 ml |
369 |
|
GST16-BTN |
Monoclonal Anti-Glutathione Transferase (GST, E. coli) IgG-Biotinylated |
50 ug |
434 |
|
GST16-M |
Monoclonal Anti-Glutathione Transferase (GST, E. coli) IgG#2, purifed |
100 ug |
434 |
|
GSTA11-S |
Anti-Rat Glutathione Transferase alpha (GST-alpha) antiserum |
100 ul |
369 |
|
GSTA12-C |
Recombinant purified human GST-alpha (GST-A1) protein WB +ve control |
100 ul |
258 |
|
GSTA12-S |
Anti-Human Glutathione Transferase alpha (GST-alpha) antiserum |
100 ul |
369 |
|
GSTA15-R-100 |
Recombinant purified human GST-alpha (GST-A1) protein biologically
active |
100 ug |
889 |
|
GSTA15-R-25 |
Recombinant purified human GST-alpha (GST-A1) protein biologically
active |
25 ug |
369 |
|
GSTM11-C |
Purified rat liver GST-mu (GST-M1) protein WB +ve control |
100 ul |
258 |
|
GSTM11-S |
Anti-Rat Glutathione Transferase mu (GST-mu) antiserum |
100 ul |
369 |
|
GSTM12-C |
Recombinant purified human GST-mu (GST-M1) protein WB +ve control |
100 ul |
258 |
|
GSTM12-S |
Anti-Human Glutathione Transferase mu (GST-mu) antiserum |
100 ul |
369 |
|
GSTM25-R-100 |
Recombinant purified human GST-mu (GST-M1) protein biologically active |
100 ug |
889 |
|
GSTM25-R-25 |
Recombinant purified human GST-mu (GST-M1) protein biologically active |
25 ug |
369 |
|
GSTP11-C |
Purified rat GST-pi (GST-P1) protein WB +ve control |
100 ul |
258 |
|
GSTP11-S |
Anti-Rat Glutathione Transferees pi (GST-pi) antiserum |
100 ul |
369 |
|
GSTP12-C |
Recombinant purified human GST-pi (GST-P1) protein WB +ve control |
100 ul |
258 |
|
GSTP12-S |
Anti-Human Glutathione Transferase Pi (GST-pi) antiserum |
100 ul |
369 |
|
GSTP35-R-100 |
Recombinant purified human GST-pi (GST-P1) protein biologically active |
100 ug |
889 |
|
GSTP35-R-25 |
Recombinant purified human GST-pi (GST-P1) protein biologically active |
25 ug |
369 |
|
GT101-A |
Anti-Human Glucose Transp. 10 (Glut-10) IgG # 1, aff pure |
100 ug |
434 |
|
GT101-P |
Human Glucose Transp. 10 (Glut-10) Control/blocking peptide # 1 |
100 ug |
161 |
|
GT101-S |
Anti-Human Glucose Transp. 10 (Glut-10) antiserum # 1 |
100 ul |
369 |
|
GT111-A |
Anti-Human Glucose Transp. 11 (Glut-11) IgG # 1, aff pure |
100 ug |
434 |
|
GT111-P |
Human Glucose Transp. 11 (Glut-11) Control/blocking peptide # 1 |
100 ug |
161 |
|
GT111-S |
Anti-Human Glucose 11 (Glut-11) antiserum # 1 |
100 ul |
369 |
|
GT11-A |
Anti-Mouse Glucose Transp. 1 (Glut-1) IgG # 1, aff. pure |
100 ug |
434 |
|
GT11-P |
Mouse Glucose Transp. 1 (Glut-1) Control/blocking peptide # 1 |
100 ug |
161 |
|
GT11-S |
Anti-Mouse Glucose Transp. 1 (Glut-1) antiserum # 1 |
100 ul |
369 |
|
GT122-A |
Anti-Human Glucose Transp. 12 (Glut-12) IgG # 1, aff pure |
100 ug |
434 |
|
GT122-P |
Human Glucose Transp. 12 (Glut-12) Control/blocking peptide # 1 |
100 ug |
161 |
|
GT122-S |
Anti-Human Glucose Transp. 12 (Glut-12) antiserum # 1 |
100 ul |
369 |
|
GT12-A |
Anti-Human Glucose Transp. 1 (Glut-1) IgG # 2, aff pure |
100 ug |
434 |
|
GT12-P |
Human Glucose Transp. 1 (Glut-1) Control/blocking peptide # 2 |
100 ug |
161 |
|
GT12-S |
Anti-Human Glucose Transp. 1 (Glut-1) antiserum # 2 |
100 ul |
369 |
|
GT132-A |
Anti-Human Glucose Transp. 13 (Glut-13/HMIT) IgG # 1, aff pure |
100 ug |
434 |
|
GT132-P |
Human Glucose Transp. 13 (Glut-13/HMIT) Control/blocking peptide # 1 |
100 ug |
161 |
|
GT132-S |
Anti-Human Glucose Transp. 13 (Glut-13/HMIT) antiserum # 1 |
100 ul |
369 |
|
GT13-A |
Anti-Human Glucose Transp. 1 (Glut-1) IgG # 3, aff pure |
100 ug |
434 |
|
GT13-P |
Human Glucose Transp. 1 (Glut-1) Control/blocking peptide # 3 |
100 ug |
161 |
|
GT13-S |
Anti-Human Glucose Transp. 1 (Glut-1) antiserum # 3 |
100 ul |
369 |
|
GT14-A |
Anti-Human Glucose Transp. 1 (Glut-1) IgG # 1, aff pure |
100 ug |
434 |
|
GT14-P |
Human Glucose Transp. 1 (Glut-1) Control/blocking peptide # 1 |
100 ug |
161 |
|
GT15-M |
Mouse monoclonal Anti-Human Glucose Transp. 1 protein (Glut-1) IgG # 5 |
100 ug |
434 |
|
GT21-A |
Anti-Rat Glucose Transp. 2 (Glut-2) IgG # 1, aff pure |
100 ug |
434 |
|
GT21-P |
Rat Glucose Transp. 2 (Glut-2) Control/blocking peptide # 1 |
100 ug |
161 |
|
GT21-S |
Anti-Rat Glucose Transp. 2 (Glut-2) antiserum # 1 |
100 ul |
369 |
|
GT22-A |
Anti-Human Glucose Transp. 2 (Glut-2) IgG # 2, aff pure |
100 ug |
434 |
|
GT22-P |
Human Glucose Transp. 2 (Glut-2) Control/blocking peptide # 2 |
100 ug |
161 |
|
GT22-S |
Anti-Human Glucose Transp. 2 (Glut-2) antiserum # 2 |
100 ul |
369 |
|
GT23-M |
Mouse monoclonal Anti-Human Glucose Transp. 2 protein (Glut-2) IgG # 3 |
100 ug |
434 |
|
GT24-M |
Rat monoclonal Anti-Mouse Glucose Transp. 2 protein (Glut-2) IgG # 4 |
100 ug |
434 |
|
GT31-A |
Anti-Mouse Glucose Transp. 3 (Glut-3) IgG # 1, aff pure |
100 ug |
434 |
|
GT31-P |
Mouse Glucose Transp. 3 (Glut-3) Control/blocking peptide # 1 |
+32 1658 9045
+32 1650 9045
